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Abstract 
Human C4b-binding protein (C4BP) protects host tissue, and those pathogens able to hijack 
this plasma glycoprotein, from complement-mediated destruction. For example, C4131? 
localises to apoptotic and necrotic cells, via its affinity for DNA, whereupon this regulator 
helps to prevent complement activation and subsequent inflammation and tissue damage. 
The first two CCP modules of the C413P a-chain, plus the four residues connecting them, are 
necessary and sufficient for binding a bacterial virulence factor, the Streptococcus pyogenes 
M4 (Arp4) protein. Structure determination of this region of C413P by NMR reveals two 
tightly coupled CCP modules in an elongated arrangement. Chemical shift perturbation 
studies demonstrate that the N-terminal, hyper-variable, region of M4 binds to a site 
including strand 1 of CCP module 2. This interaction is accompanied by an intermodular 
reorientation within C413P. The DNA-binding site of C4BP also involves CCP 1 and CCP2 of 
the a-chain. Chemical shift changes locate the binding site for DNA to a groove at the 
CCP1/2 interface enabling the use of data-driven docking to produce a model of the 
C4BP12:DNA complex. The work described in this thesis thus provides detailed pictures of 
interactions whereby a pathogen evades complement and that help protect host tissue during 
programmed cell death. 
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Chapter 1 
INTRODUCTION: THE COMPLEMENT SYSTEM AND THE 
REGULATORS OF COMPLEMENT ACTIVATION 
CHAPTER 1- INTRODUCTION 
1.1 Overview 
The complement system is a key molecular component of innate immunity. It consists of 
more than thirty proteins that participate in a well co-ordinated series of specific protein-
protein recognition and catalytic events accompanied by the formation and destruction of 
multi-protein complexes. The complement system is potentially destructive to the host 
organism and is thus tightly regulated. Several •inhibitors, known as the regulators of 
complement activation (RCA) family, are particularly important in the early stages of the 
complement cascade. The majority of RCA proteins act on the bimolecular C3 convertases 
that are the crucial enzymatic complexes of both the classical and alternative pathways of 
complement activation. The C3 convertase of the classical and lectin pathways is C4bC2a 
and this is regulated by C4b-binding protein (C4BP) which competes with C2 for binding to 
C4b and acts a co-factor for the factor I mediated èleavage of C4b (Fujita et al. 1978; Fujita 
etal. 1979); it also accelerates the decay of the C4bC2a complex (Gigli etal. 1979). 
Like many members of the RCA family, C4131? is a target of several major pathogenic 
bacteria. This was first shown for Streptococcus pyogenes which expresses surface M 
proteins that in many strains have the ability to bind C4131? (Them et al. 1995). More 
recently, C4131? has been shown to bind to all strains of Bordetelia pertussis (Berggârd et al. 
2001 b), some strains of Neisseria gonorrhoeae (Ram et al. 200 1) and Neisseria meningitidis 
(Jarva et al. 2005), Escherichia coil (Prasadarao et al. 2002; Wooster et al. 2006), Candida 
a/b icans (Meri et al. 2004) and Moraxeiia catarrhalis (Nordstrom et al. 2004). Binding of 
this potent inhibitor of complement activation has been-shown to contribute to bacterial 
virulence (Carlsson et al. 2003). 
Unlike in the case of all other RCA proteins, until now there has been no detailed 
experimental 3D structural information for C4BP. Hence the atomic resolution basis of its 
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interactions with pathogen-borne and natural ligands has remained unknown. Opportunities 
for rational design of therapeutic interventions - e.g. to counter streptococcal infections, or 
to inhibit complement-mediated inflammation - have consequently been limited. 
The work described in this thesis focuses on the structural details of the interaction between 
C4131? and Streptococcus pyogenes M proteins. In this chapter an overview of the 
complement system and the role of C4131? in complement regulation is described. A 
discussion of the pathogens that 'hijack' C413  to evade the complement system follows, 
with emphasis on the S. pyogenes M proteins. 
1.2 The complement system 
Complement was first described in the 1890s as a heat labile serum protein that 
'complemented' antibodies in the destruction of bacteria. The complement system is now 
known to consist of over thirty proteins that undergo a series of specific protein-protein 
recognition and enzymatic cleavage events (Figure 1.1). The first major outcome of attack 
by the complement system is the deposition of C3b on the surface of unprotected particles 
such as an invading microorganism. This process, known as opsonisation, marks the particle 
as a target for phagocytosis by cells such as macrophages and neutrophils. These cells are 
attracted to the site of infection by the chemoattractant properties of the anaphylotoxins C3a 
and C5a, which are the products of C3 and C5 cleavage respectively. Further fragmentation 
of C3b generates C3d (and C3dg) which stimulate antibody production by B-cells. C3b also 
nucleates assembly of further C3 convertase complexes, driving the progression of the 
cascade towards the assembly of the membrane attack complex (MAC) - a multi-component, 
membrane-spanning pore that punches holes in the outer membranes of invading 
microorganisms leading to lysis. 
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Figure 1.1 The complement system 
1.2.1 The role of complement in disease 
The complement system plays an important role in the pathogenesis of many diseases. Much 
of the understanding of the role of complement in disease has come from study of patients 
with inherited deficiencies of individual complement proteins (Colten et al. 1992). There are 
three types of disease linked with complement deficiencies: infectious diseases, systemic 
lupus erythematosus (SLE)-like diseases and Cl inhibitor deficiency-linked diseases. 
The role of complement in infection is illustrated by the increased susceptibility to pyogenic 
infections caused by complement deficiency. Three types of infection are observed. Firstly, 
increased susceptibility to pyogenic bacteria such as Streptococcus pyogenes occurs in 
4 
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patients with defects in either the C3 gene or in the control proteins factor I and factor H, 
deficiency of which leads to unregulated C3 consumption. This demonstrates that the normal 
pathway of defence against pyogenic bacteria is opsonisation with antibody, followed by 
complement activation, opsonisation with the covalently-bound cleavage products of C3 - 
C3b and i0b, phagocytosis and intracellular killing. Secondly, deficiencies of the 
components of the MAC lead to infections with Neisseria demonstrating that complement-
mediated lysis is critical for host defence against neisserial infection (Figueroa et al. 1993). 
Thirdly, recurrent pyogenic infections associated with mannose binding lectin (MBL) 
deficiency in young children suggest that the MBL pathway is important during the interval 
between the loss of passively acquired maternal antibody and the development of a mature 
immunologic repertoire (Summerfield et al. 1997). 
SLE-like diseases are linked to deficiencies of the classical pathway components Clq, Cir, 
Cis, C4 and C2. These diseases are thought to illustrate the role of complement in the 
clearance of immune complexes and apoptotic cells (Botto et al. 1998). 
In the autosomal dominant disease of Cl inhibitor deficiency, the single normal allele of the 
C  inhibitor gene cannot ensure sufficient production of C  inhibitor (Agostoni et al. 1992). 
This leads to loss of control of the activation of the complement serine esterases Cir and 
Cl s, kallikrein of the kinin system and activated factors XI and XII of the coagulation 
system. The main clinical feature of Cl inhibitor deficiency is recurrent angioedema 
(swelling of the deep layers of the skin or mucous membranes) which may cause severe 
illness if it affects the intestinal submucosa or death by suffocation through obstruction of 
the upper airways. 
5 
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1.2.2 The classical pathway 
The complement system is activated by one of three routes: the classical, lectin or alternative 
pathways (Figure 1.1). All three pathways converge on the central step of C3 activation 
through their respective C3 convertases, C4b2a (classical and lectin) and C3bBb 
(alternative), but differ in the method of recognition of the invading particle. The recognition 
event in the classical pathway is the binding of Cl q to either IgG or 1gM in immune 
complexes resulting from recognition of the invading particle by the adaptive immune 
system or natural 1gM antibodies. Clq circulates in blood bound to the two serine proteases 
Cir and Cis in the Cl complex (Clqr2 s2) (Arlaud et al. 2002). Upon binding of the 
recognition component of Clq to the Fc subunit of an immunoglobulin the serine protease 
Cir is auto-activated and cleaves and activates Cis (Arlaud et al. 1993). Activated Cis 
translates the activation of the Cl complex into activation of the classical pathway by 
cleaving C2 and C4 to C2a and C4b respectively (releasing C2b and C4a) which together 
form the C3 convertase of the classical pathway - C4b2a (Arlaud et al. 1998). 
1.2.3 The lectin pathway 
The recognition event in the lectin pathway is mediated by the binding of either mannose 
binding lectin (MBL) (Presanis et al. 2003) or ficolin (Matsushita et al. 2000), associated 
with the mannose associated serine proteases (MASPs) MASP1 and MASP2, to specific 
patterns of carbohydrate groups on the surface of a bacterial cell. This leads to the cleavage 
of C2 and C4 by MASP2 leading to formation of the same C3 convertase (C4b2a) as in the 
classical pathway. MASP1 is also able to cleave C3 directly (Matsushita et al. 1995). 
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1.2.4 The alternative pathway 
In contrast to the specific recognition events leading to activation of the classical and lectin 
pathways, the alternative pathway is constantly activated at a low 'tick over' level by the 
hydrolysis of C3 to C3(H2 0) - also known as C3i - which binds to factor B. Once factor B is 
cleaved and activated by factor D the C3iBb compex cleaves C3 to form C3b which then 
binds randomly via a thioester bond to any nearby host or bacterial surface. Factor B then 
binds to surface bound C3b and is cleaved to the active form Bb by factor D resulting in the 
formation of the C3 convertase of the alternative pathway - C3bBb. This activates an 
amplification loop resulting in deposition of many molecules of C3b on the surface 
surrounding the region of complement activation. 
1.3 The regulators of complement activation 
The C3 convertases represent, therefore, a crucial step in the complement system and it is at 
this point that many of the regulators of complement activation act. The serine proteases of 
the classical and alternative pathway C3 convertases - C2 and factor B, respectively - are 
only active when cleaved by proteolysis and transiently complexed to C4b or C3b. There is 
no natural inhibitor of the C3 convertases but the activity of the C4b2a and C3bBb 
complexes is regulated in other ways. Firstly, the complexes are unstable and dissociate with 
a half-life of a few minutes. Secondly, the human complement regulatory proteins C413P, 
factor H (fH), decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, 
CD46) and complement regulator type 1 (CR1, CD35) interact with the complexes and 
promote dissociation - a process termed decay acceleration. Once C2a or Bb dissociates they 
do not reassociate with C4b or C3b. Thirdly, C4BP, fF1, MCP or CR1 bind to the C4b or C3b 
subunits of the convertase and promote their cleavage by factor I to C4c plus C4d or i0b 
respectively - a process termed (factor I) cofactor activity. 
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The properties of the human RCA proteins C4BP, factor H, DAF, MCP, CR1 and CR2 are 
summarised in Table 1.1. CR2 has neither decay accelerating nor cofactor activity but acts as 
the receptor for C3d and i0b and thus enhances the humoral immune response of B 
lymphocytes (Molina et al. 1996) and follicular dendritic cells (Fang et al. 1998). Factor H-
like protein 1 (FHL-1), a splice variant of ff1 containing the N-terminal seven CCP modules 
and a C-terminal extension of four residues (Zipfel et al. 1999) also acts as a complement 

















C4BP 570 a-chain: 
7* 
13-chain: 3 
C4bt X X (Scharfstein etal. 
 1978) 
FH —155 20 C3b X X (Sim etal. 1982) 
FHL-1 43 7 C3b X X (Misasi etal. 1989) 





MCP -65/55 k 4 C3b/C4b  X (Seyaetal. 1986) 
CR1 -.250 30 C3b/C4b X X (Fearon 1979) 
CR2 145 15 iC3IC3dIC3dg  (Weis etal. 1988) 
Table 1.1 Members of the RCA family. Notes: * Most common isoform in human plasma; t 
Also binds C3b in vitro; 1 Also accelerates decay of CS convertase; § Two forms found in 
plasma. 
1.3.1 The complement control protein module 
The proteins involved in the complement system are often 'mosaic' in nature, built up from a 
mixture of module (domain) types (Bork et al. 1996). Each module type is defined by a 
specific consensus sequence. The most common protein motif found in the RCA family is 
the complement control protein (CCP) module - also referred to as a short consensus repeat 
(SCR) or sushi domain. Of the RCA proteins two - factor H and the viral homologues 
produced by pox virii such as vaccinia virus complement control protein (VCP) - are 
composed entirely of multiple CCP modules (Reid et al. 1989), the remaining five - C4BP, 
MCP, DAF, CR1 and CR2— are composed almost entirely of CCP modules (Table 1.1). 
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In 1990 a single CCP module - the 16th module of factor H (f}I-16) - was expressed in 
Saccharomyces cerevisiae and studied by two-dimensional homonuclear NMR (Barlow et 
al. 1991) This confirmed the presence of p3-strands as predicted by circular dichroism (Sim et 
al. 1982) and Fourier transform-infrared spectroscopy (FT-IR) (Perkins et al. 1988). 
Subsequently the three-dimensional (313) solution structure of fH-16 was solved (Norman et 
al. 1991) - the first of any CCP module. This structure (Figure 1.2) showed that fH-16 is 
based on a fl-sandwich arrangement with one fl-sheet composed of three strands and the 
other of two. As the last strand is composed of two segments separated by a fl-bulge this may 
be regarded as two separate strands (as shown in Figure 1.2). A hydrophobic core is formed 
from side chains from both sheets and the whole arrangement is stabilised by two disulphide 
bonds between the four consensus cysteines in a 1-3, 2-4 arrangement. Overall the module 
has an elongated shape with the N- and C-termini at opposite ends of the long axis. The two 
disulphides lie far apart, forming the boundaries of the hydrophobic core. 
Figure 1.2 Cartoon showing the solution structure of fH-16 solved by NMR (pdb = MCC). 
The 2 conserved disulphide bonds are shown in yellow and the conserved tryptophan in 
purple. Figure produced using PyMol (www.pymol.org ). 
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Examination of sequence alignments (Figure 1.3) of CCP modules with reference to the 
structure of fl-1-16 showed that many residues that are structurally important - for example, 
the buried tryptophan prior to the last consensus cysteine - are conserved or conservatively 
replaced. This suggested that the structure of other CCP modules would be similar to that of 
fl-l— 16. This has been confirmed by the solution NMR structures of CCP modules from other 
RCA proteins such as VCP (Wiles et al. 1997; Henderson et al. 2001), CR1 (Smith et al. 
2002), fH (Herbert et al. 2006) and DAF (Uhrinova et al. 2003) as well as the structures of 
modules from MCP (Casasnovas et al. 1999), VCP (Murthy et al. 2001; Ganesh et al. 2004), 
DAF (Williams et al. 2003; Lukacik et al. 2004), fl-1 (Jokiranta et al. 2006) and CR2 
(Szakonyi et al. 2001; Prota et al. 2002) solved by X-ray crystallography. The structures 
show a common scaffold-like structure with up to eight 13-strands with variable loops, bulges 
and turns. 
Name 	SS 131 	132 NV-loop 133 	134 	135 	136 	 137 	138 
C4BPA_0 1 	NCGPPPTLSFAAPMDITLTETRFKTGTTLKYTCLPGYVRSH-STQTLTCNSDG---EWV-YNTFCIYK 
DAF_0 2 SCEVPTRLNSASLXQPYITQNYFPVGTVVEYECRPGYRREPSLSPKLTCLQNL- --KWSTAVEFCKKK 
CR1_1 5 	HCQAPDHFLFAXL-KTQTNASDFPIGTSLKYECRPEYYGRP --- FSITCLDNL- --VWSSPKDVCKRI< 
CR10 1 QCNAPEWLPFARP- TNLTDEFEFPIGTYLNYECRPGYSGRP---FSI ICLKNS---VWTGAXDRCRRI< 
C4BPA_02 	RCRHPGELRNG-QVE --- IKTDLSFGSQIEFSCSEGFFLIG--STTSRCEVQDRGVGWSHPLPQCEIV 
DAFO3 SCPNPGEIRNG-QID--- VPILFGATISFSCNTGYKLFG--STSSFCLISGSSVQWSDPLPECREI 
CR1_1 6 	SCKTPPDPVNG-MVH--- VIruIQVGSRINYSCTTGHRLIG--HSSAECILSGNTAHWSTKPPICQRI 
CR1_0 2 SCRNPPDPVNG-MVH--- VII<GIQFGSQIKYSCTKGYRLIG--SSSATCI ISGDTVIWDNETPICDRI 
Figure 1.3 Sequence alignment of CCP1 and CCP2 of the C4131? u-chain with CCP2 and 
CCP3 of DAF, and CCP1, CCP2, CCP15 and CCP16 of CR1. The location of the eight 13-
strands and the hypervariable (HV-) loop (indicated with italics) commonly observed in the 
structures of CCPmodules is indicated in the line designated ss (secondary structure) 
In cases where the structures of the same CCP module were solved by both NMR and x-ray 
crystallography, the agreement varies from good (e.g ca  rmsd of 1.14 A for VCP3) to poor 
(C rmsd of 3.31 A for VCP-2). In the case of VCP3 this difference could be explained by 
the presence or absence of the neighbouring modules as the NMR structure was of the 
VCP2,3 module pair whereas the crystal structure was of the intact protein. However the 
NMR structures of CR1--16 as a single module or in the context of the CR115,16 and 
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CR1--16,17 pairs are essentially identical. The variation in structures may, therefore, 
represent differences in conformation under the different conditions (i.e pH, salt 
concentration, presence/absence of detergent) under which the structures were solved. 
1.4 CO-binding protein 
C4BP is a 570 kDa plasma glycoprotein with a plasma concentration of —200 mg/l 
(Dahlbäck et al. 1983). C4BP is the only circulating complement inhibitor with a polymeric 
structure. In humans the most common isoform (75-80% of C4BP in plasma) consists of 
seven identical a-chains containing eight CCP modules and a C-terminal region that forms 
two disulphide bridges with the C-terminal region of a single n-chain containing three CCP 
modules (Scharfstein et al. 1978; Hillarp et al. 1990). The less abundant forms consist of 
seven a-chains or six a-chains and one 3-chain (Hillarp et al. 1989; Sanchez-Corral et al. 
1995). 
C4BP was first visualised by electron microscopy (EM) (Dahlbäck et al. 1983) and reported 
to have a spider like structure with the a-chains forming 330 A-long tentacular structures 
extending from a small central body together with the short arm of the 13-chain. This chain 
length corresponds to 41 A per module - suggesting that the average tilt angle between 
successive modules is shallow. Some arms are bent in one or two places. X-ray scattering 
and hydrodynamics (Perkins et al. 1986) suggest a less sprawling arrangement with an angle 
of approximately 10° between the a-chains. A schematic representation of C4BP (with the 
spider-like arrangement shown in the EM studies) is shown in Figure 1.4. 
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S. pyo genes 
N. gonorrhoeae (pili) 
	




E. coil (Omp A) 	CD40 	 N. gonorrhoeae 
(PorlA, Pori B) 
SAP 
/ 
M. catarrhali (Usp2) 	r 	B. pertussis 
(Hemagglutinin) 
Protein S 
N. meningitidis (PorA) 
Figure 1.4 Schematic representation of C4BP with indicated binding sites for ligands 
1.5 C4BP interactions 
To date, there has been no high-resolution structural work on C4BP, however, homology 
modelling has been used in combination with site-directed mutagenesis to investigate 
structure-function relationships (Blom et al. 1999; Villoutreix et al. 1999). C413P controls 
C4b-mediated reactions and, therefore, inhibits the classical pathway of complement 
activation in at least three ways. First C4BP acts as a cofactor in the proteolytic inactivation 
of C4b by the serine protease factor I (Fujita et al. 1978; Fujita et al. 1979). The mechanism 
by which C4BP acts as a cofactor to factor I is not fully understood. Second, C4BP prevents 
assembly of C4bC2a - the classical C3-convertase. Third, C4BP accelerates decay of the 
C4bC2a complex (Gigli et al. 1979). C4BP has been shown to exist in complex with the 
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vitamin K-dependent anti-coagulant protein S (PS) (Dahlbäck et al. 1981), and to bind 
heparin (Hessing et al. 1990), serum amyloid P component (SAP) (Schwalbe et al. 1990), 
DNA (Trouw et al. 2005) and C-reactive protein (CRP) (Sjoberg et al. 2006). 
1.5.1 C4b binding 
The EM studies of Dahlbäck et al. showed that up to six molecules of CO bind to C4BP and 
that the binding site for C4b is located at the end of each a-chain. Hardig et al. showed, 
using chimeric proteins composed of C4BP a-chains with one, two or three of the amino-
terminal CCPs replaced by corresponding CCPs from the C4BP 3-chain, that the N-terminal 
CCP module of the C4BP cc-chain (CCP1) is crucial for C4b binding and factor 1-cofactor 
activity (Hardig et al. 1997). Previously Ogata et al. had used cell surface-bound forms of 
murine C4b-binding protein (mC4BP), which enabled the binding of mC4BP to C4b to be 
monitored with relatively simple erythrocyte rosette assays, to demonstrate that CCP 1-3 of 
mC4BP are necessary and sufficient for binding to C4b (Ogata et al. 1993). To further 
investigate C4BP binding to C4b, Blom et al. constructed a panel of eight mutants in which 
individual CCP modules were removed one at a time. Truncated monomeric forms of the a-
chain were also created by inserting stop codons after each CCP (Figure 1.5). The 
recombinant proteins were expressed in a eukaryotic cell line and purified by affinity 
chromatography using monoclonal antibiodies. These mutants were assayed for their ability 
to bind C4b using a competition assay in which the variants were allowed to compete with 
1251-labeled wild-type C4BP for binding to immobilised C4b. The ability to bind C4b was 
severely impaired in the case of C4BP mutants lacking CCPI, CCP2 (in particular) or CCP3 
indicating that CCPs 1-3 are crucial for binding (Blom et al. 2001a). The spacing between 
the CCPs was also shown to be important - alanine insertions between CCP1 and CCP2, and 
between CCP2 and CCP3, both disrupted C4b binding (Blom et al. 2001 a). 
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AACCP1 /2 (zXX CCP7 
AACCP2/3 cTX X3X4X5 6X7 8 LCCP8 
Figure 1.5 Recombinant forms of C4BP a-chain constructed by Blom et al. (left) C-terminal 
truncated forms and alanine insertion forms, (right) individual CCP module deletions. 
The interaction between C4b and C4BP has been shown to be highly sensitive to salt 
concentration (Blom et al. 2001a) suggesting that ionic interactions between charged 
residues are involved. Using information from a homology-based model of cc-chain CCP1-2 
to guide site-directed mutagenesis, Blom et al. found that Arg 39, Lys63 , Arg64 and His67 , 
which are all located in a positively charged cluster on the CCP1/CCP2 interface of the 
model structure, are crucial for CO binding (Blom et al. 1999; Blom et al. 2000). Using 
these mutants, and truncated a-chains of C4BP, this group also showed that CCPs 1-3 of the 
a-chain are sufficient for cofactor activity in the cleavage of C4b molecules (Blom et al. 
2001a). Recently the same group have demonstrated that C4BP' can serve as a cofactor to 
factor I in the cleavage of fluid phase C3b (a role normally played by fl-1) and thus influence 
the alternative pathway of complement (Blom et al. 2003). All four N-terminal CCP 
modules of the a-chain are required for this activity, with CCP2 and 3 being the most 
important. Since C4BP has also been shown to regulate the lectin pathway of complement 
(due at least in part to mannan-binding lectin enhancement of C4BP binding to C4b) 
(Suankratay et al. 1999), C4BP is now known to be involved in regulating all three pathways 
of complement. 
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C4BP has very recently been shown to bind to both the C4c and C4dg sub fragments of CO. 
(Leung et al. 2006). CCPs 1-3 were required for binding, and analysis of the panel of 
mutants used in previous studies by Blom et al. suggested the C4c and C4dg binding sites 
were different but cooperative. The kinetics observed in the surface plasmon resonance 
(SPR) study led the authors to conclude that there were two affinity states of the C4c binding 
subsite in each C4BP molecule and that the equilibrium between these two states is shifted 
towards the high affinity state upon C4dg binding to the C4dg subsite. 
1.5.2 Heparin binding 
C4BP has been shown to bind heparin, a model for glycosaminoglycans, tightly (Hessing et 
al. 1990) although the affinity constant for this interaction has not been determined. High 
concentrations of heparin inhibit the interaction between C4BP and C4b suggesting that the 
C4b- and heparin-binding sites overlap (Garcia de Frutos et al. 1994). Blom et al. used 
heparin affinity chromatography and surface plasmon resonance (SPR) with biotinylated 
heparin immobilised on a streptavadin chip, to characterise the mutants of C4BP described 
previously. These experiments showed that deletion of CCP 1 and CCP3 had minor effects on 
heparin binding. Deletion of CCP2 or insertion of two alanine residues between CCP1 and 
CCP2 compromised binding suggesting that CCP2 is the most important module for heparin 
binding. Additionally mutation of the positively charged residues on the putative CCP1/2 
interface almost abolished binding (Blom et al. 1999). This suggests that the interaction 
between C4BP and heparin is similar in nature to the interaction between C4BP and C4b. 
The C4BP-heparin interaction is physiologically interesting as the multivalency of C4BP 
would permit occupancy of some heparin-binding sites by host cell-surface 
glycosaminoglycans, leaving others to mediate decay acceleration and cofactor activity, thus 
protecting host cells from the destructive and inflammatory results of complement activation. 
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1.5.3 Protein S 
The 3-chain of C4131? contains a high affinity binding site for the vitamin K-dependent 
protein S (PS) and protein S is bound to all C4131? circulating in plasma (Dahlback et al. 
1983; Hillarp et al. 1988; Hardig et al. 1996). The Gla domain of protein S binds to 
negatively charged phospholipids which aids in the localisation of C4131? to apoptotic cells 
(Webb et al. 2002). Studies have suggested that early complement components are important 
for the rapid clearance of apoptotic cells (Korb et al. 1997; Taylor et al. 2000). However, 
the cell must be protected from assembly of later components in order not to provoke an 
inflammatory response triggered by the complement system through the release of the 
anaphylatoxins C5a and C3a. Thus the localisation of C4131? to apoptotic cells may be vital to 
prevent inflammation in the surrounding area. 
1.5.4 DNA binding 
Recently C4131? was shown to bind to 25-bp double-stranded DNA with an affinity of 190 
nM (Trouw et al. 2005). Dot blot analysis showed binding to both single and double 
stranded DNA and also to RNA. Module deletion studies localised the DNA binding site to 
CCP2 with a small contribution from CCP 1. Mutagenesis studies showed that the positively 
charged residues Arg 39, Lys63 and Arg66 were essential for DNA binding with some 
contribution from Arg 64 . Mutation of His 67 (which is required for CO-binding) had no effect 
on DNA binding. CO and heparin both compete with DNA for C4131? binding. The C4BP-
PS complex was shown to localise to necrotic cells both via the interactions between PS and 
phosphatidylserine, and that between C4131? and DNA. C4131? then acts to inhibit complement 
activation on these cells preventing C5  release, inflammation and cell lysis. 
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1.6 Interaction with pathogens 
Many pathogens have developed strategies that enable them to avoid clearance and 
destruction by complement, either by hijacking host RCA proteins to locally down-regulate 
complement activation, or by expressing their own regulators that are remarkably similar to 
the host proteins [reviewed in (Lindahi et al. 2000)]. The list of pathogens that bind C4131? in 
order to evade the immune system is growing rapidly and to date a direct link between C4BP 
binding and resistance to serum-mediated killing has been shown for three pathogens: 
Streptococcus pyogenes (Carlsson et al. 2003), Neisseria gonorrhoeae (Ngampasutadol et al. 
2005) and Escherichia coil (Wooster et al. 2006). These interactions are summarised in 
Table 1.2, together with the binding sites for the 'natural' ligands: C4b, protein S and 
heparin, and also DNA and C3b. 
Ligand/organism Interaction site on C4BP Interaction References 
C4b CCP1-2-3 of a-chain: +ve charged aa at Ionic (Blom etal. 1999) 
CCP1/2 interface  
Heparin CCPI-2-3 of a-chain: +ve charged aa at Ionic (Blom etal. 1999) 
CCP1/2 interface  
C3b CCP1-2-3-4 of a-chain Ionic (Blom etal. 2003) 
Protein S CCP 1-2 of 13-chain Hydrophobic (Hardig etal. 
1996) 
DNA CCP1-2 of cc-chain: +ve charged aa at Ionic (Trouw etal. 2005) 
CCP1/2 interface  
S. pyogenes CCP1-2 of a-chain Hydrophobic (Blom etal. 2000) 
M proteins  
B. pertussis +ve charged aa at CCP1/2 interface Ionic (Berggârd etal. 
2001b) 
N gonorrhoeae PorlA: CCP1 of a-chain Hydrophobic (Ram etal. 200 1) 
PorlA/PoriB/pili PorlB: CCP1 of a-chain Ionic (Ram etal. 200 1) 
Pili: CCP1-2 of a-chain Ionic (Blom etal. 2001b) 
N meningitidis CCP2-3 of a-chain Ionic (Jarva etal. 2005) 
PorA  
C. albicans CCP1-2 of a-chain Ionic (Meri etal. 2004) 
M catarrhalis CCP2, 5 & 7 of a-chain Hydrophobic (Nordstrom etal. 
UspAl, UspA2 S  2004) 
E. co!i CCP3 of a-chain Hydrophobic (Prasadarao etal. 
OmpA  2002) 
Table 1.2 Interaction sites on C4131? for various ligands and pathogens. For some cases the 
major interaction site is indicated with bold text. 
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1.6.1 Streptococcus pyogenes 
The most extensively studied S. pyogenes virulence factor, identified over 75 years ago 
(Lancefield 1928), is M protein - a dimeric coiled coil protein that has antiphagocytic 
function and is a target for protective antibodies. This protective immunity is directed against 
an amino terminal hypervariable region (HVR) that it a source of antigenic variation 
(Robinson et al. 1992). The HVR, which has a length of —50-100 residues, is stable within a 
strain, but —100 different HVRs with highly divergent sequences have been identified 
through analysis of different clinical isolates. The function of the HVR was unclear until it 
emerged that many HVRs, with very different sequences, share the ability to bind to C41313 
(Them et al. 1995; Johnsson et al. 1996). More recently it has been shown that C4BP-
binding HVRs bind their ligand with high specificity; moreover these HVRs can be emulated 
by synthetic peptides that bind only C4131? among all human serum proteins (Morfeldt et al. 
2001). The five different C4BP-binding HVRs (shown in Figure 1.6) exhibit no or very little 
sequence identity. The conserved L-X(2)-E-X(8)-D motif (highlighted in Figure 1.6) occurs 
in many streptococcal proteins that do not bind C4BP and do not cross-react 
immunologically; these include M5 as shown in Figure 1.6. 
M2 	 NSKNPVPVKKEAKLSEAELHDKI 
M4 AEIKKPQADSAWNWPKEYNALLKEN 









Figure 1.6 Multiple sequence alignment of the hypervariable regions of five M proteins that 
bind C4131? with the sequence of the non-C4BP-binding MS protein shown for comparison. 
The sequences of the M2, M4 and M22 proteins are those of the synthetic peptides used by 
Morfeldt et al. (2001). The conserved L-X(2)-E-X(8)-D motif is highlighted. 
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The M protein can be divided up into a the HVR, a semi-variable and a conserved region as 
shown for M4 in Figure 1.7. Two well defined ligand binding regions have been identified in 
many M proteins - a C4BP-binding region as previously described, and an IgA-Fc binding 
region (Johnsson et at. 1994; Johnsson et at. 1996) in the semivariable region. These sites 
are non-overlapping - binding of C4131? does not affect binding of IgA and vice-versa (Them 
et at. 1995). Also synthetic peptides corresponding to each region specifically bind either 
C4131? or IgA (Johnsson et at. 1999; Morfeldt et at. 2001), further evidence that each 






variable semivaiiable 	 conserved 
,4 
AEIKKPQADSAWNWPKEYNALLKENEELKVEREKYLSVADDKEKD 
Figure 1.7 Schematic representation of the M4 protein showing the hypervariable, semi-
variable and conserved regions. The amino acid sequence of the 45 residue hypervariable 
C413P-binding region is shown. 
Until recently no high resolution structural work had been published on the M proteins but 
they had been proposed to have a dimeric coiled-coil structure (Nilson et at. 1995; Cedervall 
- et at. 1997). It was not known whether this coiled-coil structure extended into the HVR. 
• Originally circular dichroism (CD) spectroscopy indicated that the peptides corresponding to 
M2, M4 and M22 are 30-50% cc-helical but they do not appear to have a coiled-coil structure 
when dimerised via a C-terminal disulphide bond between a non-native cysteine residue in 
each peptide (Morfeldt et al. 2001). Computational modelling of secondary structure 
supported the CD data, with three different neural network-based prediction servers 
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[PsiPred2 (McGuffin et al. 2000), Jnet (Cuff et al. 2000) and and PhD (Rost 1996)] all 
predicting helix (60% in each HVR) and coil only. For all the HVRs except M2 the 
consensus prediction amongst the three servers includes two cc-helices with the connecting 
loops well-aligned when the sequences are positioned as in the multiple sequence alignment 
(Figure 1.6). Analysis with fold recognition methods such as 3D-PSSM (Kelley et al. 2000) 
indicated that all five C4BP-binding HVRs adopt a helix-turn-helix conformation (Morfeldt 
etal. 2001). 
Recent NMR studies on a peptide corresponding to the HVR of the M4 protein dimerised via 
a non-native C-terminal cysteine - termed M4-N - led the authors to conclude this peptide 
does in fact form a coiled-coil structure in solution, but only the central 27 residues are 
structured with residues 1-12 and 40-46 unstructured (André et al. 2006). No evidence to 
support a helix-turn-helix structure was found. Upon binding to C413P 12 the disappearance 
of certain peaks in the 15N-HSQC spectra showed that all of the 27 structured residues are 
affected by C4BP binding and that the remaining residues remain flexible when bound to 
C4BP. 
The important role of C4BP binding in phagocytosis resistance of S. pyogenes, potentially 
through cooperativity with IgA binding, has been well documented (Berggârd et al. 2001a; 
Carlsson et al. 2003). 
1.6.2 Bordetella pertussis 
All clinical isolates of Bordetella pertussis, the Gram-negative bacterium that causes the 
childhood disease whooping cough, bind C413P through at least two different surface-
exposed components. One of these is thought to be the virulence factor filamentous 
hemagglutinin (FHA) on the basis that Jha mutants show reduced C4BP binding. Purified 
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FHA does not bind C4BP, however, so FHA may act indirectly. The mode of binding of B. 
pertussis to C4131? resembles that of C4b - i.e. ionic in nature and involving a cluster of 
positively charged residues at the CCPI/2 module interface, with mutagenesis data 
suggesting that Arg 64 and Arg66 are involved (Berggárd et al. 2001b). 
1.6.3 Neisseria gonorrhoeae 
Neisseria gonorrhoeaeThuter membrane porin molecules (PorlA and PoriB) have been 
shown to bind to C4BP (Ram et al. 2001). This study showed that C4BP-PorlB interactions 
are ionic in nature and can be inhibited by high salt or by heparin - whereas C4BP-PorlA 
binding is predominantly hydrophobic. Only C4131? molecules that contain CCP1 bound to 
PorlA and PoriB gonococci, suggesting that CCPI contributes to both porin-binding sites. 
Inhibiting C4131? binding with fAb fragments against C4131? CCP 1 resulted in complete 
killing of otherwise fully serum-resistant strains in serum that had been diluted 10-fold; this 
demonstrates the importance of C4131? in mediating gonococcal serum resistance. Isolated 
type IV pili from Al. gonorrhoeae have also been demonstrated to bind human C413P (Blom 
et al. 2001b). An inhibition assay with C4b, and a competition assay in which Blom et al. 
tested mutants of C4131? lacking individual CCPs, led to the conclusion that the binding area 
for pili is localized to CCP1 and CCP2 of the a-chain. The binding between pili and C4131? 
was abolished at 0.25 M NaCl, implying that like C4b-C4BP binding it is mainly mediated 
by ionic interactions. 
More recently, Ngampasutadol et al. showed that N. gonorrhoeae strains expressing PorlA 
bound only to human C4131? and not to chimpanzee or rhesus monkey C4131? (Ngampasutadol 
et al. 2005). Strains expressing PorlB could bind human and chimpanzee C4131? but not 
rhesus C4BP. Comparing the sequences of C413P from these three species suggests that up to 
four residues that are different in CCP1 between human and chimpanzee C4131? - Ala 12 , 
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Met ' 4 , Arg22 and Leu34 are critical in PorlA binding to C4BP. Three of these substitutions - 
M14V, R22H and L34R - are also present in rhesus C4BP, however there are an additional 
ten amino acid differences between rhesus and human C4BP, suggesting that other residues 
are involved in PoriB binding to C4BP. 
1.6.4 Neisseria meningitidis 
In 2005 Jarva et al. showed that serogroup B Neisseria meningitidis, one of the most 
common serotypes isolated from patients with meningitis, binds C4BP (Jarva et al. 2005). 
Analysis of wild-type Group B meningococcus and 11 isogenic mutant strains showed that 
all strains expressing the surface porin PorA were able to bind C4BP, whereas strains 
lacking in PorA expression showed significantly reduced C4BP binding. Through a C4b-
cofactor assay for the factor I-mediated degradation of C4b, the bound C4BP was shown to 
be active and this suggested that the resistance of PorA-expressing strains to complement-
mediated killing was due to these strains binding functionally active C4BP, leading to down-
regulation of the classical pathway of complement deposition on the surface of the 
bacterium. 
Module-deletion studies suggested that the binding site for PorA on C413P involved CCP2 
and CCP3. Peptide scanning assays with radiolabelled C4BP and peptide sequences 
corresponding to putative surface-exposed loops in PorA identified two similar sequences 
from loop 1 that bound C413P most strongly. 
1.6.5 Candida albicans 
Both the fungal and hyphal forms of Candida albicans, an important pathogenic yeast, have 
been shown to bind C4BP (Meri et al. 2004). C. albicans also binds fl-1 and FHL-1 and 
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simultaneous binding of C4131? and fF1 was observed by confocal microscopy. Surface-
attached C4131? was shown to retain activity and thus down-regulate complement activation, 
leading to immune evasion by C. albicans. 
1.6.6 Moraxella catarrhalis 
Ubiquitous surface proteins Al (UspAl) and A2 (UspA2) of the mucosal pathogen 
Moraxella catarrhalis have been shown to bind C4131? (Nordstrom et al. 2004) with the K4 of 
the UspA2:C4BP interaction being 10-fold smaller than that of the UspAl:interaction. 
Module-deletion studies suggested that CCP2, and surprisingly CCP5 and CCP7 - which 
have not previously been implicated in interactions between C4131? and either its 'natural' 
ligands or pathogens - were involved. Again CO-degradation assays showed that bound 
C4131? maintained its cofactor activity suggesting that C4131?-binding enables M catarrhalis 
to evade the classical pathway of complement activation. 
1.6.7 Escherichia coli 
The pathogenic Ki strain of the Escherichia coli, which is responsible for meningitis in 
neonates, binds C4131? (Prasadarao et al. 2002). The interaction site was localised to the N-
terminus of outer protein A (OmpA). Module deletion studies showed that the interaction 
site on C4131? was CCP3 of the a-chain. The interaction was not significantly inhibited by 
C4b or heparin and was not sensitive to salt concentration - suggesting that it is mainly 
hydrophobic in nature. This study also showed that synthetic peptides corresponding to 
CCP3 sequences block the binding of C4131? to OmpA and significantly enhance serum 
bactericidal activity. 
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1.6.8 Borrelia recurrentis and Borrelia duttonii 
The spirochetes Borrelia recurrentis and Borrelia duttonii are, respectively, the causative 
agents of louse-borne relapsing fever (transmitted by the human body louse) and endemic or 
tick-borne relapsing fever (transmitted by soft-bodied ticks). Both these pathogens have 
recently been shown to evade the complement system by specifically binding both factor H 
and C4BP (Meri et al. 2006). Both complement regulators were shown to retain functional 
activity when bound to the surface of the spirochetes. This is the fourth example of a 
pathogen that has been demonstrated to bind factor H and C4BP - the others are: N. 
gonorrhoeae, S. pyogenes (although the strains that bind C4BP do not appear to bind lB and 
vice versa) and C. albicans. 
1.7 Conclusions 
CO-binding protein, the key fluid phase regulator of the classical pathway is targeted by 
many pathogenic micro-organisms, which 'hi-jack' C4BP in order to evade the complement 
system. The most widely studied interaction of a pathogen with C4BP is that of S. pyo genes 
M proteins. This interaction is becoming increasingly relevant as the prevalence of antibiotic 
resistant strains of S. pyogenes increases (Lamagni et al. 2005) and therefore, the need to 
develop alternative therapeutics to treat S. pyogenes infections becomes more pressing. 
The C4BP-binding region of the M protein has been localised to the N-terminal 
hypervariable region (HVR) and the high sequence variation in this region between M 
proteins has to date prevented the identification of a C4BP binding motif in the M proteins. 
The interaction site on C4BP has been more closely defined through a series of mutagenesis 
studies, however, without the 3D structure of the M protein binding region of C4BP - CCP 
modules 1 and 2 of the cc-chain - the role of these residues in binding M protein versus their 
role in maintaining the structure of the CCP1/2interface has remained unclear. Therefore, to 
understand the structural basis for the interaction of M proteins with C4BP the structure of 
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this region of C4BP is required. This will allow the residues involved in the interaction of M 
protein with C4BP to be identified by chemical shift mapping experiments and plotted onto 
the 3D structure of C4BP12. The mutagenesis data can then be interpreted in the light of the 
structure and the method of interaction of M protein with C4BP can be elucidated. 
It has been shown that CCPs 1-3 of the C4BP cc-chain are required for binding of the 
'natural' ligand C4b (Blom et al. 2001a). Therefore, whilst the involvement of residues 
shown by mutagenesis to be critical for CO binding in CCPs 1 and 2 can be investigated in 
relation to the 3D structure of this region, to fully interpret the structural basis of C4b-
binding the structure of modules 1-3 is required. This work is in progress but is beyond the 
scope of this thesis. 
1.8 Aims of this thesis 
The aims of this thesis are as follows: 
Use NMR spectroscopy to solve the 3D structure of C4131`12. 
Interpret the mutagenesis data gathered to date in light of this 3D structure. 
Investigate the binding of the M4 HVR from S. pyogenes to C4BP12 using NMR 
spectroscopy and other biophysical techniques. 
Map the binding site for DNA onto the C4BP12 structure. 
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2.1 Introduction 
The first aim of this project was to solve the 3D solution structure of C413PI2. In order to 
achieve this, as many as possible of the ' 3C, ' 5N and 'H resonances of C4131`12 must first be 
assigned to specific nuclei. This procedure, known as resonance assignment, is now routine 
for proteins of less than -25 kDa that are uniformly isotopically labelled with ' 3 C and ' 5N. 
After assignment has been completed, the conversion of NOE cross-peaks into inter-proton 
distance restraints (Chapter 3) becomes possible. Resonance assignment requires the 
recording of a series of 3D NMR spectra (as detailed in Section 2.3) followed by assignment 
of firstly the backbone resonances (Section 2.4.3), then the side-chain resonances (Sections 
2.4.4 and 2.4.5) and finally assignment of the NOESY spectra (Section 2.4.7). 
An in-depth discussion of the theory of nuclear magnetic resonance spectroscopy is beyond 
the scope of this thesis and for more information the reader is referred to (Cavanagh et al. 
1996). 
2.2 Sample preparation 
The C413P12 samples were provided by Prof. Anna Blom (Lund University, Sweden). The 
details of the expression and purification are described in full in (Jenkins et al. 2006). 
Briefly, human C4BP CCP1-2 cDNA was amplified by PCR yielding the protein sequence: 
MNCGPPPTLSFAAPMDITLTETRFKTGTTLKYTCLPGYVRSHSTQTLTCNSDGEWVY 
NTFCIYKRCRHPGELRNGQVEIKTDLSFGSQIEFSCSEGFFLIGSTTSRCEVQDRGVWS 
HPLPQCEILEHHHHHH. This was cloned in the Bluescript vector and transferred into the 
pET16 vector. The DNA was transfected into BL21 (DE3) CodonPlus-RP E. coil, which 
were cultured in Luria-Bertani broth containing kanamycin and chloramphenicol at 37 °C. 
After cooling to 30 °C, expression was induced with IPTG and bacteria grown for 5 h. The 
bacteria were then centrifuged and resuspended in cold phosphate-buffered saline, lysed, and 
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sonicated. The sonicate was centrifuged and the pellet resuspended in 6 M guanidine HC1, 20 
mM Tris-HC1, pH 8.0, 10 mM reduced glutathione. The crude material was applied to a 
nickel-nitrilotriacetic acid Superfiow column (-100 ml), and the protein eluted with the same 
guanidinium buffer plus 0.7 M imidazole. Refolding conditions [from (Heiring et al. 2001)] 
were screened using a conformation-dependent monoclonal antibody and buffer 11 (55 mM 
Tris-HC1, pH 8.5, 10.6 mM NaCl, 2.2 mM CaC1 2, 2.2 MM M902, 0.055% 
polyethyleneglycol-4000, 0.55 M arginine, 0.1 mM oxidized glutathione, 1 mM reduced 
glutathione) selected. Pooled fractions containing C4BP12 were diluted (20 mg/litre) in 
buffer 11 and incubated overnight. lodoacetamide was added to 5 mM, and the solution 
incubated and dialyzed against 50 mM Tris-HC1, pH 8.5. The protein solution was then 
applied to an —10-ml SourceQ column and C4BP12 eluted with 50 mM sodium phosphate 
buffer, pH 8.5. ' 5N and 13 C, 15N labelling were achieved using M9 medium supplemented 
with ' 5NH4CI and [' 3C]-glucose. 
NMR samples were prepared by adding a protease inhibitor mixture (Sigma-Aldrich) and 
0.05% (v/v) NaN3 and concentrating to 500 1, followed by buffer-exchange through three 
rounds of 10-fold dilution in NMR buffer (20 mM deuterated NaOAc, pH 4.5, 0.05% NaN3) 
and concentration. The final sample volume was 600 iii with protein concentrations of 1.3 
MM (' 5N sample) and 2.5 MM ( 13C, 15N sample), containing 10% (v/v) D 2 0. The SDS-PAGE 
of the final 13 C, 15N-labelled NMR sample of C4BP12 is shown in Figure 2.1. 








Figure 2.1 SDS-PAGE of C4BP12. Lanes as follows (left to right): Molecular weight 
markers labelled in kDa; purified C4BPI2 as received from Lund University; C413PI2, in 
NMR buffer with protease inhibitor cocktail and NaN 3 added, after 10 days incubation at 
370 C - i.e. to demonstrate the sample is stable over this time scale. 
2.3 Data collection 
NMR spectra were acquired at 37 °C on Bruker AVANCE 600 and 800 MHz spectrometers. 
The majority of the experiments were acquired at 600 MHz ('H frequency) with the 
exception of the ' 3C- and ' 5N- edited NOESY spectra, the ' 3 C- and 15 N-HSQC spectra and 
the HBCBCGCDHD and HBCBCGCDCEHE spectra which were acquired at 800 MHz ('H 
frequency). All spectra were acquired by the author with the assistance of Dr Dugan Uhrin 
and Mr Juraj Bella (University of Edinburgh). The spectra recorded are summarised in Table 
2.1. All the spectra were processed using AZARA (W. Boucher, Department of 
Biochemistry, University of Cambridge, UK). 
The ID 'H spectrum of u[' 3C,' 5N]-labelled C4BP12 is shown in Figure 2.2. There is no 
decoupling of carbon in this pulse sequence so the peaks appear as doublets due to the ' 3 C-
'H coupling. The wide chemical shift dispersion in the amide region and the clear upheld 
shifted methyl resonances are indicative of a well-folded protein. The sharp lines at 2 and 3.5 
ppm arise from compounds in the protease inhibitor cocktail used in the sample preparation. 
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Figure 2.2 ID 'H NMR spectrum of 2.5 mM u[' 3 C,' 5N]-labelled C413P12 (20 mM NaOAc 
pH 4.5, 37 °C). The Shaka method of water suppression was used (Hwang et al. 1995). 
2.4 Resonance assignment 
2.4.1 	General strategy 
The assignment of all the resonances in a protein is a stepwise procedure. Firstly the 
backbone shifts N", H   and CO) together with the C, HO shifts of sequential 
residues are identified. Then experiments that utilise TOCSY transfer along the sidechain 
atoms are used to identify the ' 3C and 'H shifts of all assignable resonances in the residue. 
This information is used to assign the cross-peaks in the HCCH-TOCSY spectrum which 
contains signals for all the covalently linked atoms in the sidechain of each residue in the 
protein. These assignments can then be transferred to the ' 3C- and ' 5N-edited NOESY 
spectra and thus cross-peaks arising from NOE transfer between non-covalently linked 
protons that are close in space can be identified and assigned. 
30 
CHAPTER 2- RESONANCE ASSIGNMENT OF C4BP12 
The backbone assignment makes use of triple-resonance spectra, so called as the pulse 
sequence involves magnetisation transfer between all three of the NMR active nuclei 
('H,' 5N,' 3 C) in the isotopically labelled protein. These experiments make use of the large J -
couplings between nuclei in the protein backbone (Figure 2.3) which enable efficient transfer 
of magnetisation along the protein backbone. These 3D experiments finish with acquisition 
on amide HN,  thus the 15N and 'H projections of these spectra overlay on the ' 5N-HSQC 
(Figure 2.8) which provides a convenient frame of reference during the assignment 
procedure. 
The names of the triple-resonance experiments reflects the order of the nuclei that the 
magnetisation is transferred through during the pulse sequence. Nuclei that are not 
frequency-labelled in the experiment and hence whose chemical shifts cannot be determined 
from the spectrum acquired, are included in parentheses in the name of the pulse sequence, 
for example 13 C0 in the CBCA(CO)NH experiment illustrated inFigure 2.5Figure 2.6. 
140 H 	C 	H 	H 	C 	H 
35 .4-9 
N 	C; 	15N 7-11 Ca 	C 
I 145 	 94 
i-i 
Figure 2.3 J-coupling constants in protein NMR (figures in Hz). 
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''N-HSQC' H 1024 11160.7 ' 5N 256 1800.5 u[' 3C, 15N]-C4BP12 
' 3 C-HSQC2 'H 1024 11160.7 ' 3 C 256 7648.2 u[' 3C,' 5N]-C4BPI2 
CG(CB)H3 'H 1024 7183.9 13Carom 160 6035.0 u[ 13C,' 5N]C4BP12 
CG(CD)H3 'H 1024 7183.9 ' 3Carom 120 6035.0 u[' 3 C,' 5N]-C4BPI2  
CG(C0m)HTOCSy3 'H 1024 7183.9 13Carom 120 6035.0 u[ 13 C,' 5N]-C4BP12 7.6 
(HB)CB(CGCD)HD 4 'H 2048 9615.4 ' 3 Carom 64 4025.0 u[ 13C,' 5N]-C4BP12 
(HB)CB(CGCDCE)HE 4 'H 1024 9615.4 ''Carom 64 4025.0  u[' 3C,' 5N]C4BP12 
CBCA(CO)NH 5 'H 1024 8389.3 ' 3 CUJ 128 12070.0 ' 5N 64 1349.7 u[' 3C,' 5N]-C4BPI2 
CBCANH6 'H 1024 8389.3 13 COJ 128 11312.2 ' 5N 64 1349.7 u[' 3CN}-C4BP12 
HBHA(CO)NH7 17 H 1024 8389.3 'H 128 6598.5 ' 5N 64 1349.4 u[' 3 C,' 5N]-C4BP12 
HBHANH 8 'H 1024 8389.3 'H 128 5997.9 15N 64 1349.4 u[ 13 C,' 5N]-C4BP12 
HNCO9 'H 1024 8389.3 ' 3C0 64 1659.6 ' 5N 64 1349.4 u[' 3 C,' 5N]-C4BP12 
HN(CA)CO' ° 'H 1024 8389.3 ' 3C0 64 1659.3 15N 64 1349.4 u[' 3 C,' 5N]-C4BP12  
H(C)(CO)NHTOCSY" 'H 1024 8389.3 ' Hs idechain 128 5399.6 15N 64 1349.7 u[' 3 C,' 5N]-C4BPI2 20.1 
(H)C(CO)NHTOCSY" 'H 1024 8389.3 13Cs idechain 128 11312.2 15N 64 1349.4 u[' 3 C,' 5N]-C4BP12 20.1 
HCCH-TOCSY' 2 1 H 1024 . 8389.3 'H 128 5398.1 13C 64 5731.5 u[' 3C,' 5N]-C4BP12 15.2 
13C-edited  'H 2048 11160.7 'H 192 9615.4 ' 3C 64 7646.7 u[' 3C,' 5N]-C4BP12 100 
15N-editedNOESY 14 'H 2048 11160.7 'H 256 9615.4 ' 5N 96 1800.5 u[' 3C,' 5N]-C4BP12 100 
15N-editedTOCSY 14 'H 1024 8389.3 'H 196 7500.5 ' 5N 64 1349.7 u[' 5N]-C4BP12 60 
Table 2.1 Acquisition parameters of the NMR spectra recorded for C413P12. 
'(Bodenhausen et at. 1980), 2 (Vuister et at. 1992) 3(Prompers et at. 1998), 4(Yamazaki et at. 1993), 5 (Grzesiek et at. 1992a) , 6(Grzesiek et al. 1992b), 
7(Grzesiek et al. 1993a), (Wang et at. 1994), 9(Grzesiek et at. 1992c), ' °(Clubb et at. 1992) "(Montelione.et at. 1992), 12 13  et at. 1993), ' 3 (Pascal et 
at. 1994), 14(Sklenar et at. 1993) 
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An example of the magnetisation transfer in a triple-resonance experiment is shown for the 
HBHANH pulse sequence (Wang et al. 1994) in Figure 2.4. This pulse sequence gives, for a 
certain HN,  cross-peaks for the H and W resonances of both the residue containing that H  
(labelled i in Figure 2.4) and also the preceding residue (labelled i-i in Figure 2.4) in the 
protein backbone. By overlaying this spectrum with the HBHA(CO)NH spectrum (Grzesiek 
et al. 1993c), which has cross-peaks corresponding to the H and W resonances of only the 
preceding residue (labelled i-i in Figure 2.4) at the shift of the H" of residue i, pairs of 
sequential amino acids can be identified. 
H 	CP 	H 	H 	c o 	H 
Ii ____________ _____U
C
~ go _____ 
C 
I 	C  
i-i 
Figure 2.4 Magnetisation transfer pathway in the HBHANH experiment (Wang et al. 1994) 
The magnetisation transfer pathway in the triple-resonance 3D CBCA(CO)NH experiment 
(Grzesiek et al. 1992a) is illustrated in Figure 2.5.This experiments connects the C  and C 
shifts of residue i-i with the NH  and H"' shifts of resonance i. The pulse sequence for this 
experiment is reproduced from (Grzesiek et al. 1992a) in Figure 2.6.The localisation of the 
magnetisation during the two constant-time chemical shift evolution periods ti and t2 and the 
acquisition time t 3 is shown in Figure 2.5. 
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Figure 2.5 Magnetisation transfer pathway in the CBCA(CO)NH experiment. 
0, 	0102 





13 	 H 
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DECOUPLE 	 I 	1T•1 TN 	 I 	DEC. 
Figure 2.6 The pulse scheme of the CBCA(CO)NH experiment reproduced from (Grzesiek 
et al. 1992a). Narrow pulses correspond to 90° flip angles and wider pulses to 1800.  Pulses 
for which no phase is indicated are applied along the x axis. 
A brief description of the mechanism of the CBCA(CO)NH experiment is as follows. The 
pulse sequence starts with INEPT (insensitive nuclei enhanced by polarisation transfer, 
(Morris et al. 1979)) transfer from protons to ' 3C°. From points a to b in Figure 2.6, the 
"C' and 13C shifts are labelled in a constant-time evolution period (t,) of duration 1/(4J). 
During t 1 the Jcco coupling is removed by the 180° shaped pulse applied t 1 /2 after point a. 
The application of this ' 3 C0 pulse changes the resonance frequency of the 13C0  due to the 
Bloch-Siegert effect (Bloch et al. 1940). The phase error due to this Bloch-Siegert effect is 
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removed by the identical 1800  shaped 13C0 pulse applied at the end of the constant time 
evolution period. At time b the 900  pulse transfers magnetisation from 13C to 13  C'. Between 
c and d INEPT transfer of magnetisation between ' 3C° and 13C0 occurs. The Bloch-Siegert 
phase error caused by the fourth 1800.  shaped 13C0 pulse that is part of this INEPT transfer 
step is compensated for by the third shaped 13C0 pulse. Another INEPT transfer step 
between e and f transfers magnetisation to ' 5N. During this transfer the JCaCO  coupling is 
removed by the 180° 13CU  pulse (with an identical 180° ' 3C pulse to compensate for Bloch-
Siegert phase error applied during W. The 1 5NH  chemical shift is labelled during the second 
constant time evolution period 02) during which the JNCO  coupling is destroyed by the 180° 
13C0 pulse. Finally, at point g, ' 5N magnetisation is transferred to its directly attached IHN  by 
a reverse INEPT transfer before detection during the acquisition time t 3 . 
2.4.2 Visualisation of 3D spectra 
The programme ANSIG (Kraulis 1989) was used to display the 3D experiments as a series 
of stacked 2D planes (Figure 2.7). A scrollbar corresponding to the 3rd  dimension enabled 
the selection of the plane corresponding to the desired chemical shift in this dimension. 
0000 F2 F2 	 F1 	
Figure 2.7 Representation of a 3D spectrum as a stack of 2D planes. Overlap, in the 2D 
spectrum on the left is resolved by the addition of a third dimension on the right, separating 
the peaks by a third chemical shift (F3). 
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2.4.3 Backbone assignment 
The Ce', C, CO. NH  and H  resonances of C4BP12 were assigned using the 2D 1 5N-HSQC 
(Figure 2.8) and the 3D CBCA(CO)NH, CBCANH, HNCO and HN(CA)CO experiments 
(Bodenhausen et al. 1980; Clubb et al. 1992; Grzesiek et al. 1992b; Grzesiek et al. 1992c; 
Grzesiek et al. 1992a). For a certain H   peak (residue i) in the 15N-HSQC the 
CBCA(CO)NH and CBCANH spectra corresponding to this H   were overlaid in order to 
identify the ca  and COfrom this residue and from the preceding (i-i) residue. A macro called 
close_in_C was used to find cross-peaks in the CBCANH spectrum that matched cross-
peaks in the CBCA(CO)NH spectrum. By matching peaks in this way a series of connected 
strips (each corresponding to a single H" cross-peak in the 15N-HSQC) was produced. The 
strips were located in the primary sequence of C4BP12 through identification of residues 
with characteristic chemical shift patterns - primarily glycine, serine and threonine. An 
example series of strips is shown in Figure 2.9. A similar procedure using the 3D 
HBHA(CO)NH and HBHANH (Grzesiek et al. 1993b; Wang et al. 1994) spectra and the 
macro close_in_H_Fl was used to resolve ambiguity in possible matches in the ' 3 C 
spectra, and to assign the H,  and HO resonances. The strips for the same residues as Figure 
2.9 are shown in Figure 2.10. For cases in which both the pairs of ' 3 C and 'H triple-
resonance spectra were unable to provide a single match, the 3D HINCO and RN(CA)CO 
spectra (Clubb et al. 1992; Grzesiek et al. 1992c) were used to resolve this ambiguity. These 
spectra were also used to assign the carbonyl resonances of C4BP12. Example strips from 
these 13 C0 spectra are shown in Figure 2.11. 
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30.0 	 . 	AH67CP  
R66C' 
R64C 













55.0 	 K63Ca 	 ,... 
H67Ca 
Y62Ca 
60.0 	 C65C. 
8.4 	 7.8 	7.8 
1 H (ppm) 
8.6 	 8.4 	 9.0 
Figure 2.9 Series of strips from the CBCA(CO)NH (black) and CBCANH (blue and red) 
spectra showing sequential assignment of residues from Tyr 62 to His67 
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R64H K63H  
















8.4 	8.19 	7.8 	7.8 	7.7 	8.6 




8.5 	8.4 	8.3 9.0 	89 
Figure 2.10 Series of strips from the HBHA(CO)NH (black) and HBHANH (red and blue) 
spectra showing sequential assignment of residues from Tyr 62 to His67 
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Figure 2.11 Series of strips from the HNCO (black) and HN(CA)CO (red) spectra showing 
sequential assignment of residues from Tyr 62 to His67 
2.4.4 	Aliphatic side-chain assignment 
The 13C and 'H shifts of resonances from aliphatic side-chains were assigned using the 3D 
H(C)(CO)NH-TOCSY and (H)C(CO)NH-TOCSY spectra (Montelione el al. 1992) which 
give the complete 'H and 13C sidechain shifts, respectively, for the residue preceding a 
certain H   in the ' 5N-HSQC. These assignments were transferred to the 13C-HSQC and this 
acted as a reference point for the assignment of the HCCH-TOCSY spectrum (Kay et al. 
1993) which enabled the resolution of ambiguities such as arise from methyl resonances in 
isoleucine and leucine residues. 
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2.4.5 	Aromatic side-chain assignment 
The HBCBCGCDHD and HBCBCGCDCEHE spectra (Yamazaki et al. 1993) that aid 
aromatic side-chain assignment were dominated by strong un-phaseable peaks arising from 
the Ws in the flexible histidine residues in the His 6-tag at the C-terminus of C4131`12. 
Unfortunately this meant that it was impossible to use these spectra for assignment. 
Although the ' 3C-edited NOESY spectrum can be used to assign the aromatic side-chain 
resonances this does rely on the assumption that the most intense cross-peaks arise from 
intra-residue NOEs between protons in the aromatic ring. It is, therefore, beneficial to have 
spectra which make use of magnetisation transfer via through-bond couplings between atoms 
in the aromatic side-chain. 
In an alternative series of experiments described by Prompers et al. the ' 3C resonances are 
first correlated with the Hs using the CG(CB)H pulse sequence and then correlated with the 
aromatic protons in 4 other experiments: with H [CG(CD)H], with H [CG(CDCE)H], with 
H [CG(CDCECZ)H] or with all aromatic proton resonances [CG(C °)H-TOCSY] 
(Prompers et al. 1998). Juraj Bella (University of Edinburgh) implemented the CG(CB)H, 
CG(CD)H and the CG(Caro  pulse sequences and these spectra were recorded by 
the author with his assistance (using two different mixing times - 7.6 and 15.2 ms - for the 
CG(C&)HTOCSY) on C4BPI2. The CG(C °)H-TOCSY with a mixing time of 7.6 ms 
produced a better spectrum and so this was used for assignment. 
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Figure 2.12 Overlay of ' 3C-HSQC (blue), CG(CB)H (red), CG(CD)H (yellow) and 
CG(C&o)HTOCSY spectra (orange). The assignment pathway for Phe 59 is illustrated with 
arrows and labelled peaks. 
These C correlation spectra still contain intense un-phaseable peaks from the His 6-tag, 
however, the wider dispersion of C shifts compared to that of COmeans that these signals do 
not overlap with the cross-peaks from the other aromatic side-chains in these spectra, unlike 
in the HBCBCGCDHD and HBCBCGCDCEHE spectra. Figure 2.12 illustrates the 
assignment procedure for aromatic side-chain protons using the CG(CB)H, CG(CD)H and 
42 
CHAPTER 2- RESONANCE ASSIGNMENT OF C4131`12 
CG(Caro)HTOCSy spectra together with the ' 3 C-HSQC. First a pair of CPHO cross-peaks 
from an aromatic residue are located in the 13C-HSQC. By matching the HO shifts the pair of 
cross-peaks corresponding to the CHO correlation can be found in the CG(CB)H spectrum - 
bottom right of Figure 2.12. This enables the assignment of the CT of this residue. The CT 
shift can then be matched in the CG(CD)H spectrum to find the cross-peak corresponding to 
the CH° correlation and the CG(C °)H-TOCSY spectrum to also find the cross-peak 
corresponding to the CTHt correlation (bottom left of Figure 2.12). This gives the shifts for 
the H° and W of the aromatic side-chain and these assignments can be transferred to the 
aromatic region of the 13C-HSQC (top left of Figure 2.12). 
Using these spectra it was possible to assign all the aromatic Ho  s and H's and also the 
tryptophan Ws. The remaining assignments - phenylalanine Hs and the rest of the side-
chain protons in the two tryptophan residues in C4BP12 were made using the 13C-NOESY 
spectrum. The aromatic side-chain protons of the native histidines could not be assigned as 
this region of the CG(CB)H, CG(CD)H and CG(C °)H-TOCSY spectra is dominated by 
strong signals from the His 6-tag. The side-chain assignments of His 41 , His 67  (except for H°) 
and His' 7 are, therefore, missing. 
2.4.6 	Proline isomers 
The configuration of the eight proline residues in C4BP12 was determined by calculating the 
difference in chemical shift 60 - CT for each residue and by inspecting the proline C  and 
C° strips in the ' 3C-edited NOESY spectrum. The difference in the chemical shifts, 8CO - 
for Pro4 , Pro 5, Pr06, Pro 13,  Pr035 , Pr068 and Pro"' (Pro 121 CT could not be assigned) is shown 
in Table 2.2. Based on a statistical analysis of the ' 3C chemical shifts of 1,033 prolines from 
304 proteins deposited in the BioMagRes database (Schubert et al. 2002) it is known that 
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- 	is 4.51 ± 1.17 ppm for trans and 9.64 ± 1.27 for cis proline residues. The shift 
differences in Table 2.2 indicate that these seven proline residues are in the trans 
conformation. 








Table 2.2 Chemical shift difference 60 - 6C 1 for seven of the eight proline residues in 
C4BP 12 
The pattern of sequential NOE cross-peaks observed in the ' 3 C-edited NOESY spectrum is 
also indicative of the conformation of proline residues. As shown in Figure 2.13, strong Ho 
H NOEs and weak W H NOEs between the proline and the previous residue indicate a 
trans conformation whilst weak H ° H NOEs and strong H  H' NOEs indicate a cis 
conformation. The NOE patterns observed confirmed that the seven prolines listed in Table 
2.2 were in the trans conformer and that Pro 120  was also in the trans conformer. This 
information was used in building the template structure used in the calculation of the 
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Strong sequential Ha Ho NOE 
Weak sequential Ha Ha NOE 
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Strong sequential H' Ha  NOE 
Weak sequential Ha  H° NOE 
Figure 2.13 Proline isomers. The thickness of the arrows indicates the intensity of the 
sequential NOEs observed. 
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2.4.7 NOE assignment 
Overlaying the 'H-'H planes of the HCCH-TOCSY and ' 3C-NOESY allowed identification 
and assignment of intraresidue NOEs. Interresidue NOEs were assigned by inspecting pairs 
of symmetry-related cross-peaks and with reference to the assigned nuclei. When no unique 
match to a specific nucleus existed the cross-peak was ambiguously assigned. A total of 
3266 NOEs were assigned in the ' 3C-edited NOESY spectrum together with an additional 
1170 NOEs in the 15N-edited NOESY spectrum. There were a total of 895 ambiguous NOEs 
(included in the above figures) - 581 and 314 in the ' 3C- and ' 5N-edited NOESY spectra 
respectively. 
2.4.8 	Extent of assignment 
With the exception of Phe 59 the backbone H  and  NH  resonances for all of the native residues 
(Asn'-Ile' 24), excluding the eight proline residues, could be assigned. The cu, H, C, HO and 
CO resonances for all native residues as well as the cloning residues Met ° , Leu' 25 and Glu' 26 
were completely assigned. For the native residues Asn'-Ile' 24 , 96.4% of the total resonances 
were assigned. The aromatic side-chain resonances of the native histidines were not assigned 
due to overlap with strong signals from the His 6 tag as explained in section 2.4.5. Cross-
peaks for the majority of the side-chain resonances of GIn 44 were also missing probably due 
to this residue being in a very mobile loop in CCP1 - as judged from relaxation studies on 
C4131?12 (Section 4.5). Resonance assignments for C4BP12 are listed in Appendix A. The 
assignments have been deposited in the BioMagResBank under accession number 6712. 
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2.4.9 	Chemical shift index 
Chemical shift indexing (CSI) (Wishart et al. 1992; Wishart et al. 1994) is a fast and 
relatively accurate method for predicting secondary structure based on the deviation of H", 
C", C, and CO shifts of each amino acid from those observed in "random coil" regions of 
proteins with known 3D structure. For H", C" and CO shifts, a shift greater than the range 
given is assigned the CSI value of 1, a shift smaller than the range is assigned -1, and a shift 
within the range is assigned 0. A series of four or more values of - i, not interrupted by a 1, is 
taken to indicate an a-helix and a series of three or more values of 1, not interrupted by a -1, 
indicates a 3-strand. For CP shifts the deviation from "random coil" values are in the 
opposite direction and only 13-strands can be identified (Wishart et al. 1994). A series of four 
or more values of -1, not interrupted by a 1, is taken to indicate a 13-strand. The CSI program 
(Wishart et al. 1994) was used to calculate the CSI for H", C", C, and CO shifts of C4131? 12, 
and also to output the consensus chemical shift index from the results for the four nuclei 
used in the calculation. The results are shown in Figure 2.14. As expected for a protein 
known to contain two CCP modules (Section 1.4), the consensus CSI predicted only 13-
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Figure 2.14 Chemical shift index for H ,  C, C, and CO and the consensus. Values 
calculated using the CSI programme (Wishart et al. 1994). 
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2.5 Conclusions 
Almost complete resonance assignment of C4BP12 was achieved. These assignments were 
transferred to the NOESY spectra from which interproton distances were derived and used as 
input in structure calculations to solve the 3D structure of C4BPI2 using the method of 
restrained molecular dynamics as described in Chapter 3. 
Chapter 3 
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3.1 Introduction 
The process of converting a set of inter-proton distance restraints calculated from the 
intensities of cross-peaks in a NOESY spectrum into .a 3D structure of the protein of interest 
is non-trivial. This is predominantly because the limited amount of distance restraints 
obtained from the observed NOEs (much fewer than the theoretical maximum of two 
symmetry-related cross-peaks for each pair of protons less than -5A apart in the structure) 
means that in- order to solve the structure, considerable non-experimentally determined 
information must be used in the structure calculation. Therefore, weighting of this 
information relative to the experimentally-derived information is of critical importance 
(Habeck et al. 2006). 
The strategy used to calculate the structure of C413P12 is based on that described by Prof. 
Michael Nilges (Nilges 1995). In addition to NOE-derived distance restraints, dihedral angle 
restraints based on the chemical shift index (Wishart et al. 1994) and residual dipolar 
couplings (RDCs) measured on a sample of C413P12 aligned in filamentous phage were 
incorporated. As experiments to directly measure hydrogen bonds (Cordier et al. 1999) have 
never been successfully applied to CCP module-pairs, and H" deuterium-exchange data 
requires, inference of the carbonyl oxygen acceptor, no hydrogen bond restraints were 
included in the structure calculation. Restrained molecular dynamics from random starting 
structures was used with a simple repulsive non-bonded potential. Simulated annealing was 
used during the calculation procedure to enable the calculation to escape local minima and to 
improve the sampling of conformational space. 
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3.2 NOE based distance restraints 
Despite the increasing use of RDC restraints in structure calculation and the demonstration 
that 3D structures can be calculated solely using RDC based restraints (Hus et al. 2001), 
distance restraints obtained from the volume of NOESY cross-peaks remain the predominant 
source of experimental data used in the calculation of structures from NIMR data. Although 
many cross-peaks are present in NOESY spectra, the distance restraints obtained by 
calculating the volume of many of these cross-peaks are redundant. For example, each pair 
of symmetry related cross-peaks describes only a single distance between a pair of protons. 
Moreover, there are numerous intraresidue NOEs that give distance restraints for covalently 
bonded protons (for example the distance between a pair of Hs) that are already defined by 
the covalent geometry for each amino acid present in the topology files used as input for the 
structure calculation. Thus the number of 'long-range' NOEs, i.e. from protons separated by 
more than four residues in the primary sequence, is often only 20% of the total number of 
NOEs. Furthermore, while the integration of a NOE cross-peak to obtain the volume is 
accurate, the conversion of this to a distance restraint is problematic. This is because spin 
diffusion and local dynamics can alter the volume of the peak so that it no longer reflects the 
true distance between the protons involved. This is discussed further in Sections 3.2.2 and 
3.2.3 (and in Chapter 7). 
3.2.1 The Nuclear Overhauser effect 
In a two dimensional NOESY spectrum obtained using the pulse sequence in Figure 3.1, 
cross-peaks arise due to magnetisation transfer between the two spins arising from cross-
relaxation, commonly referred to as the nuclear Overhauser effect (NOE). The NOESY pulse 
sequence starts with a 90° pulse that creates transverse magnetisation and the spins precess 
during t1 at their characteristic Larmor frequencies. When the second 90° pulse is applied 
along the +x axis, the magnetisation vectors are rotated so a component exists along the -z 
1.3'I 
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axis. These z-magnetisation components can exchange due to cross relaxation during the 
mixing period tm. The transverse components are removed by phase cycling. The final 900  x 
pulse regenerates transverse magnetisation which is detected during the acquisition time t2. 
By varying the length of t1 the frequency of the first spin can be labelled, and after two-
dimensional Fourier transformation the incrementation of t1 gives rise to the second 
dimension in the 2D NOESY. The position of the cross-peak is determined by the chemical 
shift of the second proton (acquired in t2) in F2 - the directly detected dimension and that of 
the first spin in F I - the indirectly detected dimension. 
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Figure 3.1 The 2D NOESY pulse sequence (Jeener et al. 1979) and the resulting 2D 
NOESY spectrum of C4BP12 
In a two-spin system the NOE is proportional to the inverse sixth power of the distance 
between the two nuclei involved (Solomon 1955). For a cross-peak in the NOESY spectrum 
between spins I and S, (with frequencies of w 1 and (oS,  respectively) which are part of a 
multi-spin system, the initial rate of build up of the cross-peak (with intensity ajz) is given by 
(Macura etal. 1980) 
d( ajz  ) / dr I 	= —0r1 M 0 	 (3.1) mJ0 
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Where tm is the mixing time and M0 is the intensity of the diagonal peak at tm = 0. This 
initial rate approximation gives the important result that only the cross-relaxation rate 
between spins I and S, aj , controls the size of the NOE cross-peak. For the protons I and S 
as is given by 
Gr 
IS
= (t) 2 h2 y 4 	6t  
 	60
-r 	1 -6 




where /l is h/2.7r (i.e Plank's constant divided by 2r), yo is the permeability constant in a 
vacuum (these constants arise from the quantum mechanics used to calculate the transition 
probabilities from the dipolar interaction Hamilitonian) and y is the proton gyromagnetic 
ratio. r is the correlation time (the time taken by the molecule to rotate by roughly one 
radian about any axis). Therefore, ris - the internuclear distance between the two protons - is 
the only distance in the multi-spin network that controls the size of the observed NOE. The 
r 6 dependence arises because dipolar interactions have a r 3 dependence and cross-relaxation 
is a second order effect, hence (r 3 )2 . 
This is the basis of the isolated spin pair approximation (ISPA) which enables, for NOESY 
spectra with short mixing times, the reduction of the magnetisation transfer in a multi-spin 
system (e.g. a protein) to the transfer between pairs of spins such that: 
D, 6 ccNOE 
	
(3.3) 
where NOE,J is the intensity of the observed NOE cross-peak and Dij is the internuclear 
distance between the protons involved. Experimentally the NOE can deviate significantly 
from this approximation as a result of spin diffusion and internal dynamics. 
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3.2.2 	Spin diffusion 
In a protein, the dense network of protons means that magnetisation can be transferred 
indirectly between a pair of protons as illustrated in Figure 3.2. This magnetisation transfer 
via indirect pathways usually leads to increased NOE intensities. Thus distances derived 
from NOEs using the ISPA are often underestimated (Linge et al. 2004). It is possible to 
include spin diffusion corrections in the structure calculation. This can be achieved by direct 
refinement against the NOE intensities, although this is computationally expensive as the 
NOESY spectra must be simulated from the coordinates at every minimization step. Another 
method uses complete relaxation matrix analysis to derive distances corrected for spin 
diffusion that can be used in conventional structure calculation protocols (Linge et al. 2004). 
In practice, however, the least complicated and, therefore, most common method of 
accounting for spin diffusion is the use of a minimal mixing time and appropriately wide 
bounds on the distance restraints used in the calculation (this is discussed further in Chapter 
7). This simple method was the approach used in the calculation of the structure ofC4BPl2. 
Figure 3.2 Spin diffusion in a protein. Indirect magnetisation transfer via spins k and 1 
(dashed lines) influences the size of the NOE between i and j (solid line). 
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3.2.3 	Local dynamics 
Accounting for the effect of dynamics on the intensity of the NOE is much more difficult 
than correcting for spin diffusion as, depending on the type of fluctuation, the NOE intensity 
can be either increased or decreased. The common approach to this problem is again to use 
large error bounds for the distances and, subsequently, to estimate the dynamics from the 
spread of structures in the final ensemble. This is far from ideal as the diversity of the 
ensemble reflects solely the distribution of the experimental data and while dynamics does 
influence this distribution, other factors such as the presence of experimental artefacts in the 
spectra and overlap will also contribute. Furthermore the diversity depends on the protocol 
used to calculate the distance bounds from the NOE data. It is also important to bear in mind 
that the measured NOE is a time- and ensemble-averaged value whereas the bounds of a 
distance restraint refer to instantaneous distances in a single structure. There is currently 
much work on improving the way NOE-derived distance restraints are used in structure 
calculation such as using a potential for these restraints in the structure calculation that 
reflects the error in calculating these distances rather than using wide upper and lower 
bounds to account for the error (Nilges et al. 2006), this is discussed in Chapter 7. For 
reasons of simplicity the only correction for spin diffusion and local dynamics used in the 
calculation of the structure of C4BP12 was the use of large error bounds on the distances 
derived from the volume of NOE cross-peaks. 
3.2.4 	Ambiguous distance restraints 
In the above section an underlying assumption was made that each experimental distance 
restraint can be unambiguously assigned to a pair of protons. Clearly there are special cases 
such as methyl protons, certain pairs of methylene protons and equivalent protons on 
aromatic rings, which have degenerate shifts. In the calculation of the structure of C4BP12 
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these cases were treated in exactly the same way as the ambiguous NOE restraints described 
below. Moreover, in proteins, several unconnected protons may have the same chemical 
shift. This leads to NOE cross-peaks that can not be immediately converted to a distance 
restraint between two atoms and these are termed ambiguous NOEs. They cannot be 
assigned even after the complete chemical shift assignment of the protein has been 
completed. Traditionally, ambiguous NOEs were assigned manually in an iterative procedure 
based on inspection of preliminary structures calculated using the distance restraints derived 
from unambiguously assigned NOEs, followed by calculation of a new set of structures 
calculated with these additional restraints. These new structures were used to derive further 
discrimination between possible matches for an ambiguous NOE and so on, until no further 
assignments could be made. This method relied heavily on the quality of the preliminary 
structures and there is a danger that errors made in the initial assignment may be further 
propagated throughout the calculation, leading to an incorrect final structure. 
In an alternative method proposed by Nilges (1995), the distance restraints derived from the 
NOESY spectra are incorporated into a target function that allows all possibilities to be 
specified for each restraint. Such restraints are termed ambiguous distance restraints (ADRs). 
The target function is minimised using simulated annealing (Section 3.5.1). This method 
proposes that an ambiguous NOE cross-peak at coordinates F1,F2 contains contributions 
from all proton pairs with those chemical shift assignments: 
NOEFIF2 = 	 NOE,J 	 (3.4) 
iE{F141},jE{F2, 2) 
where {F1 ,A 1) is defined as the set of all protons with chemical shifts within a tolerance 
A from shift F. Under the ISPA, contributions to the volume of this cross-peak depend on the 
distances D1 for each spin pair i,j. The rate of build up of this NOE is given by: 
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where Tm is the mixing time and c is a constant. If the assumption is made that the order 
parameters and correlation times for all the spin pairs are identical, combining equations 3.4 
and 3.5 results in 
NOE) 	 (3.6) 
Tm 	 iE{F141},jC{F2,A2} 
As the ambiguous NOE depends on the sum of the inverse sixth powers of the individual 
distances a "r 6-summed" distance D can be defined: 
-1/6 
D FF, = 	 (3.7) 
iE{F1,AI},jC{F2,A2} 
enabling equation 3.6 to be written as: 
--NOEF1F2 = CDFI,p2 	 (3.8) 
d-r. 
This is similar to the <r 6> 1 "6 average distance (Brunger et al. 1986) originally defined for 
methyl and methylene groups. However, since Equation 3.7 is a sum, a scale factor n 116 is 
included where n is the number of spin pairs in the sum. As this approach can be applied to 
highly ambiguous data sets (i.e n is large), this factor is not negligible. Another difference is 
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that the value of the <r-6>- 1 /6 average distance is always between that of the smallest and 
largest distances, whereas D is always shorter than any of the contributing distances. 
3.2.5 Filtering of ADRs 
The number of possible contributions to an ADR can be incrementally reduced as the 
structure calculation progresses. This process, which increases the precision of the calculated 
structures, is termed 'filtering'. In the filtering procedure, possible assignments are compared 
with the corresponding distances in the ensemble of low-energy structures from the previous 
-  round of structure calculation. Using an approach developed for the programme ARIA 
(Ambiguous Restraints for Iterative Assignment) (Nilges et al. 1997), the relative size of the 
contribution of the N different assignment possibilities to the volume of a cross-peak at 
frequencies Fl and F2 can be estimated as follows. For each contribution k to the ADR the 
minimum distance Dnin  in the ensemble of converged structures is determined. The 




(3.9) N(F1,F2) 	j -6 
j 	Dmin 
The C" are then sorted by size and the N largest contributions chosen such that: 
N P 
(3.10) 
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where p is a parameter set by the user. The parameter p is often expressed as a percentage - 
e.g - "filtering at 99%" - i.e p = 0.99 which removes assignment possibilities contributing 
less than 1% of the intensity of the NOE cross-peak that gives rise to the restraint. 
3.2.6 	Calculation of NOE-derived distance restraints 
NOE-derived distance restraints were generated by integration of the NOESY cross-peaks in 
ANSIG. The chemical shift ranges over which the cross-peak intensity was integrated were 
set to the halfwidth at half height of the peaks (Figure 3.3) and were as follows: 13C = 0.3 
ppm, ' 5N = 0.5 ppm, 'H (indirect dimension) = 0.1 ppm, 'H (acquisition dimension) 0.05 
ppm. The intensities were scaled relative to the average intensity which was set to a value 
1.0. After scaling, the restraints were divided into four classes or 'bins'. The classes used 
were: strong: intensity? 3.0; medium: 1.5 < intensity < 3.0; weak: 0.3 < intensity < 1.5 and 
very weak: 0 < intensity <0.3. The distance bounds chosen for these classes are shown in 
Table 3.1. 
Figure 3.3 The halfwidth at half-height of a peak is distance x. 
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Distance Class Lower Bound (A) Upper Bound (A) 
Strong (intensity? 3.0) 0 2.7 
Medium (1.55 intensity <3.0) 0 3.3 
Weak (0.3 	intensity <1.5) 0 5.0 
Very Weak (0 -< intensity <0.3) 0 	1 6.0 
Table 3.1 Distance restraint classes used in the structure calculation ofC4BP12 
The lower limit of the distance classes was set to 0 A to account for the effects of spin 
diffusion and local dynamics on the size of the observed NOEs. 
3.3 CSI-derived distance restraints 
As described in the previous chapter, secondary distance restraints can be used to predict 
secondary structure in proteins via the programme CSI (Wishart et al. 1994). An in house 
script (CSIt0DIHE . awk) was used to generate dihedral angle restraints based on the 
consensus chemical shift index. The weak restraints (angles are allowed to vary by ± 30°) 
used are shown in Figure 3.4. No special treatment was applied to residues predicted to be at 
the beginning or end of a strand. The predicted 13-strand in the linker was omitted from the 




- ~N 	7C 
H 	
Ha 
a-helix: 	,i4) = -65°, 400 	(± 30°) 
n-sheet: p = -120°, +1300 (± 30°) 
Figure 3.4 Dihedral angle restraints used in the structure calculation ofC4BP12 
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3.4 Residual dipolar coupling restraints 
For experiments intended to measure residual dipolar couplings (RDCs) the sample was 
aligned in Pseudomonas filamentous (Pfl) phage with a final 2H splitting of 0.9 Hz. The 
sample conditions were as follows: 0.70 mM C4BP12, 7.3 mg/ml Pfl phage, 20 mM 
NaOAc, pH 5.5, 90 mM NaCl. ' DNH (Ottiger et at. 1998), 'Dc '' (Permi et at. 1999) and 
I DCaH (  (Ball et at. 2006) couplings were measured for both aligned and non-aligned samples. 
The aligned sample was prepared by Dr Graeme Ball who also recorded the experiments and 
measured the values of the RDCs from the spectra. RDCs for residues 1, 15-23, 43, 79, 110-
112 and 125+ were excluded on the basis that heteronuclear NOE data indicate significant 
local motion occurs at these residues (Section 4.5) Further details of the use of RDC 
restraints in the calculation of the structure of C4BP12 can be found in (Ball 2005). 
3.5 Structure calculation from NMR data 
There are two optimisation methods in general use for calculating 3D structures from NMR 
data. The first is minimisation in torsion-angle space with residue-by-residue build up of 
distance and non-bonded information (Braun 1987; Guntert et at. 1997). The second is based 
on global optimisation of a hybrid energy function by molecular dynamics-based simulated 
annealing (MDSA) in Cartesian space with a simplified soft non-bonding potential. The 
calculation strategy for C4BP12 was based on that described in (Nilges 1995) and is detailed 
below. 
3.5.1 	Molecular dynamics based simulated annealing 
The basis of simulated annealing (Kirkpatrick et at. 1983) is the raising of the temperature of 
the system followed by slow cooling steps in order to allow local minima to be overcome on 
the path towards the global minimum of the target function. Originally the Metropolis 
algorithm (Metropolis et at. 1953) was used for simulation of the system, but in MDSA 
integration of Newton's equations of motion is used in a similar manner to that used in 
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molecular dynamics (Brooks et al. 1983). The target function Ff0, for which the global 
minimum is searched contains both experimental and empirically determined terms: 
	
F,01 = Fcovaient  + Frepei  + Fexperimentai 	 (3.11) 
where Fcovajen, maintains the correct bond lengths, angles, planes and chirality, Frepej is a 
simple repulsive term to prevent unduly close contacts and Fexperimentai contains the 
experimentally derived information. For example, the target function used in the final round 
of structure calculation of C4BP12 was as in equation 3.12 
E,0, = EbOflaS  + Eangies  + Eimproper  + EVdW  + ENQE 	+ Edihe  + Erdc 	(3.12) 
where Ecovajent consists of Eb0d5, Eangies and Eimproper, Erepei is Ed and Eexperimentai consists of 
ENOE, Edihe and Ed,.  The terms in equation 3.12 are defined in the following section. E,0 , 
represents the total effective potential energy in the calculation, and as the force on an atom 
can be expressed as the gradient of the potential energy this can be calculated by integrating 
Newton's laws of motion for all n atoms in the system: 
--i—E,01(x1,x2,...,x) 	 (3.13) 
ot 2 - 
where x, is the coordinate of an atom (of mass m 1) in the system. The temperature of the 
system can be calculated from the sum of the kinetic energies of all n atoms in the system at 
time t: 
2 
T, = _______ 	
ii 	 (3.14) 
kB(3n - 6) 2 J 
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where kB is the Boltzmann constant and v, is the velocity of an atom with mass m i . 
Ecovaient , the first of the two empirical energy terms, maintains the correct bond angles, 
lengths, planes and chirality, and is defined as: 
 00 )2 
Ecovaient =. 	kb(r — 
 )2 
+ 	 + 	 - 	 + 	k(1+ 
 COS (0)
2. 	(3.15) 
bonds 	 angles 	 impropers 	 dihe 
where kb, k0, k, k, are the force constants for bonds, angles, improper angles (angle terms 
that are used to maintain the planarity and chirality of the peptide bond which is assumed to 
be planar and trans and also the planarity of aromatic rings), and peptide bond dihedral 
angles respectively. The dihedral angle force constants for other rotatable bonds are set to 0 
as the motion of these groups is covered by the non-bonded interactions. The values of the 
force constants are are varied throughout the calculation. 
Originally, NOE-derived distance restraints were represented by a square well potential with 
a force constant kNOE: 
I ( , - r1 
2
) ,if r;. < 
ENOE =kNQE O 	,ifr ~ ru : r. 	 (3.16) ij 
[(
u)2 
ifi > r 
ij 
where 	and 	are the upper and lower bounds of the distance restraint and r the 
calculated values. This potential can cause distorted structures due to the large energy 
penalty for distances that slightly exceed the upper bounds and so for the calculation of the 
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structure of C4BPI2 a modified harmonic flat-bottom potential with linear behaviour for 
large deviations termed a 'soft potential' was used: 
I rij - '; )
2 	
, if r < r! if 
0 	 ,ifp :r.:r. 
ENOE = kNoE 
I(r_r)2 	 rij < 	:5
(3.17) 
(a + j6(rij - riu)-' + y(rij - ri,'.')) 
I 
i f rij > 	+ 
where y is the gradient of the asymptote, r determines the distance where the potential 
switches from the square well function to the 'soft' asymptote and a and f3 are determined 
such that the potential is continuous and differentiable at 	+ r. These potentials are 
illustrated in Figure 3.5. 
ENQE 
1;•; 	' 	 1_ 
	
r , 	 il 
Figure 3.5 Potentials for ENOE  used in structure calculation by MDSA. 
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The covalent bond energy is defined by the equation of a simple harmonic spring: 
EbO,.d = 	kb(r_ro)2 	 (3.18) 
bonds 
where r is the actual bond length, kb is the bond energy constant and r0 is the equilibrium 
bond length as defined in the force field. 
The angle bond energy is defined by the term: 
Eangie = 
	(k, (0 _ 00 ) 
2 + kb(rD — r.b )2) 
	 (3.19) 
angles 
where k0 and kb are energy constants and 00 and rub  are equilibrium values. 0 is the actual 
value of the angle. The second term in Equation 3.19 is the Urey-Bradley term which is used 
only in certain forcefields and hence the default value of kUb is 0. 
The torsion angles between planes are defined by dihedral and improper statements with 
energy terms Of Edihe and Ejmproper respectively and is of the general form: 
J k (1 + cos(nØ, + 	if n 1 >0 E= 	 (3.20) 
0, is the actual torsion angle, k0 is the energy constant and n, m, and 4 are periodicities, 
multiplicities and phase shifts respectively. The definition of dihedral and improper angles is 
identical but two separate topology and parameter lists are maintained in CNS for these 
angles. As described above, improper angles are used with n, = 0 to maintain planarity or 
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chirality, whereas dihedral angles are used with n,> 0 to describe multi-minimum torsion 
potentials. Therefore, the actual energy terms for Eimproper and Edihe  are: 
E improper = 	 (3.21) 
impropers 
Eli he = 	k(1 + cosw) 	 (3.22) 
dihedrals 
where k4, and ka, are the improper and dihedral energy constants and w is the actual dihedral 
angle. 
The non-bonded interactions are described by a simple repulsive term - Erej,ei with a force 
constant of krep which prevents close contacts: 
0, if r 2-s.rmjn 
Erepei = 	- r2)2, if r:5 s.rmi,, 	
(3.23) 
 
The values of rmjn are taken from the CHARMM empirical energy function (Brooks et al. 
1983) and are standard values for the van der Waals radii as calculated from the Lennard-
Jones potential. The factor s, which allows for scaling of the value of rmjn, is varied 
throughout the calculation. 
3.5.2 	Calculation strategy 
The calculation strategy is divided into three consecutive protocols: randomise, regularise 
and refine. This is because when starting from random Cartesian coordinates a modified 
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simulated annealing protocol is required. In this protocol the weights on the covalent 
geometry terms are very low at the start and are increased throughout the calculation. The 
first stage 'randomise' is a high temperature search phase. 'Regularise' involves enantiomer 
selection and then 'refine' contains two cooling stages. 
Randomise 
The random starting conformation is generated by assigning random values to the x, y and z 
coordinates of the atoms. Qualitatively this represents a high-temperature conformation of 
the system. To remove very close non-bonded contacts, 50 cycles of Powell (Powell 1977) 
minimisation are performed with all the force constants set to very low values. In the early 
stages of the 'random' phase, the residues in the protein are represented by a reduced non-
bonded form (Nilges 1993; Nilges etal. 1997) to increase the efficiency of computation. One 
non-bonded sphere with a van der Waals radius of 2.25 A is centred on the C  atom, and a 
second sphere with the same radius is placed at the position of a single carbon atom in each 
side chain as defined in Table 3.2. 
Amino Acid Non-bonded atoms 
Gly C 
Ala, Ser C", C 
Pro, Cys, Thr, Asn, Asp Ca,  c 
Val, Ile Ca, CYI  
Met, Gin, Glu, Lys, Arg C", C 
Leu, Phe, Tyr, His C", C 1 
Trp C", C' 2 
Table 3.2 Atoms used in the reduced non-bonded representation 
This minimisation is followed by three steps of molecular dynamics (MD); the first step uses 
the reduced non-bonded representation and the subsequent two use all atoms. The first step 
is carried out at 2000 K and the second two at 1500 K. The weighting of the experimental 
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restraints is kept low (kNQE = 0.5 kcal.mor'.k2) in the first stage of MD and increased (kNQE  
=5.0 kcal.mol*k2 ) in the second two stages. The force constants for bond, angle, and non-
bonded interactions (kb, k9 and krep) are increased throughout the three stages of MD. 
Throughout the 'random' stage all the torsion angle terms are removed from Etotai (i.e k9 and 
= 0) and these are re-introduced together with the complete non-bonded interactions in the 
regularisation stage. 
Regularise 
This step is based on the standard X-PLOR DGSA protocol, which was derived from the 
protocol published in (Nilges et al. 1988b). The input structures are those produced by the 
previous 'random' step. Amino acids in an extended conformation ( = -120, fl' = 120) are 
fitted to the structure residue-by-residue and a mirror image of the structure is generated. 
This is because distance geometry methods cannot discriminate between enantiomers so both 
enantiomers are refined and the one with the lowest energy is chosen. 
Two rounds of energy minimisation, the first with bond angle restraints turned off and the 
second with angles included, are followed by MD at 2000 K during which the weightings of 
the improper and dihedral angles are increased. In this round of MD the value of krep is 
decreased to a level which is sufficient to maintain the global structure but small enough to 
allow atoms to get very close to each other (and even move through each other) in order to 
improve the structure locally. Next the correct handedness of the structure is determined by 
evaluating the energies of the two enantiomers. A round of. MD at 2000 K involving 
prochiral swapping (see section 3.5.4) is carried out with increasing weighting of the 
experimental terms (kNOE = 5.0 - 50.0 kcal.moV 1 .A 2) and the non-bonded term as before. 
After energy minimisation,the first cooling stage begins. MD is performed as the system is 
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cooled from 2000 to 100 K and the weighting of the non-bonded term is increased. Prochiral 
swapping is included in this step and the weighting of the experimental energy terms is kept 
high. After further prochiral swapping there is a final energy minimisation step and the 
structures are output for the final round. 
Starting with the structures produced at the end of the previous rounds, three rounds of MD 
are performed. The first is at high temperature (2000 K) and the system is cooled from 2000-
1000 K in the second step, and from 1000K-100 K in the third step. Prochiral swapping is 
included in the second and third stages. In the high-temperature stage the weighting of the 
experimental terms is set very high compared to the non-bonded and covalent terms. During 
the first cooling stage the weighting of the non-bonded and covalent terms is increased so 
that in the second cooling stage the weighting of the experimental terms is comparable to 
that of the empirically defined terms. After a final round of energy minimisation the final 
structures are output. 
3.5.3 	RDC restraints 
RDC restraints are included in a modified 'refine' stage starting from structures calculated 
from random starting coordinates with NOE- and CSI-derived dihedral angle restraints as the 
only experimentally determined restraints. The structures are taken after the 'regularise' 
round of simulated annealing. RDC restraints were introduced by including the TENSO 
energy term (Sass  et al. 200 1) within CNS using a harmonic potential. The weighting is kept 
low (kTENSO = 0.001) in the high temperature stage and increased (to kTENSQ = 1.0) in the first 
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cooling stage. Further details of the use of RDC restraints in the calculation of the structure 
ofC4BP12 can be found in (Ball 2005). 
3.5.4 Prochiral swapping 
Amino acid side chains include numerous prochiral centres - carbon atoms with two 
identical and two different substituents, such as methylene protons and isopropyl groups. 
The stereospecific assignment of these groups has been shown to increase the accuracy and 
precision of the ensemble of calculated structures (Driscoll et al. 1989). However, 
stereospecific assignment by careful analysis of intra-residue and sequential NOE patterns is 
time consuming. One method for dealing with these missing assignments is to introduce 
pseudoatoms to replace the methylene or methyl protons. This requires widening of the 
bounds of the experimental distance restraints to correct for the position of the pseudoatom 
relative to those of the protons for which the NOE has been measured and results in a loss of 
information from the distance restraint. Prochiral floating or swapping (FOlmer et al. 1997) 
can be used to allow for missing stereospecific assignments, without the use of pseudoatoms. 
In this procedure the NOEs are measured for both individual resonances of a methylene or 
isopropyl group which are arbitrarily assigned (e.g H 2 and H 3 for a 3-methylene group). 
Then, during the calculation, the stereo-related atoms or methyls are allowed to float 
between the pro-R and pro-S configurations. In this way the groups can move to find the 
most energetically favoured configuration. This requires removal of all the energy terms that 
define chirality at the prochiral centre and also a reduction in the weighting of the bond angle 
energy terms that define the bonds to the methyls or methylene protons so that these atoms 
or methyls can swap positions during the calculation. The prochiral swapping protocol was 
modified from the original X-PLOR protocol (Folmer et al. 1997) by Dr Brian Smith, Dr 
Andrew Raine and Dr Peter Domaille (University of Cambridge) to use the Metropolis 
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criterion thus allowing swaps that temporarily increase the energy of the system. Prochiral 
swapping was included at several points in the regularise and refine steps as detailed above. 
	
3.5.5 	Disulphide restraints 
In initial rounds of structure calculation the two conserved disulphide bonds in each CCP 
module were not defined in the template structure. In the structure calculations the sulphur 
atoms of all the pairs of cysteine residues expected to form disulphide bonds based on 
homology with other CCP modules (Cys 2 and Cys48 , Cys33 and Cys60, Cys65 and Cys 106 , 
Cys92 and Cys 122 ) converged to within 4 A. The template was, therefore, modified to remove 
the sulphydryl protons and replace them with a bond between the pairs of sulphur atoms 2 A 
long. 
3.6 Calculation of the structure of C4BP12 
3.6.1 	Initial structures 
The distance restraints were generated from the 3266 NOE cross-peaks assigned in the 13C_ 
edited NOESY spectrum, and the 1170 NOE cross-peaks assigned in the 15N-edited NOESY 
spectrum, using the connect tool in AZARA. Ambiguous distance restraints were 
generated in the same manner using the chemical shift assignments from the 15N- and 13 C-
HSQC spectra, the ' 3C- and 15N-edited NOESY spectra and the HCCH-TOCSY spectrum. 
Structure calculations were performed in CNS (BrUnger et al. 1998) using the protocols 
described in section 3.5.2. 
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3.6.2 	Refinement of structures 
Initial calculations of 100 structures used only distance restraints derived from 
unambiguously assigned NOEs. Restraints that were violated in all 100 structures (a 
violation is reported where a distance in a calculated structure exceeds the upper bound of 
the distance restraint by more than a preset threshold) were subsequently analysed in ANSIG 
(Kraulis 1989) by inspecting the cross-peak in the NOESY spectrum from which the 
restraint was generated. Where violations were judged to have arisen from mistakes in 
assignment, or noise peaks that were incorrectly picked, the assignment was corrected or the 
peak removed. Restraints were then regenerated from the cross-peaks in the NOESY spectra 
and the calculation repeated using the new restraints. 
The second stage of the refinement strategy involved 'filtering' (Section 3.2.5) the ADRs to 
reduce the number of contributions to each restraint. After each round of filtering the new 
restraint list was used to calculate another set of structures, which was then used to filter the 
original restraint list again. At each filtering stage duplicate restraints generated from 
symmetry-related cross-peaks in the NOESY spectra were removed by selecting the restraint 
that more closely matched the distance in the ensemble of low energy structures. This avoids 
bias due to the duplication of a subset of the total restraints, and also reduces the number of 
restraints, which decreases the computational time required for the structure calculation. As 
before, restraints that were violated in structures that were within the ensemble of low 
energy structures were analysed in ANSIG by inspecting the NOESY cross-peak from which 
the restraint was generated, and assignments were corrected as required. 
The final structures of C4BP 12 were calculated using NOE and dihedral angle restraints 
(from CSI) in three rounds, as shown in Table 3.3. The structures after regularisation 
(Section 3.5.2) were used as input for a final refinement stage in which the RDC restraints 
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were incorporated as described in Section 3.5.3. In each round 100 structures were 
calculated. 
Round Level of 
filtering 
Restraints used   No. of converged 
structurest UnA 
M 
Dihe ADR RDC 
nla X X  24 
2 p=0.99 X X X  27 
3 p=0.99 X X X  28 
RDC nla X X X X 40 
Table 3.3 Calculation strategy. Notes: Unamb = unambiguous restraints; Dihe = dihedral 
angle restraints derived from CSI; t these structures were used to filter the restraints for the 
next round of structure calculation; :1 ADRs filtered before use in structure calculation to 
remove incorrect intra-modular restraints which prevented convergence of the structures. 




Short-range ( 2~ Ii—jI 4) 240 
Long-range (li-i 1>4) 763 
Intermodular 7 
Intralinker ill 
From Module 1 to linker 35 
From Module 2 to linker 21 
Total unambiguous NOEs 3541 
Total ambiguous NOEs 895 
Final unique distance restraints 3032 
Unique interresidue distance restraints 1250 
Residual dipolar couplings 
'DNH 62 
'DNC' 65 
I Dcuc , 41 
lrcza 
t-'C H  24 
Total  RDC restraints 192 
Table 3.4 Final restraints used in the calculation of C4131? 12 
The unambiguous restraints summarised in Table 3.4 are plotted per residue in Figure 3.6. 
The nature of ADRs mean that it is not meaningful to plot these restraints in this way. This 
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figure over estimates the total number of NOEs as each restraint is included twice - once for 
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Figure 3.6 The number of unambiguous distance restraints used in the structure calculation 
plotted by sequence number: intra-residue in black, sequential (residue i - residue i+l) in 
dark grey, short-range (2Ii—jI4) in light grey and long-range (Ii -jI>4) in white. 
A contact plot of the final set of distance restraints, after filtering and removal of duplicate 
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Figure 3.7 Contact map of final NOE distance restraints used for calculation of the structure 
of C4BP 12. (; ) sidechain-sidechain and sidechain-backbone restraints; (+) backbone-back-
bone restraints. 
3.7 Conclusions 
The large number of distance and RDC restraints led to excellent convergence (40 of 100) 
structures in the final round of structure calculation. The NOE contact plot (Figure 3.7) 
shows the characteristic pattern of a protein composed of-sheets. The structure of C4BP12 
is discussed further in Chapters 4 and 7. 
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4.1 Introduction 
The methods described in Chapter 3 were employed to calculate the 3D structure of C4BP12 
using NOE-derived distance restraints, RDC-derived orientation restraints anddihedral angle 
restraints calculated from CSI information (Table 3.4). The structures show the features 
expected of a pair of CCP modules. The interface between modules 1 and 2 is well defined 
due to interactions between the bulky side-chains of residues, both within the linker and 
within the individual modules close to the interface. Regions of the structure that show low 
convergence in the ensemble of structures are inferred to be flexible from the T1/T2 ratio and 
heteronuclear NOE measurements (Section 4.5). 
4.2 Convergence of the ensemble of structures 
A plot of the overall and NOE energy terms, per structure, is shown in Figure 4.1. The level 
of convergence appears to be excellent - based on the low energies of 40 (out of the 100 
calculated) structures. The similarity in NOE energy for this ensemble of 40 structures 
indicates that these structures are all equally good solutions to the experimentally derived 
restraints. Outside this ensemble, the values of the NOE energy term diverge and the overall 
energy rises rapidly which is indicative of structures that do not fit the experimental data. 
The lowest energy 40 structures were selected as the final ensemble and these structures 
were submitted to the protein databank (PDB - http://www.rcsb.org/pdb)  with accession 
code 2A55. A plot of the C rmsd (compared to the closest to mean structure) is overlaid on 
the plot of the number of NOE-derived distance restraints per residue in Figure 4.2. As 
expected, a clear correlation is observed between the number of distance restraints and the 
precision of the structure - i.e. regions that have few NOE-derived distance restraints show 
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Figure 4.1 Plot of overall (x) and NOE (+) energy per structure. The low energy ensemble 
of 40 structures is indicated by the vertical line. Structures are ranked by overall energy. 
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Figure 4.2 The number of unambiguous distance restraints per residue (bars, left-hand 
scale): intra-residue in black, sequential (residue i - residue i+1) in dark grey, short-range 
(2r.Ii—j:s4) in light grey and long-range (Ii-j>4) in white. The rmsd of the C" coordinates of 
residues 2-122 from the mean structure overlaid on both modules is also shown (right-hand 
scale). 
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4.3 Structural statistics 
The structural statistics for the 40 structures in the low-energy ensemble are presented in 
Table 4.1. The precision of the structures is high and the PROCHECK (Laskowski et al. 
1993; Laskowski et al. 1996) quality scores are acceptable for a small protein domain with 
disordered loops ; 90% of residues within the ensemble occur in the most favoured and 
additionally allowed regions of the Ramachandran (Ramachandran et al. 1963) plot (Figure 
4.3). 
rmsd for ensemble of 40 structures ± SD 
NOE (A) 	 0.0423 ± 0.0028 
Bond Lengths (A) 	 0.0025 ± 0.0001 
Bond Angles (°) 0.5123 ± 0.0177 
Coordinate rmsd (A) 
Backbone atoms (Ca,  N, CO): Excluding loopsa  (all residues") 
Module 1 0.528 (0.895) 
Module 2 0.488 (0.597) 
Both Modules 0.856 (1.042) 
All heavy atoms : Excluding loopsa  (all residues") 
Module 1 0.851 (1.487) 
Module 2 0.922 (1.108) 
Both Modules 1.147 (1.507) 
Number of violations > 0.5 A 	 46 
Ramachandran assessment (% 
Most favoured 52.4 
Additionally allowed 37.5 
Generously allowed 7.1 
Disallowed 3.1 
a excluding residues 15-21, 35-45 (module 1)78-82,  107-111 (module 2) 
b residues From CysI to CysIV of each module 
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Figure 4.3 Ramachandran plot for the 40 lowest energy structures. Boxed numbers indicate 
the structure number; residue numbers indicate residues that lie outside the favoured regions. 
4.4 The ensemble of structures 
Figure 4.4 . Figure 4.6 show the backbone overlays of the low-energy ensemble of 40 
structures (from 100 calculated) of C4BP12. These structures are overlaid on CCP1 (Figure 
4.4), CCP2 (Figure 4.5) and both CCP modules (Figure 4.6). The residues used to fit the 
backbone overlays are the same as were used for the calculation of rmsd excluding loops in 
Table 4.1 and were obtained by analysis of the relaxation data (Section 4.5). 
CHAPTER 4- THE STRUCTURE OF C4BPI2 
Figure 4.4 Stereo-view (cross-eyed) showing backbone overlay of the 40 lowest energy 
structures. Residues 2-122 are shown. Residues 2-60 (CysI to CysIV) excluding the loops 
consisting of residues 15-21 and 35-45 were used for the overlay. 
Figure 4.5 Stereo-view (cross-eyed) showing backbone overlay of 40 lowest energy 
structures. Residues 2-122 are shown. Residues 65-122 (CysI to CysIV) excluding the loops 
consisting of residues 78-82 and 107-111 used for the overlay 
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Figure 4.6 Stereo-view (cross-eyed) showing backbone overlay of 40 lowest energy 
structures. Residues 2-122 are shown. Residues 2-60 and 65-122, excluding loops as 
described above, were used for the overlay. 
4.5 Relaxation data for C4BP12 
Steady-state {'H}—' 5N NOEs and ' 5 N T1 and T I 	were measured at 600 and 800 MHz 
These experiments were recorded by the author with the assistance of Dr Dusan Uhrin. The 
data was processed and analysed with the help of Dr Graeme Ball. The T, and T2 relaxation 
times were calculated from data at 600 MHz and 800 MHz by nonlinear least-squares fitting. 
To allow estimation of the experimental error of the measured peak intensities the spectrum 
corresponding to one of the relaxation delay values was re-acquired. Heteronuclear {'H}—
' 5N NOEs were calculated from the ratio of the intensities of the cross-peaks in the reference 
spectra to those recorded with saturation of the 'H signal. The plots of T1 , T2 and {'Fl}—' 5N 
NOEs are shown in Figure 4.7. 
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Figure 4.7 Relaxation data versus residue number. (top) T1 ; (middle) 7'2;  (bottom) {'H}-' 5N 
NOE . Data collected at 600 MHz (black) and 800 MHz (red). 
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4.6 Discussion of the structure of C4BP12 
The programme uwmn (M. Hartshorn and L. Caves, University of York) was used to 
identify the structure from the ensemble that was closest to the mean structure of the 
ensemble. The structures were fitted over the backbone of residues Cys 2 to Cys 122 - the first 
cysteine of CCP 1 to the last cysteine of CCP2. The structure refine_rdcs_2 I .pdb was closest 
to the mean structure with a rmsd of 0.655 A. Secondary structure was calculated for all the 
members of the low-energy ensemble using STRIDE (Frishman et al. 1995) and the 












Figure 4.8 Two views of the closest to mean structure, with secondary structure as predicted 
by STRIDE (Frishman el al. 1995) for> 50% of structures in the ensemble, shown. Cysteine 
side chains, yellow; Tryptophan side chains, purple. Selected loops are labelled. 
4.6.1 	The individual modules 
As can been seen from Figure 4.4 and Figure 4.5, the structures of the individual modules 
converge well. Each CCP module has a similar, elongated, shape (Figure 4.6) in which short 
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p-strands and other extended segments [that do not satisfy the criteria used to define 3-
strands (Frishman et al. 1995)] are aligned with the long axis. Five strands/extended 
segments wrap around a hydrophobic core that is bounded by the two invariant disulphide 
bridges. The strands/extended segments run up-down-up-down-up such that the N- and C-
termini are at opposite ends of the module. The connecting turns and loops also generally lie 
towards the ends of the module, but the "hypervariable loop" - a site of high sequence 
variation and of insertions or deletions (Figure 1.3) - projects laterally (labelled in Figure 
4.6). The longer hypervariable loop of CCP1 (residues Asp ' 5 -Thr2 ) is poorly defined by the 
data and corresponds to a prominent dip in the plot of {'H}- 15N NOEs (Figure 4.7) that is 
consistent with motion on the nanosecond timescale. The {'H}-' 5 N NOE data and the high 
value of the T11T2 ratio for Thr45 indicate a second, poorly defined, flexible region in CCPI 
that includes residues 35-45 (Figure 4.7) and is close to, but does not participate in, the 
interface. A prominent feature of CCP2 is the loop (residues Val' °8-Val' ' 3), between the 
fourth and fifth extended segments, that carries a three-residue insertion relative to CCP1 
(see Figure 1.3). This loop is flexible, as judged by {H}-' 5N NOEs, (see Figure 4.7), and it 
lies close to the intermodular interface. In general, the values of Tj , T2 and heteronuclear 
NOEs are more variable in CCP1 than in CCP2, reflecting a higher level of flexibility in the 
first module. 
4.6.2 	Intermodular flexibility 
The ensemble of structures converge well when superimposed over both modules (Figure 
4.6) although not as well as when superimposed over the individual modules. The 
intermodular interface is mainly hydrophobic with contributions from all four linker residues 
(Ile 61,  Tyr62 , Lys63 and Arg64) and from Tyr 37  and Va1 38 of CCP1, along with Phe 84 , Val' °8 
and Val' 3  of CCP2. The Tyr 37, Tyr 62  and Arg64 side-chains line up on one side, while on the 
other, Va1 38 and Val' °8 bracket Phe 84 and all three contact Lys 63 , which in turn lies alongside 
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Ile 61 . The observed arrangement comprises a well-structured hydrophobic pocket exhibiting 
only limited flexibility (as indicated by the {'H}- 15N NOE data for this region). This region 
is shown in detail in Figure 4.9. 
4 
Figure 4.9 The CCP1/2 interface in the closest to mean structure. Colours: CCPI- red; CCP2 
- blue; linker - orange. The side-chains of residues discussed in the text are shown in stick 
representation and labelled. The orientation of C4BP 12 is indicated in the boxed insert. 
Figure produced with PyMOL (www.pymol.org) 
There is no evidence from the relaxation measurements for fast- or slow-timescale motion in 
the backbone of the linker (Figure 4.7). However, a superposition based on individual 
modules is better than a superposition of the module-pair (Figure 4.4 - Figure 4.6), reflecting 
a small range of intermodular angles amongst the ensemble. These angles (illustrated in 
Figure 4.10) are calculated using for reference a vector connecting the principal inertia 
tensor of each module with the C' of its consensus tryptophan. The values of the 
intermodular angles are listed in Table 4.1 and shown graphically in Figure 4.10. This could 
be interpreted in terms of a restricted degree of intermodular movement, but could also 
reflect a limitation of the experimental data. Both the mean tilt and twist angles are relatively 
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small so that the two modules form an elongated structure in which equivalent features - 
such as the hypervariable loops - lie on the same face of the molecule (Figure 4.8). 
0 
0 	/it 






Figure 4.10 Intermodular angles for the ensemble of structures. Arrows show mean values 
4.6.3 Comparison with other CCP module structures 
The structures of CCP1 and CCP2 of C413P12 were compared to each other and to all the 
experimentally solved CCP module structures using the programme Combinatorial 
Extension (Shindyalov et al. 1998). Comparison of CCP 1 with CCP2 yielded a C' rmsd of 
3.4 A over 57 residues. The second module of the C413P a-chain is highly similar in 
structure to the 16 th module of CR1 (pdb 1 GKN) and the 3rd  CCP module of decay 
accelerating factor (DAF, pdb = 1 H03) (C rrnsd of 1.6 A over 62 residues in both cases). It 
is also similar to the 2   module of MCP (pdb = 1CKL) (2.0 A over 62 residues). All of these 
modules belong to the same sequence cluster (cluster C) as defined by Soares et al. (Soares 
et al. 2005) and occupy the second-module positions within the C3b/C4b-binding sites of 
their respective parent proteins (Kirkitadze el al. 2001) On the other hand, CCP 1 of C4BP 
is a rather more structurally divergent module. Its closest known structural relatives include 
the 15th  module of CR1 (2.2 A over 60 residues) and the 2nd  module of DAF (2.5 A over 63 
residues), both of which are first modules within C3b/C4b-binding sites. Therefore, both at 
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the level of individual module structures, and from a functional perspective, there are 
parallels between module pairs C4BPI2, DAF23 and CR1-1516. These structures are 








Figure 4.11 Comparison of the structures of C4BP 12 (closest to mean structure) with 
modules 2 and 3 of DAF (crystal structure, pdb = 10K3) and modules 15 and 16 of CR1 
(closest to mean structure of ensemble of 24 NMR structures, pdb = 1 GKN). 
From inspection of Figure 4.11 it can be seen that whilst the tilt and skew angles of C4BP12, 
DAF23 and CR1-1516 are similar the twist angle for C4BP12 is almost 180° to that of 
DAF23 and CR1-l5 16. As these module pairs represent part of the CO-binding site in CR1, 
DAF and C4BP it appears that the ability of a protein to bind C3b/C4b does not appear to 
require a specific intermodular arrangement in the free protein. This is discussed further in 
Chapter 7. 
A prominent structural feature of C4BP 12 is the loop in module 2 formed by the residues 
between Val' 08 and Val' 3 (sequence - QDRG). This loop is marked in Figure 4.8. The 
presence of such an exposed loop - four mostly polar residues (which are not involved in the 
intermodular interface) bounded by two hydrophobic residues that contribute to the interface 
with the preceding module - is unique to cluster-C CCP modules. As mentioned above 
cluster-C members form the second modules of C3b/C4b recognition sites in C4BP, MCP, 
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DAF, and both sites 1 and 2 of CR!. Some conservation amongst these modules in the use of 
specific features for CO-binding might be expected and this loop would be an obvious 
candidate. It is indeed critical to the C3b/C4b-binding activities of CR1 sites 1 and 2 (Krych 
etal. 1994a; Krych et al. 1998a). This means that substitution of residues between Val' 08 and 
Val' 3 of C4BP represents a worthwhile exercise; this is currently in progress. 
The electrostatic surface of the closest to mean structure was calculated using APBS (Baker 
etal. 200 1) and is shown in Figure 4.12. 




Figure 4.12 Electrostatic surface potential of closest to mean structure. Calculated using the 
Adaptive Poisson-Boltzmann Solver (Baker et al. 2001) plug-in within PyMOL: red is 
negative charge and blue is positive charge. A range of -51+5 kT was used. Those amino 
acids substituted in mutagenesis studies by Blom et. al. are marked. 
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4.6.4 	Interpretation of mutagenesis data for C4b binding 
The design and interpretation of site-directed mutagenesis data for C4BP (mutated residues 
marked on Figure 4.12) previously relied upon models built on the basis of homology with 
other RCA protein structures. The experimentally determined structure of C4BP12 allows 
the mutagenesis data pertaining to C4BP 12 to be considered in a more accurate structural 
context. The proposed contribution of Arg 39 , Lys63, ArgM  and His67 - all of which are 
functionally critical for C4b binding. (Blom et al. 1999; Blom et al. 2000) - to a contiguous 
positively charged surface patch is not consistent with the observed solution structure 
(Figure 4.13). The intermodular twist rotates Arg 39 in module 1 away from His 67 in module 
2. Furthermore, within the linker, the positive charges of Arg 64 and Lys63 are exposed on 
opposite faces. When an cc-chain of C4BP binds to C4b either it may lie within a valley or 
groove on the surface of the bigger protein or, alternatively, an inter-modular motion occurs 
that brings these four critical residues onto the same face of the molecule. This is discussed 
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Figure 4.13 Residues shown to be critical for CO binding mapped on the closest to mean 
structure of C4BP 12. 
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4.7 Refinement of the structures in explicit solvent. 
Refinement of NMR structures in a full molecular dynamics force field including 
electrostatic and Lennard-Jones non-bonded potentials and interaction with solvent has been 
shown to improve the quality of the structures (Linge et al. 2003). This technique was 
successfully applied to over 500 NMR structures from the PDB to generate the RECOORD 
(recalculated coordinate) database (Nederveen et al. 2005). In order to quickly investigate 
the effect of water refinement on the structure of C4BP12, the RECOORD scripts (available 
from http://www.ebi.ac.uklmsdlrecoord ) were used to refine the 40 low-energy structures in 
explicit solvent. The final NOE-derived distance restraints were used in the refinement but 
the RDC and dihedral angle restraints were omitted as these are not incorporated into the 
RECOORD protocols. As found in the RECOORD study, the RMSD of the ensemble 
increased with water refinement but the overall fold remained identical (Figure 4.14). The 
backbone rmsd for Cys 2-Cys' 22 between the two closest to mean structures was 1.39 A. The 
quality scores were significantly improved by water refinement (Table 4.2. Figure 4.15). 
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Figure 4.14 Backbone overlays of 40 lowest energy structures before (blue) and after (red) 
water refinement. Residues 2-122 are shown. (left) overlaid on CCP1 (right) overlaid on 
CCP2, the residues used for the overlay are as in Figure 4.4 and Figure 4.5. 
Original structures After water refinement 
Coordinate rmsd (A) 
Backbone atoms (Ca,  N, CO): Excluding loops' (all residues') 
Module 1 0.528 	(0.895) 0.616 	(0.890) 
Module 2 0.488 	(0.597) 0.588 	(0.723) 
Both Modules 0.856 	(1.042) 0.898 	(1.073) 
Ramachandran assessment (%) 
Most favoured 52.4 70.2 
Additionally allowed 37.5 22.9 
Generously allowed 7.1 4.1 
Disallowed 3.1 2.8 
WHATCHECK structure Z-scores, positive is better than average 
2nd generation packing quality 	-3.002 	 -2.424 
Ramachandran plot appearance -6.405 -4.489 
xl'x 2  rotamer normality 	-3.623 	 -2.915 
Backbone conformation -8.294 -9.481 
a  excluding residues 15-21, 35-45 (module 1)78-82, 107-111 (module 2) 
b residues  From CysI to CysIV of each module 
Table 4.2 Structural quality scores before and after water refinement 
92 




I X i I, 	 I 	I 
90- 1 LELELI 
I 	 #.IEi 
4 J J SER 40 
J) 	 '  I  
o -t--- 	 -i.4 
1 I 	I c''- 
Li 
PIE 




AS 11% 	 VA L 
IIt W 1 5, 41 
-180 	-135 	-90 	-45 	0 	45 	90 	135 	180 
Phi (degrees) 
Figure 4.15 Ramachandran plot for the 40 lowest energy structures after water refinement. 
Boxed numbers indicate the structure number in the ensemble red boxed numbers annotated 
with residue numbers indicate residues that lie outside the favoured regions of the plot 
4.8 Conclusions 
The structure of C4BP 12 was solved using the methods described in Chapter 3. The 
structures show the features expected of a pair of CCP modules and compare well to 
previously solved CCP-module structures. The cluster of positively charged residues present 
on the model structure of C4BP, and implicated in function by mutagenesis studies, is not 
present in the experimental structure and this suggests that intermodular re-orientation may 
occur on C4b binding. This is discussed further in Chapter 7. Whilst the quality statistics for 
the C4BP12 structure are acceptable, refinement in explicit solvent can improve the quality 
93 
CHAPTER 4-THE STRUCTURE OF C4BPI2 
of the structures without changing the overall fold. As the inclusion of RDC derived 
restraints into the water refinement protocol is non-trivial these restraints were not included 
in the water-refined structures. For this reason the refined structures were not judged to be an 
improvement on the original structures that were submitted to the PDB and so the PDB 
deposition has not been updated. 
Chapter 5 
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5.1 Introduction 
The interaction between C4BP 12 and M proteins from Streptoccus pyogenes is the most well 
characterised host-pathogen interaction involving C4BP. As C4BP is active on the surface of 
S. pyogenes, this interaction allows the bacterium to avoid opsonisation and subsequent 
phagocytosis (Carlsson et al. 2003). Previous experiments had located the binding site for M 
protein to CCP 1-3 of the cc-chain (Accardo et al. 1996) and shown that the site overlapped 
with, but was not identical to, the C4b-binding site (Blom et al. 2000). Prior to the structure 
of C4BP12 presented in this thesis, there was no high-resolution information for this region 
of C4BP. Therefore, a primary motivation for solving the structure of C4BP12 was to map 
the binding site for M proteins at an atomic level. This was achieved and the unexpected 
result that binding of M protein involves intermodular re-orientation of C4BP12 was 
obtained. 
5.2 CCP1 and CCP2 are necessary for M protein binding 
Prof. Anna Blom performed M4-binding assays with full length S. pyogenes M4 protein and 
the module-deletion and alanine-insertion C4BP mutants described in Section 1.5.1. More 
details of these experiments are given in (Jenkins et al. 2006). These studies showed that 
none of CCP modules 3-8 were required for M4 binding but that deletion of CCP2 led to 
significantly (.-10-fold) reduced affinity. Deletion of CCP1 destroyed binding almost 
completely. The addition of alanine residues between CCP2 and CCP3, or between CCP3 
and CCP4, had no effect on binding, whereas insertions between CCP1 and CCP2 caused a 
loss of M4 binding (Figure 5.1). These results show that CCP1 and CCP2 are necessary for 
M4 binding to C4BP. 
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Figure 5.1 Binding of CCP module deletion mutants (A), and double-alanine insertion 
mutants (B) of C4BP to M4. Microtiter plates coated with M4 were exposed to recombinant 
C4BP molecules in which one of the eight CCP modules of the a-chain was deleted (A), or 
in which two Ala residues were inserted - into the linker between CCPs 1 and 2, 2 and 3 or 3 
and 4 (B). Binding was expressed as a percentage of the maximum binding of wild type 
observed in each experiment. Figure reproduced from Jenkins et al. (2006). 
5.3 CCP1 and CCP2 are sufficient for M4 binding 
In order to demonstrate that modules CCP1 and CCP2 were sufficient for M4 binding, 
isothermal titration calorimetry (ITC) was used to measure the binding affinity between 
C4BP12 and a dimerised peptide corresponding to the hypervariable region of M4. This 
peptide consisted of residues 1-45 of the M4 (also known as Arp4) protein with a C-terminal 
non-native cysteine added and was termed M4-N. A dimer was used as previous studies had 
shown that dimerisation of M4 strongly enhanced C4BP binding (Morfeldt et al. 2001). The 
peptide was expressed in E. coli by Jenny Persson (Lund University, Sweden) as described 
in (André et al. 2006). The ITC was performed at the BBSRC/EPSRC Biological 
Microcalorimetry Facility, University of Glasgow, by the author with the assistance of 
Margaret Nutley and Prof. Alan Cooper. The results were consistent with a 1:1 stoichiometry 
and a Kd of 0.5 !LM. The data was corrected for heat of dilution effects by subtracting the 
results of a blank titration (i.e. injecting M4-N into buffer) and fitted using a one-site model 
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resulting in the following: stoichiometry, N = 0.787 ± 0.015; Kj = 0.5 ± 0.07 [tM; AH = - 
9450± 243 cal moF 1 ; AS = -2.96 cal moF'K'. These results are shown in figure 5.2. 
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Figure 5.2 Isothermal titration calorimetry profile for the interaction of M4-N with C4BP12. 
Top, heat differences obtained for 20 injections (corrected for heat of dilution effects). 
Bottom, integrated curve with experimental points (• ) and the best fit (—). 
5.4 C4BP12 and M4-N model system 
The results summarised in Figure 5.1 and Figure 5.2 prove that the N-terminal two CCP 
modules of the C4BP a-chain, along with the four residues that link them, are both necessary 
and sufficient for M protein recognition. The data confirm that M4-N represents a useful 
model of the C413P-binding region of the bacterial protein (Morfeldt et al. 2001). Therefore, 
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the C4BP12 M4-N interaction could be used to map the binding site of S. pyogenes M 
proteins on C4BP (Section 5.6). 
5.5 Initial studies with M22 
Prior to the studies with M4, Prof Gunnar Lindahi sent two peptides corresponding to the 
HVR (53 residues, termed M22-N) and the HVR and IgA binding domain (83 residues, 
termed M22-rec) of the C4BP-binding M22 (also called Sir22) protein. Both peptides were 
dimerised via a non-native C-terminal cysteine. The M22-N was produced by peptide 
synthesis and M22-rec was produced in E. coli. Due to problems exchanging the M22-N 
peptide into NMR buffer it was abandoned and M22-rec was used for a preliminary titration 
with 50 p.M u[ 15N]-C4BP12. This was performed using a 500 MHz spectrometer equipped 
with a cryoprobe at the University of Dundee with the assistance of Dr David Norman. 
The results of this titration are shown in Figure 5.3. Addition of the peptide led to the 
broadening and disappearance of many peaks in the 15N-HSQC spectrum. This could either 
be due to the formation of a large, slowly tumbling complex, non-specific aggregation of the 
C4BP12:M22-rec complex, or an exchange rate between free and bound C4BP12 that is 
intermediate on the NMR time-scale. Adding more peptide pushed the equilibrium towards 
formation of the complex and led to the reappearance of many peaks. Overlaying the first 
and last spectra in Figure 5.3 showed that the shifts of the cross-peaks induced by the peptide 
were small. A 15N-TROSY spectrum of the complex (at 500 MHz) yielded.no improvement 
over the 15N-HSQC, suggesting that it was not the size of the complex (-35 kDa) that led to 
the poor quality of the spectrum but rather the intermediate exchange regime. Adjusting the 
experimental conditions (i.e buffer, pH, salt concentration and temperature) might improve 
the quality of the spectra. As the initial titration studies with the related peptide M4-N were 
much more successful, no further work on M22 was performed. 
CHAPTER 5- M PROTEIN BINDING 
, 	.'c'..ø 	 •' 	• 
• 	. . 	 I • 	
S ) • 	 • 
a ..,i 	, 	• .- 	 I 
	
• .;
;, * 	 4 	
4 	 ..Q 
Figure 5.3 15N-HSQC spectra for 50 tM C4131?I2 before addition of M22-rec (left) and at 
M22-rec:C413P ratios of 4:1 (centre) and 8:1 (right). Samples were in 20 mM deuterated 
NaOAc buffer, pH 4.6. Spectra acquired at 500 MHz ( 'H frequency). 
5.6 Titration with M4-N 
Significant changes in the 15N-HSQC spectrum of C4BPI2 occurred upon addition of M4-N 
(Figure 5.4). At a low ratio (0.5:1) of M4-N to C413P12, some cross-peaks disappear (peaks 
labelled in Figure 5.4) while others move a small distance within the spectrum. As this ratio 
is increased, those peaks that had previously vanished reappear at a new frequency, while 
those that had moved shift further from their original positions. The disappearance and 
subsequent reappearance of some peaks reflects exchange between free and bound forms of 
C4BP12 with a frequency comparable to the difference between the frequencies of the 
original peak (free) and the new one (bound). On the other hand, when the difference 
between the frequencies of the original peak and the new one is smaller, then the exchange 
rate is faster relative to the frequency difference, giving rise to the peaks that move 
incrementally during the course of the titration. The line-widths of the cross-peaks for the 
complex are not significantly broader than those of free C4131?I2, despite the increased 
molecular weight of the complex (15 kDa for C4BP 12 + 11 .3 kDa for M4-N). One 
explanation is that the complex is less anisotropic than free C413P12 and tumbles 
accordingly - this could happen if the bound form of M4-N is relatively compact and binds 
towards the centre of C4131? 12, as opposed to at either end. 
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Figure 5.4 Overlay of five 15N-HSQC spectra of 20 RM C413P12 (20 mM NaOAc. pH 6.0, 
37 °C) with increasing concentrations of M4-N. Colours as follows: black - 0 .tM M4-N, red 
- 10 ,tM M4-N, orange - 25 p.M M4-N, green - 50 p.M M4-N, blue - 100 [LM M4-N (all 
concentrations are for the dimer). Cross-peaks that disappear and then reappear are labelled 
at their positions in the free spectrum (black). 
5.7 Location of the residues on the structure of C4BP12 
Most of the significantly perturbed residues (Figure 55) are in the intermodular linking 
sequence, or in loops or turns near the intermodular interface. From the surface 
representation (Figure 5.5) it is obvious that these residues do not all reside on one face of 
the molecule. It is therefore improbable that they are all simultaneously involved in 
contacting the peptide. More likely the chemical shifts of some of these residues are 
perturbed by re-orientation of the two modules upon M4-N binding. Within CCP2, however, 
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significantly perturbed chemical shifts. These do form a contiguous surface, and together 
comprise a feasible binding patch. The protein engineering experiments described above 
establish that residues from the interface-proximal region of module 1 and/or in the linker 
additionally contribute directly to binding. 
1 	 10 	 20 	 30 40 	 50 	 60 
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KRCRk. LRNGQVE DLSrGSQIEFSCSEGFFLIGSTTSRCEVQ WSH L QCEI 
Figure 5.5 (Top) surface representation (N-terminus at top), indicating residues that show 
chemical shift changes upon M4-N binding. Blue - small combined chemical shift difference 
(see below); red - large chemical shift difference, unable to track cross-peak. Residues for 
which no NH shift information could be obtained (either proline residues or due to overlap in 
the HSQC spectra) are coloured grey. (Bottom) sequence of C4BP 12 illustrating the NH 
chemical shift changes on addition of M4-N. Residues coloured as follows: Black - no 
apparent change [combined chemical shift difference I((A6H) 2+(i& 5N/5)2) < 0.08 PPM]; 
grey - data missing; blue - small shift (combined chemical shift difference of> 0.08ppm, < 
0.2 ppm but able to trace peak movement); red - large shift (unable to track peak). 
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5.8 Intermodular re-orientation upon M4-N binding 
The changes in C4BPI2 chemical shifts that accompany association with M4-N implicate 
residues towards the middle of the module pair in binding, while the N-terminus of CCPI 
and the C-terminus of CCP2 are not involved. This is consistent with a complex that is 
globular, rather than linear, as also inferred from the relatively narrow line-widths of its 
NMR signals. The extent and distribution of affected residues are most convincingly 
explained by a ligand-induced intermodular conformational adjustment. There are three 
aromatic side-chains that can exert ring-current shifts in the vicinity of the interface (Figure 
5.6) - one from each of CCPs 1 and 2, and one in the linker (Tyr", Tyr 62 and Phe, 
respectively). Therefore an intermodular re-orientation upon binding would result in large 
chemical shift changes to residues around the CCP 1/2 interface as observed. The residues 











Figure 5.6 Closest to mean structure with residues that show chemical shift changes upon 
M4-N binding coloured according to position: Yellow - close to the interface (the chemical 
shift of these could be influenced by intermodular reorientation or direct contact); cyan - 
residues away from the interface likely to be in direct contact with M4-N. The aromatic side 
chains of Tyr37, Tyr62 and Phe84 are shown in space-fill representation. 
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5.9 Interpretation of the mutagenesis data for M4-N binding 
In earlier studies, K63Q - a substitution that could not be accommodated without perturbing 
the intermodular interface observed in the structure - had little effect on M4 binding (Blom 
et al. 2000). When considered in conjunction with the Ala-insertion experiments, this 
implies that while the four-residue length of the linker is critical for M4 binding, the 
interface composition, and hence the relative arrangement and flexibility of the two modules 
in the free protein, is not. This conclusion is consistent with a change of modular orientation 
upon binding, i.e. the bound conformation being different from the free one. 
The mutants R64Q and H67Q, each displayed reduced M4-binding - on the other hand 
R66Q and K79Q have increased affinity. All four of these mutated residues show significant 
chemical shift changes upon addition of M4-N. From the structure it is apparent that none of 
these mutations involve a residue that participates in the interface, rather Arg 64 and His67 
form a potential M4-binding patch on the surface of CCP2. This finding is supported by the 
observation that bovine, murine and rat C4BP lack one or both of Arg 64 and His67 and are 
indeed unable to bind M protein (Accardo et al. 1996). Arg66 and Lys 79 flank His 67 , and the 
gain of affinity resulting from the R66Q and K79Q substitutions could be explained if the 
native residues impede access to the M4 binding site either because of their positive charge 
or by virtue of their steric bulk. The lack of dependence on salt and pH suggest that binding 
of M4 requires other forces apart from electrostatics (Blom et al. 2000). In general, the 
pattern of effects on M4 binding that result from mutagenesis of charged residues is 
consistent with an interaction in which electrostatics steer the two components towards a 
productive interaction, but other forces are critical to stabilise the complex eventually 
formed. Thus while some mutations inhibit binding, others increase it, and some mutations 
compensate for one another. It is unsurprising that selected substitutions in C413P improve 
binding - the interaction is unlikely to be optimal in terms of affinity since the two partners 
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are under opposing evolutionary influences in this respect. Furthermore, the interaction is not 
specific to M4 - other M proteins with different hypervariable domains also bind to C413P. 
5.10 Conclusions 
The module deletion and ITC studies showed that CCPI and CCP2 of the C4131? a-chain and 
the linker residues between them are necessary and sufficient for M4 binding. The chemical 
shift changes observed upon M4-N binding to C4131? 12 suggest that the binding site is close 
to the CCP1/2 interface and that intermodular re-orientation occurs upon binding. This is 
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6.1 Introduction 
C413P binds to double stranded 25-bp DNA with a K. of 190 nm (Trouw et al. 2005). This 
interaction is thought to localise C4131? to areas of necrosis and apoptosis where is can act to 
down-regulate the classical pathway of complement activation. This ensures that the late 
stages of complement - i.e. C5a release and MAC assembly - do not occur, thus preventing 
inflammation and tissue damage. Studies using deletion mutants have localised the binding 
site to CCPI and CCP2 of the u-chain. Having solved the structure of this region of C413P, 
the binding site for DNA could be mapped onto the structure. This was achieved using 
dsDNA in a NMR titration with C413PI2 to map NH chemical shift changes on addition of 
DNA. As the structure of both interacting components is known, data from the titration could 
be used to produce a model of the C4BP12:DNA complex by data-driven docking using the 
HADDOCK programme (Dominguez et al. 2003). 
6.2 DNA used 
The SPR studies performed by Trouw et al. used double stranded 25-bp DNA. For the initial 
NMR titration two complementary 20mer oligonucleotides with a 'randomly' selected 
sequence (chosen to have an equal number of A, T, G and C bases, and no self-
complementarily to avoid secondary structure formation) were purchased from Sigma-
Genosys and annealed as described in Section 8.3. In an initial titration with u[ 15N]-C4BP12 
considerable precipitation of the C413P 12-DNA complex occurred (as judged by the lack of 
15N-labelled material present in the sample after the sample was spun in a microfuge to 
remove the precipitate). The precipitation was presumed to result from multiple molecules of 
C413P12 binding to one dsDNA molecule. Two shorter 10-bp oligos were purchased, and 
annealed and used for subsequent titrations. The I0-bp dsDNA caused much less 
precipitation; and any precipitate formed on addition of 10-bp DNA to C4131?I2 could be 
redissolved by warming (to 37 °C) and stirring. The sequences used are shown in Table 6.1. 
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20mer5' 5'— AAT ATA TGG CGC GCT TAC CG —3 
20mer3' 3— TTA TAT ACC GCG CGA ATG GC —5 
l Omer 5' 5'— AAT CGC GCT T —3' 
l Omer 3' 3'— TTA GCG CGA A —3' 
Table 6.1 DNA sequences used for titration with C4131? 12 
6.3 Titration of 10-bp dsDNA with C4BP12 
An overlay of five ' 5N-HSQC spectra recorded at increasing ratios of DNA:C4BPI2 is 
shown in Figure 6.1. It is clear that the system is in fast exchange and the cross-peaks track 
with increasing concentration of DNA. Unlike the situation with M4-N, all the perturbed 
cross-peaks could be tracked and the chemical shift changes for each residue in C413P12 
(excluding the eight proline residues and Asn 1 , His4 ' and Phe59 that could not be assigned at 
pH 6.0) could be measured. The combined chemical shift changes are calculated as 
)2+(Abl 	and are plotted per residue in Figure 6.2. 
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Figure 6.1 Overlay of five 15N-HSQC spectra of 50 iM C4BP12 with increasing 
concentrations of DNA. Colours: black - 0 tiM, red - 25 jM, orange - 50 .tM, green - 100 
.tM, blue - 200 1iM 10-bp dsDNA. Residues with combined chemical shift difference of> 
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Figure 6.2 Combined chemical shift changes [I((AoN/5) 2+(A&H)2)] per residue at 4:1 
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Figure 6.3 Surface of the closest to mean C413PI2 structure with residues showing chemical 
shift changes upon DNA binding coloured: red - combined chemical shift difference > 0.1 
ppm; orange - chemical shift difference > 0.05, < 0.1 ppm. Residues for which no 
information could be obtained are coloured grey 
6.4 Mapping shift changes onto the C4BP12 structure 
The chemical shift changes at 4:1 [DNA]:[C4BP12] are shown on the structure of C4BPI2 
in Figure 6.3. The largest chemical shift changes occur at the CCP1/2 interface and all the 
shift changes are located proximal to the interface. The number and extent of shift changes is 
not as great as for the M4-N interaction. This suggests that the intermodular reorientation 
proposed to occur upon M4-N binding does not feature in DNA binding. Therefore, the 
localisation of shift changes at the CCP1/2 interface indicates that DNA binds at the 
interface between CCPI and CCP2. 
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6.5 Using HADDOCK to generate the C4BPI2:DNA complex 
The programme HADDOCK (High Ambiguity Driven protein-protein Docking) was 
developed to produce the structure of a complex by docking the proteins (or protein and 
DNA) involved by making use of biochemical and/or biophysical information. Such data 
includes chemical shift perturbations obtained from NMR titration experiments or the results 
of mutagenesis experiments and is used to guide the two interacting partners together in the 
correct orientation. In HADDOCK the information regarding residues that interact is 
introduced as ambiguous interaction restraints (AIRs) to drive the docking. The AIRs are 
divided into two classes- 'active' and 'passive'. For NMR titration data, 'active' residues are 
defined as those residues that show a significant chemical shift perturbation upon complex 
formation as well as a high solvent accessibility in the free form. The 'passive' residues are 
defined as residues that show smaller chemical shift perturbations and/or that are surface 
neighbours of the active residues and have a high solvent accessibility. In the case of 
rriutagenesis data, the 'active' residues are those that when mutated prevent complex 
formation and are also solvent-exposed. 
6.5.1 	Ambiguous interaction restraints 
For the C4BP12:DNA docking the 'active' residues were defined as the eight residues that 
showed combined chemical shift changes on DNA binding of> 0.1 ppm and, in addition, 
residues Arg39 and Arg66 that were shown to be critical for DNA binding by mutagenesis but 
that did not show large shift changes on DNA binding. The 'passive' residues were solvent-
exposed residues surrounding the active residues that showed smaller shift changes on DNA 
binding and also two residues that were missing from the shift mapping data - Pro" and 
His41 . For the DNA, all the bases were defined as 'active' as there was no experimental 
information to define the location of C413P12 on the DNA duplex. These residues are shown 
on the structure in Figure 6.4. 
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'Active' residues Tyr", Va13 , Arg39, Ser, Thr43 , Tyr62, Lys63, ArgM, 	 rg66  TWO 
Passive residues  Pro" , 35 Giy 36 41 	42 	61 	3 	?6 , His 4' , Ser 	, lie , Ser 	, Ser 
Table 6.2 The active and passive residues defined for the docking with HADDOCK. 
Residues highlighted in bold were implicated by mutagenesis but did not show shift changes 
upon DNA binding. 
-4 ~ 
 1800 
Figure 6.4 The active (blue) and passive (cyan) residues used in the C4BP 12-DNA docking 
6.5.2 	Structures used 
For C4BP 12 all forty structures in the ensemble were used as input for HADDOCK. For 
DNA the NMR structure of the 12mer of double-stranded DNA with sequence 
5'-GGCAAAAAACGG -3' (PDB id = 1FZX) was truncated to 5'-GGCAAAAAAC-3' prior 
to use in the HADDOCK docking. This structure serves only as a template as the DNA 
conformation is restrained to that of canonical B-form DNA in the starting structures for the 
rigid-body docking There is no reported sequence specificity for DNA binding by C4BP12 
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so the differences in sequence between the DNA used in the titration and the DNA used for 
docking is not considered likely to cause problems. 
6.5.3 	Flexible regions 
The HADDOCK docking protocol consists of four stages: (i) a high temperature rigid body 
search, (ii) rigid body simulated annealing (SA), (iii) semi-flexible SA with flexible side-
chains at the interface, (iv) semi-flexible SA with fully flexible interface (both backbone and 
side-chains). The residues at the intermolecular interface that were defined as semi-flexible 
and hence allowed to move in steps (iii) and (iv) of the C4131`12-DNA docking protocol were 
defined as those stretches of residues that showed chemical shift changes upon DNA binding 
(Table 6.3 and see Figure 6.2). 
Segment 1 Thr32-Thr45 
Segment 2 Cys60-Cys65 
Segment 3 11e78-Gln87 
Segment 4 Asp' ' °-Trp" 5 
Table 6.3 Semi-flexible residues defined in the C413P12:DNA docking. 
In addition residues G1y36-His4 ' and Lys79-Asp8 ' were defined as fully flexible and allowed 
to move in all stages of the docking protocol because these are the two loops close to the 
intermodular interface containing active residues which are not part of the linker between 
CCP1 and CCP2. 
6.5.4 The docking 
1000 complex structures were calculated in the rigid docking stage. The 100 lowest energy 
structures from this stage were used in the semi-flexible refinement stages and then refined 
in a water shell to produce the final ensemble of complex structures. The energy term used to 
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rank the structures is the intermolecular energy which is the sum of the electrostatic, van der 
Waals, and AIR energy terms. The structures were analysed using cluster_struc 
(distributed with HADDOCK). This programme uses the pairwise-rmsd matrix of all the 
structures calculated to produce a cluster of structures whose rmsd to each other is less than a 
specified cut-off value. A rmsd cut-off of 1.2 A resulted in a single cluster containing five 
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Figure 6.5 Plot of intermolecular energy vs backbone rmsd from the lowest-energy structure 
for the 100 water refined structures of the C4BP 12-DNA complex produced by HADDOCK. 
The members of the cluster described in the text are coloured red. The mean intermolecular 
energy and rmsd of this cluster from the lowest-energy structure is shown by the blue point 
with the standard deviation shown by the error bars. 
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W 1800 W 1800 
Figure 6.6 Two stereo views (cross-eyed) of the cluster of five structures of the C413PI2-
DNA complex produced by HADDOCK. The backbone of residues 2-122 of C413P12 and 
the lObp DNA duplex is shown. Structures were overlaid on the backbone of residues 2-122. 
6.5.5 	The complex 
The lowest-energy structure of the cluster is assumed to be the 'best' structure of the 
complex and this is shown in (Figure 6.7). This complex has a buried surface area of 
1730 A2  (calculated by taking the difference between the sum of the solvent accessible 
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the solvent accessible area of the complex. The DNA is bound at the CCP1/2 interface with 
residues from both CCP 1 and CCP2 contacting the DNA. The contacts are predominantly 
electrostatic interactions between positively charged side-chains and the negatively charged 
phosphates in the backbone of the DNA duplex. 
Figure 6.7 Two views of the lowest energy structure in the cluster. The active residues used 
in the the docking are shown in stick representation and coloured red. Residues that were 
shown to be critical by mutagenesis (Arg 39, Lys63 and Arg66) are coloured orange. 
6.6 Interpretation of the mutagenesis data for DNA binding 
In the study by Trouw el al. (2003), DNA gel shift analysis with C4BP mutants showed that 
the positively charged residue Arg 39 in CCP 1, Lys63 in the linker and Arg 66 in CCP2 were 
critical for DNA binding whereas ArgM  was of intermediate importance and His 67 did not 
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seem to be required. On the other hand, in the chemical shift mapping study, the NH cross-
peaks of Arg39 and Arg66 did not show significant shift changes upon DNA binding. Lys 63 
and Arg64 showed significant shift changes (combined chemical shift change> 0.1 ppm) and 
were included as 'active' residues in the data-driven docking. His 67 shifted an intermediate 
amount (0.06ppm). These results are summarised in Table 6.4. 
Residue Effect of mutagenesis Chemical shift change Position in structure 
Arg39 destroys binding small (<0.05 ppm) side-chain contacts DNA 
Lys63 destroys binding large (0.39 ppm) side-chain contacts DNA 
Arg64 intermediate binding large (0.29 ppm) side-chain away from DNA 
Arg 66 destroys binding small (<0.05 ppm) far from DNA 
His67 no effect intermediate (0.06 ppm) far from DNA 
Table 6.4 Residues changed in mutagenesis study: effect on DNA binding, (combined) 
chemical shift changes upon DNA binding, position in HADDOCK complex. 
In the HADDOCK C4BP12:DNA complex the side-chains of both Arg 39 and Lys 63 contact 
DNA, and it is possible that both are directly involved in DNA binding. The side-chain of 
Arg64 , however, points away from the DNA and in this case the amide shift changes 
observed upon DNA binding likely reflect a slight change in the structure of the 
intermodular interface rather than resulting directly from the interaction of this residue with 
DNA. Indeed, the structure of C413P12 suggests that Arg 64 is critical to the stability of the 
CCP1/2 interface (Section 4.6.2), so its mutation would disrupt the interface and thus likely 
reduce, but not eliminate, the ability of C413P to bind DNA. This hypothesis is supported by 
the mutagenesis data indicating an intermediate role for Arg 64 . The mutagenesis results for 
Arg66 and His67 are interesting since mutation of these two consecutive, charged, residues 
has such different effects. As Arg 66 does not shift upon DNA binding, and it is located far 
from the DNA in the HADDOCK complex, its role is likely to be in steering the two 
components towards a productive interaction rather than in contacting the DNA in the final 
complex. The small chemical shift change of the NH cross-peak of His 67 may arise from a 
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slight rearrangement of the backbone of CCP2 upon DNA binding at the interface. The 
absence of shift changes for Arg 39 upon DNA binding is, however, not consistent with this 
residue contacting DNA in the complex. There are no DNA-induced shift changes seen for 
the H, H, H 2 or Hos  cross-peaks of Arg 39 in the 13C-HSQC spectra (data not shown) yet the 
shift changes of residues around Arg 39 and the mutagenesis data implicate this residue in 
binding. It is, therefore, possible that the role of Arg 39 is again in electrostatic steering of the 
DNA and that the contacts with DNA seen in the HADDOCK model are an artefact of 
erroneously defining this residue as 'active' - based on the mutagenesis data - in the docking 
procedure. 
6.7 Conclusions 
NH chemical shift-mapping was used to locate the DNA binding site on C4131?12 to the 
CCP1/2 interface. This is consistent with module-deletion studies and mutagenesis data. The 
shift-mapping data was used in conjunction with the results of the mutagenesis study in data-
driven docking with HADDOCK to generate a model of the C4BP12:DNA complex. The 
existing mutagenesis data was then interpreted in the light of this model. The role of Lys 63 in 
directly binding DNA seems clear. Arg 39 and Arg66, which are both critical for DNA 
binding, are hypothesised to be involved in steering the DNA, via electrostatic interactions, 






CHAPTER 7- DISCUSSION 
7.1 Overview 
The aims of this thesis were to: 
Use NMR spectroscopy to solve the 3D structure of C413P12. 
Interpret the mutagenesis data gathered to date in light of this 3D structure. 
Investigate the binding of the M4 HVR from S. pyogenes to C413P12 using NMR 
spectroscopy and other biophysical techniques. 
Map the binding site for DNA onto the C413P12 structure. 
Previous chapters of this thesis describe the determination of the 3D structure of C4BP12. 
This has allowed delineation of the structural basis for the interactions of C4BP with the M 
proteins of the pathogenic bacterium S. pyogenes, and with host DNA. 
In this chapter the limitations of the methods used will be critically assessed. The 
implications of the structural studies for the function of C413P will be considered, including 
its affinity for binding to CO and cell-surface glycosaminoglycans. Future directions for 
study of the structure and function of C4BP will be discussed. 
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7.2 Methods used for calculation of the structure of C4BP12 
The structure of C4BP 12 was solved on the basis of NMR-derived structural restraints using 
MDSA protocols based on the work of Prof. Michael Nilges and others (Nilges et al. 1988a; 
Nilges et al. 1988b; Nilges 1995). The calculated structures showed a good level of 
convergence, and high precision (i.e. a low rmsd for the ensemble of 40 low-energy 
structures). The quality scores were deemed acceptable for a small protein domain with 
relatively little secondary structure and some disordered loops. However, the improvement 
in quality scores obtained following water refinement suggests that the protocols used to 
calculate the structures could be improved. In particular, the strategy for dealing with the 
effects of spin diffusion and local dynamics on the intensity of NOE cross-peaks, which 
entails the use of large error bounds on the distance restraints, discards much of the 
information content of the NOE. It was shown recently that the use in structure calculation of 
a potential for NOE-derived distance restraints that reflects the error in calculating these 
distances improves the quality of the calculated structures (Nilges et al. 2006). This potential 
has the form of a log normal distribution, rather than the previously used flat-bottomed 
harmonic well (FBHW) potential with wide upper and lower bounds. A further advantage of 
this potential is that the precision of the structures automatically decreases with the quality of 
the data, making the rmsd a more meaningful number. With a FBHW potential the rmsd is 
heavily influenced by the width of the bounds (Chalaoux et al. 1999) and is, therefore, not an 
unbiased measure of structural quality. 
Recently, a new method of structure calculation has been described (Rieping et al. 2005). 
This method is based on a probability distribution that represents an unknown structure and 
its precision, derived using Bayesian inference, and simulated using Markov chain' Monte 
Carlo techniques and is known as inferential structure determination (ISD). ISD circumvents 
A Markov chain is a collection of random variables (describing the state of a system) with 
the property that, given the present, the future is conditionally independent of the past. 
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problems in conventional structure calculation protocols such as empirical choice of the 
parameters because these are determined directly from the probability distribution. However, 
at present this technique is too computationally expensive for routine use. 
7.3 Intermodular orientation of C4BP12 
The extent to which the intermodular orientation in the calculated structures reflect reality is 
a key issue. The ensemble of structures presented in Chapter 3 were calculated using a single 
alignment tensor. This would be expected to produce structures with a well-defined 
intermodular orientation. It is important to question whether this could be an artefact. There 
was good agreement between the alignment tensors produced either when separate alignment 
tensors for each module were employed, or when a single alignment tensor for the whole 
molecule was used. This indicates that the approximation that the whole molecule 
experiences the same alignment tensor is valid (Ball 2005). 
RDCs (by definition) can only be measured from aligned molecules in the sample. If only a 
subset of the conformations of the protein in solution can align, the conformational space 
sampled in the RDC measurements, and hence the apparent flexibility of the structures 
refined using these RDCs will be reduced. Interactions between the protein and the 
alignment media could also influence artefactually the conformation of the protein. 
Therefore, it is possible that the intermodular orientations in the RDC-refined structures 
presented in Chapter 3 are overly tightly defined and do not reflect the full range of 
conformations sampled by C4131`12 in solution. 
To investigate this possibility, structures were recalculated using identical protocols and 
restraints to those employed to produce the RDC-refined structures but with the TENS 0 
term removed from the energy function. The intermodular angles amongst these recalculated 
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structures are compared with the RDC-structures in Figure 7.1. This comparison suggests 
that the spread of intermodular angles is indeed wider in the NOE-only structures than when 
RDC restraints are used in refinement. However, it is important to remember that the spread 
of structures reflects only the number and strength of intermodular (and module-linker) 
restraints. Although less NOEs might be expected if the interface were flexible due to 
averaging effects and local dynamics, the spread of orientations in the structure is not, of 





Figure 7.1 Comparison of intennodular twist, tilt and skew angles from the ensemble of 40 
RDC-refined structures (red circles) and the ensemble of 42 structures calculated using only 
NOE-derived restraints. The NOE and dihedral angle restraints used were identical. 
It is slightly concerning, however, that mean twist angle in the RDC-refined structures lies 
just outside the spread of values for the structures calculated using only NOE restraints. This 
difference in inter-modular orientations may reflect genuine differences in conformation 
between aligned and non-aligned media; it could account for some of the distance-restraint 
violations in the ensemble of RDC-refined structures that are not present in the NOE-only 
structures. If, as proposed in Section 7.4, the intermodular orientation of C4BP 12 is able to 
change on ligand binding, it is conceivable that the twist angle could be different under 
different sets of conditions. The negatively charged surface of the phage used to align 
C413P 12 could well have a weak interaction with the protein that may alter the intermodular 
orientation. RDC data acquired from C413P12 aligned in a different medium would provide 
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an independent check on the intermodular orientation presented in Chapter 3. Also 
comparison of experimental RDC values with values calculated from an alignment tensor 
based on the structure of C4BP12 using PALES (Zweckstetter et al. 2000; Zweckstetter et 
al. 2004) would indicate if all the conformations present in non-aligned media can align. For 
a protein interconverting rapidly between multiple conformations, the measured dipolar 
couplings must agree with the ensemble-weighted average of couplings predicted from these 
conformations. 
The use of data from small-angle X-ray scattering (SAXS) in refinement of multi-domain 
protein structures has been recently reported (Grishaev et al. 2005). It is possible that this 
technique could be used to refine the C4BP12 structures presented in Chapter3. The most 
striking difference in the intermodular orientation of C4131`12 compared to DAF23 and CR1-
1516 is the intermodular twist angle, and the SAXS data might not be of high enough 
resolution to distinguish between different values of this angle as the overall shape of the 
module pair would remain similar. 
7.4 Intermodular re-orientation of C4BP12 
The experimental structure together with the chemical shift perturbation data for M4 binding 
indicate that binding involves an intermodular reorientation of C413P12. This is the first 
experimental evidence in support of intermodular flexibility being important for the ligand-
binding properties of a mammalian RCA protein. The viral RCA, VCP, undergoes a 
conformational change upon heparin binding (Ganesh et al. 2004). 
In the light of this information, it seems likely that such conformational flexibility could also 
be important for C4BP binding to the natural ligands, C4b and glycosaminoglycans. Indeed, 
residues implicated as critical for C4b and heparin binding by mutagenesis - Arg 39, Lys", 
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Arg64 and His67 - are not clustered together in the structure of the free protein. These residues 
would be brought into juxtaposition by a twist between the modules, creating an interaction 
that is dominated by electrostatic forces. A similar hypothesis was suggested in the case of 
DAF23 as an explanation for the pattern of functionally critical mutants within the solution 
structure (Uhrinova et al. 2003). Moreover, the lack of consistency amongst intermodular 
angles within C3b/C4b-binding regions of the free RCAs (Section 4.6) could be explained if 
each RCA undergoes a conformational change upon binding, perhaps converging on a 
common C3b/C4b-bound orientation that is necessary for cofactor and/or decay-accelerating 
activity. 
An interesting possibility is that a conformational change is induced by glycosàminoglycan 
binding - analogous to that observed for VCP (Ganesh et al. 2004) - which in turn might 
exert a positive effect on the regulatory activity of C4BP. 
7.5 The C4BP12:M4-N complex 
7.5.1 	Spectra of the complex 
The quality of the spectra of the C4BP12:M4-N complex recorded at low (20 [tM) 
concentrations of C4BP12 was good. However, the complex did not behave well at higher 
concentrations. The 'H-' 5N HSQC spectra of the complex at 0.6 mM (Figure 7.2) were poor 
with most peaks broadened compared to the spectra recorded with a C4BP12 concentration 
of 20 [tM. 
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Figure 7.2 'H- 15N HSQC spectrum of 0.6 mM C4BP12:M4-N complex, 20 mM sodium 
phosphate buffer, pH 6.0, 37 °C. 
An overlay of planes from the 3D HNCO spectrum of the C4BPI2:M4-N complex is shown 
in Figure 7.3. The only cross-peaks that are present are from the N-terminus (Asn'), the C-
terminus (Glu 126, and the His 6 tag) and residues in the flexible (see section 4.6) hypervariable 
loop (Asp' 5 , lie 16,  Thr' 7 , Leu' 8 , Thr' 9 and G1u20). The other cross-peaks in Figure 7.3 could 
not be assigned. The CBCA(CO)NH spectrum of the complex contained only cross-peaks 
from the C-terminal His 6-tag. The HNCO (the most sensitive of the triple-resonance 
experiments) spectra shown in Figure 7.3 only yielded cross-peaks from flexible residues 
that showed no or small shift changes upon M4-binding. This poor spectral quality was 
attributed to chemical exchange (the K d for the interaction measured by ITC was 0.5 &M) 
and the poor solubility of the complex. 
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Figure 7.3 Overlay of 15N-'H planes of 3D HNCO spectrum recorded on 0.5 mM 
C413P12:M4-N complex, 20 mM sodium phosphate/acetate mixture, pH 4.5, 37 °C. 
Thus assignments of C413P12 in the complex could not be made. Therefore, chemical shift 
changes for the cross-peaks in slow exchange could not be quantified. This limited the 
mapping studies described in Chapter 5. Perturbations of resonances in fast exchange could 
be tracked during the titration, while resonances in slow exchange were simply flagged as 
undergoing large chemical shift changes. Other methods that could be used to study the 
C4BPI2:M4-N interaction are discussed in Sections 7.5.2 - 7.5.4. 
7.5.2 Mapping with paramagnetism 
Paramagnetic species have permanent magnetic moments (dipoles), even in the absence of 
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of a paramagnetic tag to M4-N and the resulting paramagnetic relaxation enhancement 
(PRE) induced line broadening (Petros et al. 1990) on the 15N-HSQC spectrum of C4BP12 in 
the C4BP12:M4-N complex would provide further information about the position of M4-N 
in the complex. In an alternative approach (Deschamps et al. 2005), nitroxide radicals could 
be added to solutions of both free C413P12 and of the C4BP12:M4-N complex. The residues 
on the surface of the C4BP12 involved in M4-N would be protected in the C4BPI2:M4-N 
complex from non-specific weak protein-radical interactions and thus changed PRE effects 
would be seen between free and complexed C4BP12. These residue specific differential PRE 
effects (APRE) would provide complementary information to the chemical shift perturbation 
data. Both approaches could potentially help to discriminate between residues that are in 
direct contact with M4-N and residues that show NH chemical shift-perturbations resulting 
from intermodular re-orientation on M4-N binding. 
7.5.3 	Mapping with pseudocontact shifts 
Attachment of a paramagnetic tag to M4-N could also be used to map the C4BPI2:M4-N 
interface through pseudocontact shifts (Allegrozzi et al. 2000). The basis of these shifts is as 
follows: If the electronic magnetic dipole of the spin label does not stay aligned with the 
external magnetic field when the complex tumbles in solution then the electron-nuclear 
dipolar interaction will not average to zero. The residual electron-nuclear coupling that 
remains will result in shifts of the NMR resonances - known as pseudocontact shifts. These 
pseudocontact shift contain information on both distance (with a f3 dependence) and 
orientation of the paramagnetic centre on the ligand with respect to the reporting protein. 
Attachment of EDTA-based lanthanide binding tags can also be used to generate weak 
alignment (Ikegami et al. 2004) enabling RDCs to be measured from the complex. 
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7.5.4 Mapping with cross saturation 
Cross saturation (Takahashi et al. 2000) could also be used to map the contact site for M4-N 
onto C4BP12. This has the advantage over chemical shift peturbation based mapping that 
only protons close to the interface will be affected by saturation transfer from the donor to 
the acceptor molecule and thus decrease in intensity even if long range conformational 
changes occur. The use of this method would, however, require perdeuteration of the target 
protein (i.e C413PI2). 
7.5.5 	Structural studies of M4 
The recent work on the structure of M4-N, both free and in complex with C4BP12 (André et 
al. 2006), suggested that residues Asn' 9-Ser37 were in an cc-helical conformation. This 
conclusion is based on secondary 13  C" and 13 C0 chemical shifts and {'H}-' 5N NOE 
measurements. André et al. were unable to assign residues Asn' 3-Asn' 9 due to missing cross-
peaks. This region is nevertheless shown as structured in the model of M4-N (André et al. 
2006) which was produced using SIR4 from Saccharomyces Cerevisiae (Murphy et al. 2003: 
PDB id = 1PL5) as a template. Residues Ala'-Trp' 2 and A1a39-Cys46 are not structured based 
on the random coil values of their I3Ca  and 13 C0 chemical shifts and the { 1 H}-' 5N NOE data. 
Ala'-Trp' 2 are clearly structured in the model produced but this region of the model was not 
compared to the experimental data. Agreement between experimental and calculated values 
(from the model) for ' DNH dipolar couplings and R 21R 1 ratios was suggested to confirm the 
coiled-coil model produced, although the validity of using a model that clearly differs from 
experimental data in certain parts is questionable. Also the very limited set of R 21R 1 values 
and RDCs that could be measured means that any agreement between the experimental and 
calculated values is highly dependent on the errors in measuring the experimental values. 
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As cross-peaks for all 27 residues that were proposed to form the coiled-coil region in free 
M4-N disappeared on addition of C4BP12 (André et al. 2006) the C4BP-binding region of 
M4-N was proposed to be up to 35 A long. The authors suggested that this would mean 
M4-N was capable of simultaneously contacting both modules which is consistent with the 
module deletion (Jenkins et al. 2006) and chemical shift-mapping studies (Chapter 4). 
Binding arrangements such as one with M4-N bound at the CCP1/2 interface almost 
perpendicular to the long axis of the module pair would also explain the chemical shift 
perturbations and also the similar line-widths of NH cross-peaks of residues in C4BP 12 in 
the C4BP12:M4-N complex compared to free C4BP12. This arrangement would require a 
much shorter length for the C4131`12-binding region in M4-N. As deletion of seven residues 
in the HVR of the related M22 protein abolished C4BP binding (Berggárd et al. 2001 a), it is 
tempting to speculate that the C4BP-binding region in the HVR is much shorter than 
suggested by André et al. 
7.6 C4BP and DNA-binding 
C4BP is known to bind polyanions such as heparin, which is considered a model for 
glycosaminoglycans. DNA is, of course, a polyanion, and the question of whether DNA 
binding by C4131? is physiologically relevant must be addressed. DNA is released from 
apoptotic cells and in larger quantities from necrotic cells (Jahr et al. 2001). C4BP is known 
to localise to apoptotic (Kask et al. 2004) and necrotic (Trouw et al. 2005) cells. 
First, the role of C413P in apoptosis should be discussed. All cells have membrane-bound 
RCA proteins on their surface (i.e DAF, MCP and CR!) that act to down-regulate the 
classical pathway C3 convertase. This would seem to make the recruitment of C4131? to areas 
of apoptosis or necrosis superfluous. It is possible though that such recruitment is designed 
to achieve a level of redundancy sufficient to ensure that complement-mediated 
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inflammation and tissue destruction cannot occur even if the cell-surface RCAs are 
'swamped' by a high level of complement activation (many intracellular components, 
including DNA, are potent activators of the complement system). It is also possible that 
levels of RCA expression on dying cells might be reduced compared to normal cells. 
Next the potential role of DNA in the localisation. of C4BP to areas of cell death can be 
considered. C4BP exploits its strongly-bound protein S component to bind to apoptotic cells 
via phosphatidylserine molecules (Webb et al. 2002). Cell-surface GAGs presumably 
provide further anchor sites for C4131? via the binding sites on the alpha-chains. Since C4131? 
is polymeric, occupation of several arms by GAGs would leave others free to scavenge any 
segments of DNA that had leaked from the apoptotic or necrotic cell. The perpendicular 
orientation of B-form DNA, relative to the long axis of C4131?12, implicated by the data-
driven docking procedure is consistent with several alpha-chains binding simultaneously to 
one DNA molecule. This polyvalency would assure a slow off-rate and effective trapping. In 
this way the DNA would be prevented from diffusing away and activating complement in 
the fluid phase. So long as one alpha-chain of C4131? still remained unoccupied, this would 
leave a regulatory site free to prevent complement activation on the entrapped DNA 
molecule. 
The DNA-binding site in C4131? coincides with the putative (on the basis of mutagenesis) 
binding site for heparin, which has been shown to displace DNA bound to C4131? (Trouw et 
al. 2005). Therefore, it would be useful to measure the relative affinities of C4BP12 for 
DNA and heparin. It has also been observed that DNA binds to the C-terminal modules of 
factor H (f111920) (Figure 7.4) - and the binding appears to be much tighter than to 
C4131`12. A comparison of the affinities of C4131?I2 and fH1920 for both DNA and heparin 
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would shed light on the interplay between these fluid-phase regulators of the classical and 
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Figure 7.4 Preliminary surface plasmon resonance data for C4BP12 and fHl9-20 binding to 
20-bp dsDNA (sequence given in Chapter 6) coupled to a streptavidin chip via a biotin tag. 
7.7 Site-directed mutagenesis based on the C4BP12 structure 
One of the most obvious differences between the C4BP12 and the DAF23 crystal structures 
is the intermodular orientation (Figure 4.11). The orientation of CCP2 in C413PI2 exposes 
the Val' °5-Val' 3 loop. This loop (see Figure 7.5), which is involved in the CCP2/3 interface 
in DAF (Lukacik et al. 2004), has a very different sequence in C4131) (QDRG) to that in 
DAF (SGSS). As this loop is critical to the C3b/C4b binding activities of CR1 sites 1 and 2 
(Krych et al. 1994b; Krych et al. 1998b), it is likely to also be involved in C4b binding by 
C4BP. In particular Arg" is exposed on the surface of all the structures in the low-energy 
ensemble. Since other surface-exposed, charged residues have been shown to be critical for 
C4b-binding, this residue seems likely to be the a key component of this loop. Prof Anna 
Blom has made the following mutants of these residues Q1O9A, D11ON, RlllQ and G112S 
and is currently testing their ability to bind M. 
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Name 	SS 01 	32 HV-loop 133 	134 	135 	136 	f7 	138 
C4BPA_02 	RCRHPGELRNG-QVE--- IK1DLSFGSQIEFSCSEGFFLIG- -STTSRCEVQDRGVGWSHPLPQCE IV 
DAF03 SCPNPGEIRNG-QID--- VPILFGATISFSCNTGYKLFG--STSSFCLISGSSVQWSDPLPECREI 
CR1_02 	SCRNPPDPVNG-MVH--- VIKIQFGSQIKYSCTKGYRLIG--SSSATCIISGDTVIWDNETPICDRI 
CR1_09 SCKTPPDPVNG-MVH--- VI7DIQVGSRINYSCTTGHRLIG- -HSSAECILSGNAAHWSTKPPICQRI 
CR1_1 6 	SCKTPPDPVNG-MVH---- VI2DIQVGSRINYSCTTGHRLIG- -HSSAECILSGNTAHWSTKPPICQRI 
Figure 7.5 Sequence alignment of CCP2 from C4131? a-chain, CCP3 from DAF and CCP2 
(site 1), CCP9 (copy 1 site 2) and CCP16 (copy 2 of site 2) of CR1. The loop discussed in 
the text (comprising residues Val 108-Val" 3 in C413P) is highlighted in bold text. 
7.8 Structure of the C4b-binding site 
The structure of C4131?I2 represents two of the three modules necessary for complement 
regulation (Blom et al. 2001a). Therefore, the next target for structural studies on C413P is to 
solve the structure of the CCP2-3 module pair (C4BP23) and to produce the structure of 
C413P1-3 by overlaying the structures on CCP2, which is present in both constructs, in the 
same strategy that was used to produce the structure of the C3b-binding site of CR1 (Smith 
et al. 2002). This work is currently in progress. The 5N-HSQC spectra of C413P23 and 
C413P12 are overlaid in Figure 7.6. 
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Figure 7.6 Overlay of 'H- 15N HSQC spectra of C4BP12 (red) and C4BP23 (blu 
Conditions for both samples were identical: 20 mM NaOAc buffer, pH 4.5, 37 °C 
Comparison of the chemical shift changes between CCP2 in C4BP12 and C4BP23 show that 
the changes in shift are localised to the top and bottom of CCP2 (Figure 7.8) consistent with 
the removal of the CCP 1/2 interface and addition of the C4BP23 interface. This suggests the 
structure of CCP2 is the same in both constructs. 
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Figure 7.7 Combined chemical shift changes [4((A6l5N/5)2+(A8 I  R) 2)]per residue between 
CCP2 in C4BPI2 and C4BP23. P indicates proline residues and 0 indicates missing data. 
180 0 
Figure 7.8 Chemical shift changes between CCP2 in C4BPI2 and C4BP23 plotted onto the 
residues Ty162-Il& 24 in the closest to mean structure of C4BP 12. Residues with a combined 
chemical shift change > 0.2 ppm are coloured red. 
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8.1 Solution of the structure of C4BP12 using NMR spectroscopy 
	
8.1.1 	Sample preparation 
Details of the preparation of u[ 15N] and u[' 3 C,' 5N]-labelled C4BP12 can be found in Chapter 
3 and in (Jenkins et al. 2006). 
8.1.2 	Data collection 
Details of the NMR spectra used to solve the structure of C4BP12 are given in Chapter 3. 
8.1.3 	Quadrature detection 
During the acquisition period of an NMR experiment the oscillating magnetisation in the 
transverse plane generates an electric current in the receiver coil of the probe. The 
frequencies of the signals are measured as an offset from a reference frequency usually set to 
the centre of the spectrum. This measurement is either positive or negative depending on 
whether the signal frequency is greater or less than the reference frequency. In the 
quadrature detection approach the signal is split into two equal parts using a splitter. Each 
part is fed into a phase-sensitive detector. The first detector is fed with the reference 
frequency and the second is fed with a frequency 90° out of phase with respect to the first 
(Figure 8.1). 







sensitive fj 	channel2 detector 
reference 
Figure 8.1 Block diagram of a typical quadrature detection system. 
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Quadrature detection works as follows: The signal J(t) arising in the receiver coil from a 
vector precessing in the rotating frame with a frequency offset +Aw from the reference 
frequency is: 
f(t)= cos Acot 	 (8.1) 
Using the identity cos(x) = 4(e + e) equation 8.1 can be written as: 
f(t) +(e'" +e- 0t) 	 (8.2) 
The Fourier transform (Section 8.1.6) of this is: 
f(w) = .-(Abs(+Aw) + i Dis(+A(o) + Abs(—Aco) + i Dis(—Aw)) 	(8.3) 
which gives resonance lines at ±w - i.e the sign of the precession frequency is not 
determined. However using quadrature detection the output from the unshifted channel is 
cos(Awt) and that from the 900  phase shifted channel is (in complex notation) i sin(Awt). The 
detected signal is therefore: 
f(t) = cos(wt) + i Sin(4t(ot) 	 (8.4) 
If the additional identity sin(x) = _ 4 (e _e) is used equation 8.4 becomes: 
f (t) = (e  1t + eiw1) +(e 'Aam-  e°) = e0)t 	 (8.5) 
The Fourier transform of equation 8.5 gives: 
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f(w) = Abs(+A(ot) + i Dis(+Awt) 	 (8.6) 
In this way the sign of the precessing frequency has been determined and the absorption 
(Abs) and dispersion (Dis) components are the real and imaginary parts of the spectrum 
respectively (Figure 8.2). 
8.1.4 	Digital Sampling 
The frequency of digital sampling of the time domain data is crucial as this determines the 
maximum spectral width in the experiment. If the continuous time domain signal is x(t) and 
sampling is performed by measuring the value of the signal every At seconds the sampled 
signal is given by: 
An] = x(nAt) 	with n =0,1,2,3 	 (8.7) 
The sampling frequencyJ is defined as the number of samples obtained in one second: 
1 
At 
In order to reconstruct the original signal perfectly, the Nyquist-Shannon sampling theorem 
states that the sampling frequency must be more than twice the maximum frequency. 
Therefore, the frequency equal to one half of the sampling rate is the highest frequency that 
can be unambiguously represented by the sampled signal. This frequencyfN is known as the 
Nyquist frequency: 
fN = 	 (8.9) 
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Signals with frequencies greater than fN can be observed in the digital signal but their 
frequency is ambiguous, i.e a component with frequency f cannot be distinguished from a 
component with frequency 2fN+f, 4fNf, etc. This ambiguity is known as aliasing. Aliasing is 
often exploited in the indirect dimensions of multi-dimensional NMR experiments to 'fold' 
in outlying signals, thereby enabling the spectral width to be minimised and thus increasing 
the resolution without lengthening the experimental time. 
	
8.1.5 	Data processing 
All NMR spectra were processed using AZARA (W. Boucher, Department of Biochemistry, 
University of Cambridge, UK). A 90° shifted sine-bell squared apodising window function 
(Section 8.1.8) and zero filling (Section 8.1.9) were applied to the FID before Fourier 
transformation (Section 8.1.6) . Maximum entropy reconstruction (Section 8.1.10) was used 
for both indirect dimensions of all 3D spectra recorded. 
8.1.6 	Fourier transform 
Modem spectrometers collect data in the time domain. To convert this information into the 
frequency domain a Fourier transform is performed. The Fourier transform relates time-




f(t0)ldt 	 (8.10) 
The Fourier transform of a decaying exponential function: 
f(t)=ewte2 	 (8.11) 
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if it is assumed that for t <O,j(t) = 0, is: 
VF{ete2} = [Abs(co - ) + i DiS((o + )] 	 (8.12) 
The Fourier transform of the related function: 
FF{e1e2} = [Abs(o) - ) + i Dis(of)] 	 (8.13) 
gives similar lineshapes at negative frequencies. Again Abs(w) is the real part or absorption 
lineshape and i Dis(w) is the imaginary or dispersion lineshape. As shown in Section 8.1.3, 
the function e0)Z  is the free-induction decay (FID) of the function cos(wt) whose quadrature 
function is -sin(wt). Therefore, equations 8.12 and 8.13 represent the Fourier transforms of 
signals detected using quadrature detection. These lineshapes are illustrated in Figure 8.2. 
Figure 8.2 The absorption-mode (real) and dispersion-mode (imaginary) lineshapes. 
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8.1.7 	Convolution with a box function 
In order to remove the residual water signal from the spectrum the time domain data is 
convoluted with a box function at zero-frequency and the result subtracted from the data 
before Fourier transformation to give the spectrum. A box function has a value of 1 within 
the half-width and 0 outside. The typical half-widths used are 8-32 points. The effect of 
convolution with a box function of half-width 8 is shown in Figure 8.3. 
Figure 8.3 The effect of convoluting the data with a box function of half-width 8 is shown in 
the right-hand spectrum. The left-hand spectrum did not have this convolution applied. 
8.1.8 Window functions 
If the signal in aFID has not decayed to zero by the end of the acquisition period then 
lineshapes in the Fourier transformed spectrum will be convoluted with a sinc function 
(sinx/x) as shown in Figure 8.4. These distortions are known as 'sinc wiggles' and their 
intensity increases with the degree of truncation. As the acquisition times in the indirect 
dimensions of 3D experiments are often short, truncation is common. The effects of 
truncation can be removed by applying a window function that apodises the data - i.e a 
function that decays smoothly to zero at the end of the FID. A window function is simply the 
convolution of the time-domain data with a simple (usually trigonometric) function prior to 
Fourier transformation. The shifted sine-bell squared function was used for all spectra 
recorded on C4BP12. This consists of a sin 2(X)  function shifted by it/2 so that it has its 
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maximum value at the start of the FID. The result of applying this window function to the 
FID and the resulting lineshape after Fourier transform is shown in Figure 8.4. 
Figure 8.4 Effect of apodisation: left no window function; right sin 2((o+t/2) applied 
8.1.9 	Zero filling 
The fast Fourier transform algorithms used to process the data require that the number of 
points in the input data is 2. By extending the FID by adding zeros - a process known as 
zero filling, the digital resolution of the data is increased. As this does not increase the 
acquisition time for the data, zero filling each dimension to the next power of 2 (thus 
doubling the size of that dimension) is routinely used in data processing. 
8.1.10 Maximum entropy reconstruction 
Maximum entropy (MaxEnt) reconstruction (Sibisi et al. 1984) can be used to increase the 
signal/noise ratio and resolution in the (usually truncated) indirectly detected dimensions of 
3D spectra. Rather than computing the spectra directly from the time-domain data, MaxEnt 
reconstruction minimises the information content of a trial spectrum whilst ensuring its 
inverse discrete Fourier transform (DFT) agrees with the observed data to within the level of 
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error of the data. The agreement of the reconstruction with the data is measured using an 
unweighted x2  statistic: 
N-I 
C(f) = YlMk - dkI2 	 (8.14) 
where Mk is the mock data from the inverse DFT of the trial spectrum and di, is the 








0 def 	def) 
where M is the number of points in the spectrum and def is a scale factor. MaxEnt 
reconstruction maximises S(1) subject to the constraint that C(f) Co where Co is an estimate 
of the noise level of the data thus determining the spectrum containing the least information 
(hence the fewest artefacts) that is consistent with the experimental data. 
8.1.11 Example AZARA processing script 
An example script used for processing a 3D spectrum in AZARA is shown below with an 
explanation of the commands used: 
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script_corn 2 IThis is 1H 
ma s k_pprnm 
complex 
scale2 1 1 0.5 0.0 
end—script 
script corn 3 
	
this is 13C 
ma s k_ppmm 
complex 
scale2 1 1 0.5 0.0 
conjugate 
ends c r ipt 






npts 256 !extra zerof ill 
complex 
phase 0 0 
input data parameter file 
output data file 
commands for acquisition dimension 
data is complex 
convolution with box function to remove water 
required to correct for Bruker digital filter 
900 shifted sinebell-squared window function 
zero fill so data is twice original size 
fast Fourier transform 
phase correction for Bruker digital filter 
phase correction (0 order) (I s' order) 
discard imaginary part of data 
keep only 1st  512 points (! = not used) 
15t indirectly detected dimension 
++-- filter as data collected using States-TPPI 
data is complex 
scale 1st  data point by V2 to remove t1 noise 
2' indirectly detected dimension 
++-- filter as data collected using States-TPPI 
data is complex 
scale 15t  data point by Y2 to remove ti noise 
calculate complex conjugate of data 
2D MaxEnt process dimensions 2 and 3 
Number of iterations for Maxent algorithm 
Estimate of noise level in data 
log file for MaxEnt 
step size for MaxEnt algorithm 
1st Dimension to MaxEnt process 
zero fill 
data is complex 
phase correction in dimension 2 
dim 2 	 2nd Dimension to MaxEnt process 
npts 128 	!extra zerofill zero fill 
complex data is complex 
phase 90 -180 	 phase correction in dimension 3 
end maxent 
script_corn 1 
base_trig 8 0 	 Baseline correction for acquisition dimension 
end—script 
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8.1.12 Data analysis, assignment and structure calculation 
Spectra were visualised and assigned using ANSIG (Kraulis 1989) as described in Chapter 2. 
Structures were calculated, as described in Chapter 3, using CNS (Brunger et al. 1998) with 
a protocol incorporating molecular dynamics based simulated annealing (MDSA) (Nilges et 
al. 1988a; Nilges et al. 1988b). Ambiguous distance restraints were incorporated into the 
structure calculation using the protocols derived by Nilges (Nilges 1995) and these were 
'filtered' using ARIA (Nilges et al. 1997). 
8.2 Isothermal titration calorimetry 
Experiments were performed at 25 °C on a MicroCal VP-TIC microcalorimeter. The cell 
contained 0.01 mM C4BP12 (1.4 ml) and the syringe contained 0.15 mM M4-N. Both 
solutions were in 10 mM sodium phosphate buffer (pH 6.0). For titrations, one preliminary 
injection of I tl was made, followed by 19 injections of 10 j.tl with an injection speed of 0.5 
j.tl/s. The stirring speed was 310 rpm and the delay time between injections was 3 minutes. A 
blank titration, i.e. injecting M4-N into buffer, was used to correct the M4-N:C4BP12 
titration for heat of dilution effects. The titration was performed with the assistance of 
Margaret Nutley (University of Glasgow). Analysis of the data was performed using 
MicroCal Origin software. 
8.3 Preparation of DNA oligonucleotides 
8.3.1 	Annealing 
DNA oligonucleotides purchased from Sigma-Genosys were resuspended in annealing 
buffer (10 mM Tris, pH 7.8, 50 mM NaCl, 1 mM EDTA) and the concentration calculated 
from the A260  measurement using the extinction coefficient supplied by Sigma-Genosy. 
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Equimolar concentrations of the two oligos were mixed and 100 tl aliquots were dispensed 
into PCR tubes (600 itl volume). The tubes were placed in a thermal cycler and the following 
programme set: (i) heat to 95 °C and remain at 95 °C for 2 minutes, (ii) ramp-cool to 25 °C 
over a period of 45 minutes, (iii) cool to a storage temperature of 4 °C. After a brief spin in a 
microftige to draw all moisture from the lid, the samples were pooled and stored at 4 °C prior 
to ethanol-precipitation. 
8.3.2 	Ethanol precipitation to concentrate the DNA 
The 400 tl of dsDNA produced in the previous step was ethanol-precipitated, dried and 
resuspended in NMR buffer (20 mM sodium phosphate buffer, pH 6.0) as follows. 40 tl of 
3.0 M NaOAc, pH 5.2 was added. Subsequently M902  to a final concentratin of 10 mM 
was added along with 880 ptl of cold (4 °C) 100% ethanol. After mixing the sample was 
stored at -20 °C for> 1 hour. The sample was spun at 13,000g for 30 minutes in a microfuge 
at 4 °C. The supernatant was Jecanted and 1 ml of 70% ethanol was added. After mixing the 
sample was spun at 13,000g for 2 minutes. The supernatant was again decanted and another 
1 ml of 70% ethanol was added before mixing and a further spin at 13,000g for 2 minutes. 
The supernatant was decanted and the sample dried at room temperature. 200 tl of NMR 
buffer was added and the concentration calculated from the A 260 measurement using the 
general extinction coefficient for dsDNA of 50 (tg/ml)'cm'. 
8.4 NMR titration with M4-N 
The peptide dimer, M4-N was expressed in E. coli, as described in (André et al. 2006). 
Dimerisation was achieved by oxidation of bacterial lysates with 20 MM  CuC12 in 0.4 M 
NaCl, pH 8.0 (Morfeldt et al. 2001). The dimerised peptide was purified by ion-exchange 
chromatography and gel filtration, and was finally dialysed against doubly-distilled H 20. 
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Lyophilised peptide was dissolved in NMR buffer (deuterated NaOAc, pH 6.0) to give 100 
AM (dimer concentration). A 20 AM solution ofC4BP12 in the same buffer was added and a 
series of ' 5N-'H HSQC spectra were subsequently recorded at M4-N concentrations of 100, 
50, 25, and 10 AM (dimer concentrations), and compared to a reference spectrum of 20 AM 
C4131? 12 with no M4-N present. 
8.5 NMR titration with 10-bp DNA 
A ' 5N-'H HSQC spectrum of 50 AM u[ 15N]-labelled C4BP12 in 20 mM sodium phosphate 
buffer, pH 6.0 was recorded. Small volumes of DNA (1.99 mM concentration), prepared as 
described in Section 8.3, were added and a series of 15N- 1 H HSQC spectra were subsequently 
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ASSIGNMENT OF C4BP12 CHEMICAL SHIFTS 
Residue Atom Shift (ppm) Residue Atom Shift (pp 
Met  HA 4.07 Pr04 CD 49.31 
Met° HB2 1.96 Pro  HA 3.48 
Met° HB3 1.96 Pro5 HB2 0.24 
Met' HG2 2.54 Pr05 HB3 1.14 
Met° HG3 2.54 Pr05 HG2 0.92 
Met° C 171.22 Pr05 HG3 1.38 
Met° CA 54.85 Pro  HD2 3.01 
Met  CB 32.70 Pr05 HD3 3.47 
Met° CG 30.90 Pr05 CA 60.70 
Asn' H 8.27 Pr05 CB 30.20 
Asn' HA 4.91 Pro  CO 26.58 
Asn 1 HB2 2.62 Pro  CD 50.07 
Asn' HB3 2.76 Pro  HA 4.32 
Asn' HD21 7.26 Pr06 HB2 1.64 
Asn' HD22 6.93 Pro  HB3 2.16 
Asn 1 C 174.82 Pr06 HG2 1.48 
Asn' CA 53.04 Pro  H03 1.99 
Asn' CB 40.37 Pro  HD2 2.74 
Asn' N 119.57 Pr06 HD3 3.39 
Asn' ND2 113.12 Pr06 C 176.41 
Cys2 H 8.85 Pro  CA 61.65 
Cys2 HA 4.56 Pro  CB 31.78 
Cys2 HB2 2.24 Pr06 CG 26.45 
Cys2 HB3 3.04 Pr06 CD 50.21 
Cys2 C 175.94 Thr7 H 8.29 
Cys2 CA 58.49 Thr7 HA 3.82 
Cys2 CB 45.86 Thr7 HB 3.86 
Cys2 N 116.36 Thr7 HG2 1.05 
G1y3 . H 8.53 Thr7 C 173.75 
G1y3 HA2 3.96 Thr7 CA 63.48 
G1y3 HA3 4.86 Thr7 CB 68.89 
G1y3 C 170.70 Thr7 CG2 21.73 
G1y3 CA 44.12 Thr7 N 117.15 
G1y3 N 110.16 Leu8 H 8.43 
Pr04 HA 4.65 Leu8 HA 4.36 
Pr04 HB2 1.78 Leu8 HB2 -0.09 
Pr04 HB3 2.44 Leu8 HB3 1.24 
Pr04 HG2 2.06 Leu8 HG L03 
Pr04 HG3 2.19 Leu8 HD1 -0.29 
Pr04 HD2 3.64 Leu8 HD2 0.07 
Pr04 HD3 3.92 Leu8 C 176.84 
Pr04 CA 61.91 Leu8 CA 52.77 
Pro  CB 30.85 Leu8 CB 42.88 
Pr04 CG 28.21 Leu8 CO 26.19 
164 
Residue Atom Shift. (ppm) Residue Atom Shift (ppi 
Leu8 CD1 25.25 Pro 
13 
CA 62.24 
Leu8 CD2 22.66 Pro" CB 31.49 
Leu8 N 128.18 Pro' 3 CG 26.57 
Ser9 H 8.57 	. Pro' 3 CD 49.93 
Ser9 HA 4.03 Met" H 8.23 
Ser9 HB2 3.81 Met 
14 
HA 4.09 
Ser9 HB3 3.93 Met 
14 
HB2 1.57 
Ser9 C 173.86 Met" HB3 1.85 
Ser9 CA 59.41 Met 
14 
HG2 2.24 
Ser9 CB 63.44 Met 
14 
HG3 2.24 
Ser9 N 113.52 Met 
14 
C 176.19 
Phe' ° H 5.81 Met 
14 
CA 56.86 
Phe' ° HA 3.53 Met 
14 
CB 33.79 
Phe' ° HB2 2.15 Met 
14 
CG 32.27 
Phe' ° HB3 2.51 Met 
14 
N 120.64 
Phe' ° HD1 6.66 Asp' 5 H 8.14 
Phe' ° HD2 6.66 Asp' 5 HA 4.56 
Phe' ° HE1 6.29 Asp' 5 HB2 2.48 
Phe' ° HE2 6.29 Asp 15 HB3 2.70 
Phe' ° HZ 7.00 Asp 
15 
C 173.72 
Phe' ° C 173.68 Asp 
15 
CA 54.07 
Phe' ° CA 53.87 Asp' 5 CB 40.88 
Phe' ° CB 41.27 Asp' 5 N 118.07 
Phe' ° CD1 132.55 lie 16 H 7.81 
Phe' ° CD2 132.55 Ile 
16 
HA 4.12 
Phe' ° CE1 131.39 lie 
16 
HB 1.90 
Phe' ° CE2 131.39 lIe' 6 HG12 1.09 
Phe' ° CZ 131.16 Ile 
16 
HG13 1.35 
Phe' ° N 109.36 Ile 
16 
HG2 0.83 
Ala" H 6.46 lIe' 6 HD1 0.78 
Ala" HA 4.91 Ile 
16 
C 176.07 
Ala" HB 1.23 Ile 16 CA 61.89 
Ala" C 	. 173.30 Ile 
16 
CB 38.86 
Ala" CA 51.71 Ile 
16 
CG1 27.25 
Ala" CB 25.88 Ile 
16 
CG2 17.58 
Ala" N 120.89 Ile 
16 
CD1 13.49 
Ala 12 H 8.63 Ile 
16 
N 118.45 
Ala 12 HA 4.61 Thr' 7 H 8.21 
Ala" HB 1.17 Thr' 7 HA 4.34 
Ala 12 CA 49.34 Thr' 7 HB 4.17 
Ala 12 CB 20.81 Thr 17 HG2 1.15 
Ala 12 N 121.27 Thr' 7 C 174.54 
Pro 13 HA 3.12 Thr' 7 CA 61.45 
Pro" HB2 1.54 Thr' 7 CB 69.66 
Pro' 3 HB3 1.63 Thr' 7 CG2 21.90 
Pro' 3 HG2 1.80 Thr' 7 N 116.49 
Pro' 3 HG3 1.80 Leu' 8 . 	 H 8.07 
Pro 13 HD2 3.26 Leu' 8 HA 4.42 
Pro' 3 HD3 3.42 Leu' 8 HB2 1.62 




Residue 	Atom 	Shift 
HG - Arg22 CA 54.49 
HD1 0.89 Arg22 CB 32.66 
HD2 0.86 Arg22 CG 26.68 
C 177.45 Arg22 CD 43.27 
CA 55.48 Arg22 N 120.26 
CB 42.10 Arg22 NE 84.34 
CG 27.23 Phe23 H 8.84 
CD1 25.14 Phe23 HA 4.67 
CD2 23.78 Phe23 HB2 2.72 
N 124.58 Phe23 HB3 3.03 
H 8.09 Phe23 HD1 7.31 
HA 4.31 Phe23 HD2 7.31 
HB 4.29 Phe23 HE1 7.21 
HG2 1.12 Phe23 HE2 7.21 
C 174.78 Phe23 HZ - 
CA 61.99 Phe23 C 174.58 
CB 69.33 Phe23 CA 56.62 
CG2 21.66 Phe23 CB 42.22 
N 112.44 Phe23 CD1 132.65 
H 7.68 Phe23 CD2 132.65 
HA 4.26 Phe23 CE1 131.10 
HB2 1.73 Phe23 CE2 131.10 
HB3 1.73 Phe23 CZ - 
HG2 2.03 Phe23 N 120.85 
HG3 2.03 Lys 24 H 8.55 
.C 175.37 Lys 
24 
HA 4.39 
CA 56.24 Lys 
24 
HB2 1.74 
CB 30.11 Lys 
24 
HB3 1.76 
CG 35.46 Lys 
24 
HG2 1.43 
N 122.10 Lys 
24 
HG3 - 1.50 
H 8.15 Lys24 HD2 1.65 
HA 4.31 Lys 
24 
HD3 1.65 
HB 4.27 Lys 
24 
HE2 2.98 
HG1 4.64 Lys 
24 
HE3 2.98 
HG2 1.06 Lys 
24 
C 178.64 
C 173.41 Lys 
24 
CA 56.13 
CA 61.58 Lys 
24 
CB 33.54 
CB 69.95 Lys 
24 
CO 24.64 
CG2 21.68 Lys 
24 
CD 29.36 
N 111.06 Lys 
24 
CE 41.93 
H 7.32 Lys 
?4 
N 120.99 
HA 4.94 Thr25 H 8.60 
HB2 1.53 Thr25 HA 3.52 
HB3 1.53 Thr25 HB 3.79 
HG2 1.48 Thr25 HG2 1.04 
HG3 1.50 Thr25 C 174.53 
HD2 3.05 Thr25 CA 65.66 
HD3 3.11 Thr25 CB 69.22 
HE 7.19 Thr25 CG2 21.84 





















































Residue Atom Shift (ppm) Residue Atom Shift (ppi 
G1y26 H 9.18 Lys3° CB 33.43 
G1y26 HA2 3.48 Lys 
30 
CG - 
G1y26 HA3 4.37 Lys30 CD - 
G1y26 C 174.68 Lys 
30 
CE 41.97 
G1y26 CA 44.53 Lys30 N 122.34 
G1y26 N 115.81 Tyr 31 H 8.40 
Thr27 H 7.87 Tyr 
31 
HA 4.81 
Thr27 HA 4.06 Tyr 
31 
HB2 2.51 
Thr27 HB 4.01 Tyr 
31 
HB3 2.65 
Thr27 HG2 1.51 Tyr 
31 
HD1 6.52 
Thr27 C 173.30 Tyr 
31 
HD2 6.52 
Thr27 CA 65.81 Tyr 
31 
HE1 6.22 
Thr27 CB 69.79 Tyr3 ' HE2 6.22 
Thr27 CG2 21.89 Tyr 
31 
C 174.28 
Thr27 N 117.95 Tyr 
31 
CA 56.99 
Thr28 H 8.73 Tyr 
31 
CB 44.27 
Thr28 HA 5.43 Tyr 
31 
CD1 131.54 
Thr28 HB 3.95 Tyr 
31 
CD2 131.54 
Thr28 HG2 1.14 Tyr 
31 
CEI 117.77 
Thr28 C 173.79 Tyr 
31 
CE2 117.77 
Thr28 CA 60.87 Tyr 
31 
N 126.21 
Thr28 CB 71.14 Thr32 H 8.94 
Thr28 CG2 21.38 Thr32 HA 4.71 
Thr28 N 122.34 Thr32 HB 3.96 
Leu29 H 9.27 Thr32 HG2 1.10 
Leu29 HA 4.77 Thr32 C 173.63 
Leu29 HB2 1.30 Thr32 CA 59.47 
Leu29 HB3 1.62 Thr32 CB 71.15 
Leu29 HG 1.47 Thr32 CG2 20.31 
Leu29 HD1 0.08 Thr32 N 112.20 
Leu29 HD2 0.76 Cys33 H 8.43 
Leu29 C 176.36 Cys33 HA 5.09 
Leu29 CA 53.12 Cys33 HB2 2.79 
Leu29 CB 45.69 Cys33 HB3 3.23 
Leu29 CO 26.66 Cys33 C 175.80 
Leu29 CDI 26.18 Cys33 CA 53.95 
Leu29 CD2 22.59 Cys33 CB 38.50 
Leu29 N 126.21 Cys33 N 122.21 
Lys30 H 8.75 Leu34 H 7.39 
Lys 30 HA 4.50 Leu34 HA 4.40 
Lys 30 HB2 1.67 Leu34 HB2 1.18 
Lys 30 HB3 1.85 Leu34 HB3 1.60 
Lys30 HG2 - Leu34 HG 1.01 
Lys30 HG3 - Leu34 HD1 0.56 
Lys30 HD2 - Leu34 HD2 0.81 
Lys 30 HD3 - Leu34 C 174.09 
Lys30 HE2 2.93 Leu34 CA 54.24 
Lys30 HE3 2.93 Leu34 CB 40.63 
Lys 30 C 175.89 Leu34 CO 27.65 
Lys 30 CA 56.83 Leu34 CD1 25.35 
167 
Residue 	Atom 	Shift (ppm) 	Residue 	Atom 	Shift 
Leu34 CD2 22.45 Arg39 HB3 1.92 
Leu34 N 124.87 Arg39 HG2 1.72 
Pro 35 HA 4.34 Arg39 HG3 1.80 
Pr035 HB2 1.79 Arg39 HD2 3.18 
Pro 35 HB3 2.28 Arg39 HD3 3.18 
Pro 35 HG2 1.95 Arg39 HE 7.06 
Pr035 HG3 2.11 Arg39 C 176.56 
Pr035 HD2 3.57 Arg39 CA 57.55 
Pro 35 HD3 3.77 Arg39 CB 30.91 
Pr035 C 177.02 Arg39 CC 26.98 
Pro 35 CA 64.66 Arg39 CD 43.99 
Pro 35 CB 31.75 Arg39 N 125.12 
Pro 35 CG 28.15 Arg39 NE 84.77 
Pro 35 CD 50.61 Ser4° H 8.44 
01y36 H 8.28 Ser4° HA 4.52 
G1y36 HA2 3.25 Ser4° HB2 3.46 
G1y36 HA3 3.70 Ser4° HB3 3.91 
G1y36 C 171.71 Ser4° C 174.23 
G1y36 CA 44.92 Ser4° CA 56.99 
G1y36 N 111.29 Set" CB 64.46 
Tyr 37 H 8.14 Ser4° N 118.32 
Tyr 37 HA 5.01 His4 ' H 8.06 
Tyr 37 HB2 2.63 His4 ' HA 4.72 
Tyr 37 HB3 3.41 His4 ' HB2 3.12 
Tyr 37 HD1 6.69 His4 ' HB3 3.36 
Tyr 37 HD2 6.69 His4 ' HD2 - 
Tyr 37 HEI 6.72 His4 ' HE2 - 
Tyr 37 HE2 6.72 His4 ' C 174.63 
Tyr 37 C 175.22 His4 ' CA 55.76 
Tyr 37 CA 56.64 His4 ' CB 30.47 
Tyr 37 CB 40.75 His4 ' CD2 - 
Tyr 37 CD1 133.15 His4 ' CE2 - 
Tyr 37 CD2 133.15 His4 ' N 118.04 
Tyr 37 CE1 118.18 Ser42 H 8.16 
Tyr 37 CE2 118.18 Ser42 HA 4.37 
Tyr 37 N 116.68 Ser42 HB2 3.87 
Vat38 H 9.25 Ser42 HB3 3.94 
Va!38 HA 4.35 Ser42 C 174.27 
Va138 HB 1.72 Ser42 CA 59.09 
Va!38 HG1 0.53 5e, 42 CB 64.12 
Va138 HG2 0.56 5er42 N 115.73 
Vat38 C 175.11 Thr43 H 8.26 
Va138 CA 59.35 Thr43 HA 4.21 
Va!38 CB 34.84 Thr43 HB 4.10 
Va138 CGI 20.55 Thr43 HG2 1.17 
Va!38 CG2 20.43 Thr43 C 174.38 
Va!38 N 118.08 Thr43 CA 61.75 
Arg39 H 8.38 
Thr43 CB 69.18 
Arg39 HA 4.66 Thr43 CG2 21.75 
Arg39 HB2 1.92 Thr43 N 115.36 
Residue Atom Shift (ppm) Residue Atom Shift (ppr 
Gin 44 H 8.38 Cys4 CA 55.08 
Gin 44 HA 3.01 Cys48 CB 39.27 
Gin 44 HB2 - Cys48 N 127.78 
Gin 44 HB3 - Asn49 H 9.06 
Gin 44 HG2 - Asn49 HA 4.81 
'Gin 44 HG3 - Asn49 HB2 2.87 
Gin 44 HE21 - Asn49 HB3 3.38 
Gin 44 HE22 - Asn49 
 
14132I 7.15 
Gin 44 CA 53.41 Asn49 HD22 7.15 
Gin 44 CB 28.28 Asn49 C 176.60 
Gin 44 CG - Asn49 CA 51.72 
Gin 44 N 126.35 Asn49 CB 39.28 
Gin 44 NE2 - Asn49 N 110.36 
Thr45 H 6.53 Asn49 ND2 111.60 
Thr45 HA 5.20 Ser5° H 8,16 
Thr45 HB 3.87 Ser5° HA 4.13 
Thr45 HG2 0.89 Ser5° 
 
14132 3.80 
Thr45 C 172.88 Ser5° 
 
1-1133 3.92 
Thr45 CA 58.52 Ser5° C 174.48 
Thr45 CB 72.67 Ser5° CA 60.94 
Thr45 CG2 21.90 Ser5° CB 62.93 
Thr45 N 107.44 Ser5° N 112.53 
Leu46 H 8.50 Asp5 ' H 7.65 
Leu46 HA 4.88 Asp51 HA 4.74 
Leu46  1-1132 1.03 Asp5 ' HB2 2.55 
Leu46  1-1133 1.85 Asp5 ' HB3 2.80 
Leu46 HG 1.41 Asp5 ' C 175.85 
Leu46 HDI 0.00 Asp5 ' CA 53.72 
Leu46 HD2 -0.15 Asp5 ' CB 40.64 
Leu46 C 176.72 Asps ' N 120.07 
Leu46 CA 55.51 G1y52 H 7.93 
Leu46 CB 45.18 G1y52 HA2 3.42 
Leu46 CG 31.81 Giy52 HA3 3.69 
Leu46 CD! 24.64 Giy52 C 173.75 
Leu46 CD2 21.40 Giy52 CA 47.24 
Leu46 N 123.64 Giy52 N 108.65 
Thr47 H 8.49 Giu53 H 7.52 
Thr47 HA 5.58 Giu53 HA 4.49 
Thr47 HB 3.79 Giu53 HB2 1.75 
Thr47 HG2 0.98 Giu53 HB3 1.90 
Thr47 C 173.15 Giu53 HG2 2.06 
Thr47 CA 61.38 G1u53 HG3 2.16 
Thr47 CB 71.77 Giu53 C 174.93 
Thr47 CG2 20.85 Giu53 CA 53.22 
Thr47 N 116.42 Giu53 CB 31.18 
Cys48 H 8.52 Giu53 CG 34.26 
Cys48 HA 3.98 Giu53 N 118.95 
Cys48  14132 1.33 Trp54 H 8.40 
Cys48  14133 2.38 Trp54 HA 4.98 




Residue Atom Shift (ppm) Residue Atom Shift (ppi 
Trp HB3 3.07 Asn57 C 174.33 
Trp54 HD1 7.28 Asn57 CA 51.20 
Trp54 HE1 10.00 Asn57 CB 40.52 
Trp54  HS 7.06 Asn57 N 118.70 
Trp54 HZ2 6.94 Asn57 ND2 111.44 
Trp54  HD 6.71 Thr58 H 8.27 
Trp54 HH2 6.24 Thr58 HA 3.58 
Trp54 C 176.83 Thr58 HB 3.86 
Trp54 CA 56;41 Thr58 HG2 0.53 
Trp54 CB 30.12 Thr58 CA 62.90 
1rpM CD! 127.09 Thr58 CB 67.15 
Trp54 CE3 120.27 Thr58 CG2 21.61 
Trp54 CZ2 114.22 Thr58 N 114.77 
Trp54  CD 121.56 Phe59 H - 
Trp54 CH2 122.93 Phe59 HA 4.65 
Trp54 N 121.95 Phe59 HB2 2.93 
1rpM NE1 129.93 Phe59 HB3 3.57 
Val 15 H 9.62 Phe59 HDI 7.74 
Vat55 HA 4.44 Phe59 HD2 7.74 
Va155 HB 2.05 Phe59 HE! 6.90 
Vat55 HG1 0.88 Phe59 HE2 6.90 
Va155 HG2 0.96 Phe59 HZ 6.33 
Va155 C 176.05 Phe59 CA 56.93 
Val 15 CA 61.66 Phe59 CB 38.39 
Va1 55 CB 33.87 Phe59 CD1 134.37 
Va!55 CG1 21.12 Phe59 CD2 134.37 
Va1 55 CG2 20.98 Phe59 CE! 131.03 
Va1 55 N 123.00 Phe59 CE2 131.03 
Tyr 56 H 7.81 Phe59 CZ 129.54 
Tyr 56 HA 4.99 Phe59 N - 
Tyr 56 HB2 3.21 Cys60 H 6.54 
Tyr 56 HB3 3.65 Cys60 HA 5.55 
Tyr 56 HD1 6.82 Cys60 HB2 2.99 
Tyr 56 HD2 6.82 Cys60 HB3 2.99 
Tyr 56 HE] 6.65 Cys60 CA 55.38 
Tyr56 HE2 6.65 Cys60 CB 48.24 
Tyr 56 C 173.40 Cys60 N 118.53 
Tyr 56 CA 56.52 lie 61 H 9.22 
Tyr 56 CB 39.24 Ile 
61 
HA 4.48 
Tyr 56 CDI 133.56 Ile 
61 
HB 1.72 
Tyr 56 CD2 133.56 Ile 
61 
HG12 0.90 
Tyr 56 CE1 117.71 Ile 
61 
HG13 1.23 
Tyr 56 CE2 117.71 Ile 
61 
H02 0.72 
Tyr 56 N 121.10 Ile 
61 
HD1 0.69 
Asn57 H 8.55 Ile 
61 
CA 59.52 
Asn57 HA 4.88 Ile 
61 
CB 41.90 
Asn57 HB2 2.67 Ile 
61 
CG1 26.16 
Asn57 HB3 2.67 Ile 
61 
CG2 17.43 
Asn57 HD21 7.30 Ile 
61 
CD1 13.22 




Residue 	Atom 	Shift (ppm) I Residue 	Atom 	Shift 
Tyr 62 H 8.41 Cys65 HA 4.11 
Tyr62 HA 3.92 Cys65 HB2 2.31 
Tyr62 HB2 2.54 Cys65 HB3 2.38 
Tyr62 HB3 2.77 Cys65 C 173.55 
Tyr 62 HD1 6.55 Cys65 CA 60.59 
Tyr 62 HD2 6.55 Cys65 CB 41.72 
Tyr 62 HEI 6.69 Cys65 N 121.32 
Tyr 62 HE2 6.69 Cys65 H 8.55 
Tyr 62 HH 8.38 Arg66 H 8.36 
Tyr 62 C 176.74 Arg66 HA 4.26 
Tyr 62 CA 58.83 Arg66 HB2 1.77 
Tyr 62 CB 38.47 Arg66 HB3 1.89 
Tyr62 CDI 133.02 Arg66 HG2 - 
Tyr62 CD2 133.02 Arg66 HG3 - 
Tyr62 CE1 118.18 Arg66 HD2 3.24 
Tyr62 CE2 118.18 Arg66 HD3 3.24 
Tyr 62 N 125.92 Arg66 HE 7.17 
Lys 63. H 7.81 Arg66 C 176.26 
Lys 63 HA 4.16 Arg66 CA 55.38 
Lys 63 HB2 1.25 Arg66 CB 31.21 
Lys 63 HB3 1.43 Arg66 CG - 
Lys 63 H02 1.01 Arg66 CD 43.58 
Lys 63 HG3 1.15 Arg66 N 118.73 
Lys 63 HD2 1.29 Arg66 NE 84.87 
Lys 63 HD3 1.46 His67 H 8.94 
Lys 63 HE2 2.67 His67 HA 4.27 
Lys63 HE3 2.72 His67 HB2 2.98 
Lys63 C 174.12 His67 HB3 3.11 
Lys63 CA 55.88 His67 HD2 7.17 
Lys 63 CB 35.89 His 67 HE2 - 
Lys63 CG 26.05 His 67 C 175.80 
Lys63 CD 29.53 His 67 CA 56.74 
Lys 63 CE 42.06 His67 CB 30.32 
Lys63 N 123.01 His67 CD2 118.42 
Arg64 H 7.72 His 67 CE2 - 
Arg64 HA 4.52 His 67 N 124.60 
Arg64 HB2 1.42 Pro 68 HA 4.31 
Arg64 HB3 1.62 Pro 
68 
HB2 1.2 
Arg64 HG2 1.34 Pr068 HB3 1.66 
Arg64 HG3 1.34 Pr068 HG2 1.02 
Arg64 HD2 3.10 Pr068 HG3 1.50 
Arg64 HD3 3.10 Pr068 HD2 2.46 
Arg64 HE 7.07 Pr068 HD3 3.21 
Arg64 C 175.72 Pro 
68 
C 176.01 
Arg64 CA 54.88 Pro 
68 
CA 63.80 
Arg64 CB 33.05 Pro68 CB 31.78 
Arg64 CG 26.42 Pro68 CG 26.48 
Arg64 CD 43.76 Pro 
68 
CD 49.72 
Arg64 N 117.89 G1y69 H 9.62 
Arg64  NE • 85.38 G1y69 HA2 3.74 
171 
Residue Atom Shift (ppm) Residue Atom Shift (ppi 
G1y69 HA3 4.23 Asn73 CA 55.20 
G1y69 C 171.66 Asn73 CB 36.37 
Giy69 CA 43.55 Asn73 N 117.29 
G1y69 N 111.84 Asn73 ND2 116.26 
G1u7° H 7.73 G1y74 H 7.64 
G1u70 HA 4.13 G1y74 HA2 4.11 
G1u70 HB2 1.77 G1y74 HA3 4.33 
G1u70  1-1133 1.80 G1y74 C 172.02 
G1u7° HG2 2.04 G1y74 CA 46.70 
G1u7° HG3 2.16 G1y 74 N 104.23 
G1u7° C 175.28 Gin 75 H 8.81 
G1u7° CA 55.72 Gin 71 HA 4.73 
Giu7° CB 30.70 Gin 71 1-1132 1.78 
Giu70 CG 35.61 Gin 75 HB3 1.89 
Giu70 N 115.96 Gin 75 HG2 2.13 
Leu7 ' H 8.29 Gin75 HG3 2.13 
Leu7 ' HA 4.31 Gin 75 HE2I - 
Leu7 ' 1-1132 0.75 Gin 75 HE22 - 
Leu7 ' 1-1133 1.54 Gin 15 C 173.56 
Leu7 ' HG 1.01 Gin 71 CA 54.93 
Leu7 ' HD1 0.59 Gin 75 CB 32.43 
Leu71 HD2 0.48 Gin 75 CG 33.69 
Leu7 ' C 174.89 Gin 75 NE2 - 
Leu7 ' CA 52.46 Gin 75 N 118.42 
Leu7 ' CB 43.42 Va176 H 8.35 
Leu7 ' CG 26.79 Va176 HA 4.31 
Leu71 CD1 26.55 Va176 HB 2.00 
Leu71 CD2 24.04 Va176 HGI 0.98 
Leu71 N 126.65 Vai76 HG2 0.49 
Arg72 H 8.52 Va176 C 175.18 
Arg72 HA 3.82 Va176 CA 61.46 
Arg72 HB2 1.56 Va176 CB 32.69 
Arg72 H133 1.61 Va176 CGI 21.20 
Arg72 HG2 1.48 Va176 CG2 21.20 
Arg72 HG3 1.53 Va176 N 122.94 
Arg72 HD2 3.11 G1u77 H . 9.25 
Arg72 HD3 3.11 G1u77 HA 4.42 
Arg72 C 177.35 G1u77  1-1132 1.80 
Arg72 CA 57.81 G1u77  1-1133 1.82 
Arg72 CB 29.24 G1u77 HG2 1.97 
Arg72 CG 26.94 G1u77 HG3 2.06 
Arg72 CD 43.21 G1u77 C 174.67 
Arg72 N 129.18 G1u77 CA 55.07 
Asn73 H 8.88 G1u77 CB 30.02 
Asn73 HA 3.79 G1u77 CG 34.17 
Asn73  1-1132 0.97 G1u77 N 128.83 
Asn73 HB3 2.13 lie 78 H 8.51 
Asn73 HD21 7.31 lie 78 HA 4.05 
Asn73 HD22 6.75 lie 78 HB 1.79 
Asn73 C 172.73 Ile 78 HG12 1.38 
172 
Residue Atom Shift (ppm) Residue Atom Shift (ppi 
lie78 HG13 1.38 Leu82 HD2 0.88 
lie 78 HG2 0.68 Leu82 C 175.81 
Ile 78 HD1 0.66 Leu82 CA 53.88 
lie 78 C 175.73 Leu82 CB 40.72 
lie 78 CA 60.49 Leu 82 CG 26.62 
Ile 78 CB 37.78 Leu82 CDI 26.13 
Ile 78 CG1 27.14 Leu82 CD2 23.35 
lie78 CG2 17.14 Leu8 N 115.39 
lie 78 CD1 13.13 Ser83 H 7.92 
lie 78 N 127.92 Ser83 HA 4.25 
Lys 79 H 7.89 5er83 HB2 3.74 
Lys 79 HA 4.22 Ser83 
 
1-1133 3.74 
Lys 79 HB2 1.90 Ser83 HG 4.63 
Lys 79 HB3 1.90 Ser83 C 173.85 
Lys 79 HG2 1.32 Ser83 CA 59.08 
Lys 79 HG3 1.40 Ser83 CB 64.51 
Lys 79 HD2 1.55 Ser83 N 113.13 
Lys 79 HD3 1.55 Phe84 H 8.17 
Lys79 HE2 2.79 Phe84 HA 3.61 
Lys 79 HE3 2.86 Phe84 HB2 2.50 
Lys 79 C 177.68 Phe84 HB3 2.75 
Lys 79 CA 57.99 Phe84 HD1 6.71 
Lys 79 CB 32.81 Phe84 HD2 6.71 
Lys79 CG 24.91 Phe84 HE1 7.35 
Lys 79 CD 28.29 Phe84 HE2 7.35 
Lys79 CE 41.98 Phe84 HZ - 
Lys79 N 127.02 Phe84 C 174.78 
Thr8° H 8.95 Phe84 CA 59.73 
Thr8° HA 4.44 Phe84 CB 39.44 
Thr8° HB 4.27 Phe84 CD1 131.48 
Thr8° HG2 1.12 Phe84 CD2 131.48 
Thr8° C 173.26 Phe84 CE1 131.46 
Thr8° CA 60.25 Phe84 CE2 131.46 
Thr8° CB 69.84 Phe84 cz - 
Thr8° CG2 22.30 Phe84 N 120.81 
TWO  N 110.77 GIy85 H 8.55 
Asp 81 H 8.74 GIy85 HA2 3.02 
Asp 81 HA 4.46 G1y85 HA3 3.88 
Asp8 ' 1-1132 2.79 G1y85 C 174.72 
Asp8 ' HB3 3.01 GIy85 CA 44.29 
Asp8 ' C 175.13 GIy85 N 117.36 
Asp 81 CA 53.24 Ser86 H 8.34 
Asp8 ' CB 41.28 Ser86 HA 4.37 
Asp8 ' N 123.21 Ser86 HB2 3.99 
Leu82 H 7.94 Ser86  1-1133 3.99 
Leu82 HA 4.66 Ser86 C 172.42 
Leu82  1-1132 1.65 Ser86 CA 59.33 
Leu82  1-1133 1.96 Ser86 CB 64.48 
Leu82 HG 1.66 Ser86 N 118.47 
Leu82 HD1 0.97 Gin 87 H 8.72 
173 
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Residue 	Atom 	Shift 
HA 5.56 Phe9° CD1 132.17 
1-1132 1.88 Phe9° C132 132.17 
1-1133 1.99 Phe9° CE1 130.65 
HG2 2.16 Phe9° CE2 130.65 
HG3 2.21 Phe9° CZ 128.95 
HE21 7•54 Phe9° N 121.52 
HE22 6.80 Ser9 ' H 8.26 
C 175.55 Ser9 ' HA 4.51 
CA 54.43 Ser9 ' 1-1132 3.78 
CB 33.07 Set9 ' 1-1133 3.78 
CG 35.06 Set9 ' HG 4.65 
N 120.24 Set9 ' C 172.68 
NE2 111.99 Ser9 ' CA 57.23 
1-1 8.82 Ser9 ' CB 65.62 
HA 4.71 Set 9 ' N 112.73 
HB 1.16 Cys92 H 8.72 
HGI2 0.24 Cys92 HA 5.26 
HG13 0.42 Cys92 
 
1-1132 2.43 
HG2 0.48 Cys92 
 
1-1133 2.95 
HD1 -0.62 Cys92 C 175.00 
C 173.61 Cys92 CA 53.56 
CA 59.45 Cys92 CB 41.14 
CB 40.36 Cys92 N 117.21 
CG1 24.11 Ser93 H 8.89 
CG2 18.76 Ser93 HA 4.29 
CD1 12.80 Set 93 
 
1-1132 3.53 
N 118.74 Set 93 
 
1-1133 3.96 
H 7.82 Ser93 C 172.52 
HA 4.80 Set93 CA 59.08 
1-1132 1.69 Set 93 CB 64.05 
1-1133 1.92 Set 93 N 119.84 
HG2 2.12 G1u94 H 8.43 
HG3 2.13 G1u94 HA 4.14 
C 173.84 G1u94 H132 1.94 
CA 53.56 G1u94  1-1133 2.03 
CB 32.98 G1u94 HG2 2.32 
CG 35.51 G1u94 HG3 2.32 
N 118.68 Giu94 C 177.35 
H 8.39 Giu94 CA 58.51 
HA 5.41 Giu94 CB 29.15 
1-1132 2.54 Giu94 CG 35.34 
1-1133 2.77 Giu94 N 121.79 
HD1 7.02 Giy95 H 8.88 
HD2 7.02 Giy95 HA2 3.42 
HE1 6.68 Giy95 HA3 4.16 
HE2 6.68 Giy95 C 173.21 
HZ 6.72 Giy95 CA 44.76 
C 174.50 Giy95 N 112.82 
CA 54.93 Phe96 H 8.17 
CB 43.21 Phe96 HA 5.08 
174 
Residue Atom Shift (ppm) Residue Atom Shift (ppi 
Ph e96 HB2 2.50 lie99 HB 1.72 
Phe96 HB3 3.22 lIe99 HGI2 1.05 
Phe96 HDI 6.71 1ie99 HG13 1.32 
Phe96 HD2 6.71 Ile 99 HG2 0.81 
Phe96 HE1 7.13 Ile 99 HDI 0.70 
Phe96 HE2 7.13 lie99 C 175.16 
Phe96 HZ - Lie99 CA 60.92 
Phe96 C 174.32 Ile 99 CB 38.90 
Phe96 CA 56.64 lie99 COl 26.81 
Phe96 CB 42.18 Ile 99 CG2 17.17 
Phe96 CD1 131.65 lie99 CD1 13.10 
Phe96 CD2 131.65 lie99 N 128.13 
Phe96 CE1 131.36 Giy' °° H 8.44 
Phe96 CE2 131.36 Giy' °° HA2 3.60 
Phe96 CZ - Giy' °° HA3 4.47 
Phe96 N 118.94 Giy' °° C 172.02 
Phe97 H 9.72 GIy' °° CA 43.16 
Phe97 HA 4.85 Gly' °° N 116.74 
Phe97 HB2 2.87 Ser' ° ' H 8.15 
Phe97 HB3 2.90 Ser' ° ' HA 4.45 
Phe97 HD1 7.01 Ser' ° ' H132 3.41 
Phe97 HD2 7.01 Ser' ° ' H133 3.79 
Phe97 HE! 7.18 Ser' ° ' C 174.30 
Phe97 HE2 7.18 Ser' ° ' CA 58.09 
Phe97 HZ - Ser' ° ' CB 64.07 
Phe97 C 172.59 Ser' ° ' N 115.90 
Phe97 CA 56.12 Thr' °2 H 8.21 
Phe97 CB 42.44 Thr 102 HA 4.28 
Phe97 CD1 132.19 Thr 102 HB 4.54 
Phe97 CD2 132.19 Thr' °2 HG2 1.33 
Phe97 CE1 129.58 Thr' °2 C 174.70 
Phe97 CE2 129.58 Thr' °2 CA 63.47 
Phe97 CZ - Thr' °2 CB 69.57 
Phe97 N 120.96 Thr' °2 CG2 23.13 
Leu98 H 8.01 Thr' °2 N 111.56 
Leu98 HA 4.56 Thr' °3 H 7.57 
Leu98 HB2 1.39 Thr' °3 HA 5.06 
Leu98  1-1133 1.51 Thr' 03 HB 3.99 
Leu98 HG 1.09 Thr' °3 HGI 4.81 
Leu98 HD1 0.64 Thr' °3 HG2 1.08 
Leu98 HD2 0.40 Thr' °3 C 173.79 
Leu98 C 176.38 Thr!03 CA 59.49 
Leu98 CA 56.69 Thr' °3 CB 73.29 
Leu98 CB 43.88 Thr
103  CG2 21.35 
Leu98 CO 28.41 Thr
103  N 109.88 
Leu98 CD1 26.67 Ser' °4 H 8.05 
Leu98 CD2 25.59 Ser' °4 HA 4.56 
Leu98 N 126.50 Ser' °4 HB2 3.46 
lie99 H 9.13 Ser' °4 HB3 3.88 
Lie99 HA 4.22 Ser' °4 C 171.99 
175 
Residue 	. Atom Shift (ppm) Residue Atom Shift (ppn 
Ser' °4 CA 58.18 Gin' 09 HA 4.42 
Ser' °4 CB 64.71 Gin' 09 HB2 1.56 
Ser' °4 N 114.35 Gin' 09 14133 1.84 
Arg' °5 H 9.01 Gin' 09 HG2 2.14 
Arg' °5 HA 5.61 Gin' 09 HG3 2.14 
Arg' °5 HB2 1.65 G19 109 HE21 7.69 
Arg' °5 HB3 1.70 Gin' 09 HE22 6.13 
Arg' °5 HG2 1.33 Gin' 09 C 175.08 
Arg' °5 HG3 1.40 Gin' 09 CA 54.57 
Arg' °5 HD2 3.09 Gin' 09 CB 30.50 
Arg' °5 HD3 3.09 GIn' 09 CG 33.31 
Arg' °5 HE 7.02 GIn' 09 N 127.19 
Arg' °5 C 175.03 Gin' 09 NE2 111.00 
Arg' °5 CA 54.34 Asp' ° H 8.78 
Arg' °5 CB 34.52 Asp' ° HA 4.11 
Arg' °5 CG 27.65 Asp' ° HB2 2.61 
Arg' °5 CD 43.43 Asp' ° HB3 2.78 
Arg' °5 N 125.26 Asp' ° C 176.18 
Arg' °5 NE 84.71 Asp' ° CA 56.96 
Cys 106  H 8.39 Asp' ° CB 39.85 
'Cys' °6 HA 3.90 Asp' ° N 123.65 
Cys' °6 H132 1.62 Arg" H 8.11 
Cys 106  11133 2.62 Arg" HA 4.31 
Cys' °6 C 173.25 Arg" HB2 1.68 
Cys 106  CA 55.24 Arg" HB3 1.97 
Cys' °6 CB 38.81 Arg" HG2 1.54 
Cys' °6 N 126.17 Arg" HG3 1.54 
Glu' 07 H 9.10 Arg" HD2 3.12 
Giu' 07 HA 4.94 Arg" HD3 3.12 
Giu' °7 HB2 1.95 Arg" C 175.67 
GIu107  HB3 2.04 Arg" CA 56.09 
Giu' °7 HG2 2.27 Arg" CB 29.86 
Giu' 07 HG3 2.27 Arg" CG 27.10 
Glu' °7 C 174.76 Arg" CD 43.40 
Giu' °7 CA 54.15 Arg" N 118.67 
Giu' °7 CB 33.70 Giy" 2 H 7.74 
GIu' 07 CG 34.45 Giy" 2 HA2 3.96 
Giu' 07 N 131.22 Giy" 2 HA3 4.01 
Vai' 08 H 8.36 Giy" 2 C 173.12 
Val 108 HA 3.88 Giy" 2 CA 44.96 
Val 108 HB 1.86 GIy"2 - 	 N 109.33 
Val 108 HG1 0.70 Val' 3 H 8.15 
Val 108 HG2 0.79 Val' 3 HA 5.16 
Val 108 C 176.02 Val' 3 HB 1.89 
Val 108 CA 64.63 Val' 3 HGI 0.50 
Val 108 CB 31.81 Val' 3 HG2 0.42 
Vai' 08 CGI 22.60 Val' 3 C 175.52 
Val 108 CG2 21.41 Val' 3 CA 58.97 
Val 108 N 119.89 Val' 3 CB 34.58 
Gin' 09 H 8.06 Val' 3 CGI 22.61 
176 
Residue Atom Shift (ppm) Residue Atom Shift (ppr 
Val' 3 CO2 19.22 Pro' 8 HB2 2.01 
Val '' 3  N 115.95 Pro' 8  14133 2.25 
O!y" 4 H 8.88 Pro" 8 HG2 1.82 
GIy" 4 HA2 3.71 Pro" 8 HG3 2.03 
Gly" 4 HA3 3.86 Pro" 8 HD2 3.78 
Giy'' 4 C 171.28 Pro' 18 HD3 3.87 
G!y" 4 CA 45.02 Pro " 8 CA 61.71 
Gly" 4 N 109.92 Pro " 8 CB 32.67 
Trp" 5 H 8.02 Pro " 8 CO 26.52 
Trp" 5 HA 4.85 . 	 Pro' 8 CD 50.91 
Trp" 5 HB2 2.79 Leu" 9 H 7.87 
Trp'' 5 HB3 3.51 Leu'' 9 HA 3.36 
Trip 115 HDI 7.27 Leu" 9 HB2 1.21 
Trp'' 5 HE1 10.50 Leu'' 9 HB3 1.33 
Trp" 5 HE3 7.32 Leu" 9 HG 1.40 
Trp" 5 HZ2 7.16 Leu" 9 HD1 0.56 
Trp" 5  HD 6.85 Leu" 9 HD2 0.46 
Trp" 5 HH2 6.77 Leu" 9 CA 53.56 
Trp" 5 C 168.17 Leu" 9 CB 41.91 
Trp" 5 CA 56.46 Leu" 9 CO 26.90 
Trp" 5 CB 30.03 Leu" 9 CD1 25.55 
Trp" 5 CD! 126.79 Leu" 9 CD2 24.84 
Trp" 5 CE3 121.01 Leu" 9 N 119.27 
Trp" 5 CZ2 113.98 Pro' 20 HA 4.60 
Trp" 5 CZ3 122.93 Pro ' 2° HB2 1.66 
Trp" 5 CH2 123.87 Pro ' 2° 
 
1-1133 2.00 
Trp" 5 N 119.98 Pro 
120 
HG2 - 
Trp" 5 NE1 127.79 Pro' 
20 
HG3 - 
Ser" 6 H 9.73 Pro 
120 
HD2 2.04 
Ser" 6 HA 3.97 Pro' 
20 
HD3 2.19 
Ser" 6 HB2 3.69 Pro' 
20 
C 172.64 
Ser" 6 HB3 3.86 Pro' 
20 
CA 61.96 
Ser" 6 HG 4.63 Pro' 
20 
CB 32.72 
Ser" 6 C 174.78 Pro 
120 
CO - 
Ser" 6 CA 60.43 Pro' 
20 
CD 48.28 
Ser" 6 CB 62.77 Gin 121 H 7.97 
Ser" 6 N 120.63 Gin 
121 
HA 4.38 
His' 7 Fl 7.98 Gin 
121 
HB2 1.78 
His' 7 HA 5.34 Gin 
121 
HB3 1.92 
His' 7 HB2 3.13 Gin 
121 
HG2 2.17 
His' 7 HB3 3.36 Gin 
121 
HG3 2.17 
His' 7 HD2 - Gin 
121 
HE21 7.34 
His' 7 HE2 - Gin' 
21 
HE22 6.62 
His' 7 C 172.87 Gin 
121 
C 174.61 
His' 7 CA 52.68 Gin 
121 
CA 54.47 
His' 7 CB 31.03 Gin 
121 
CB 32.65 
His' 7 CD2 - Gin 
121 
CO 34.05 
His' 17 HE2 - Gin 
121 
N 112.71 
His' 17 N 117.85 Gin 
121 
NE2 111.38 
Pro " 8 HA 4.58 Cys 122 H 8.78 
177 
Residue Atom Shift (ppr 
Cys' 22 HA 5.27 
Cys 122 HB2 2.42 
Cys 122 HB3 2.76 
Cys 122 C 174.17 
Cys 122 CA 53.75 
Cys 122 CB 40.05 
Cys 122 N 121.54 
Giu' 23 H 9.10 
Giu' 23 HA 4.80 
Glu 123 HB2 1.47 
Glu' 23  1-1133 1.66 
Giu' 23 HG2 2.20 
Giu' 23 HG3 2.28 
Glu' 23 C 175.35 
GIu' 23 CA 54.02 
GIu' 23 CB 32.23 
Giu' 23 CG 34.82 
Giu' 23 N 125.85 
lie 124 H 8.66 
Ile 124 HA 3.60 
He' 24 HB 1.53 
Ile 124 HG12 0.83 
Ile' 24 HG13 1.10 
Ile 124 HG2 0.66 
lie 124 HD1 0.58 
Ile 124 C 175.62 
lie 124 CA 62.28 
Ile 124 CB 38.87 
Ile 124 CG1 28.52 
Ile 124 CG2 16.96 
Ile 124 CDI 13.41 
lie 124 N 124.90 
Leu' 25 H 7.83 
Leu' 25 HA 4.19 
Leu' 25 HB2 1.28 
Leu' 25 HB3 1.28 
Leu' 25 HG 1.26 
Leu' 25 HD1 0.63 
Leu' 25 HD2 0.66 
Leu' 25 C 176.93 
Leu' 25 CA 55.52 
Leu' 25 CB 42.69 
Leu' 25 CG 27.05 
Leu' 25 CDI 25.11 
Leu' 25 CD2 24.16 
Leu' 25 N 126.54 
Giu' 26 H 8.18 
Glu' 26 HA 4.09 
Giu' 26 HB2 1.78 
Giu 126 HB3 1.78 
Residue 	Atom 	Shift 
GIu' 26 HG2 2.09 
Glu' 26 HG3 2.09 
Giu' 26 C 176.21 
Giu 126 CA 56.65 
Giu' 26 CB 29.97 
Giu' 26 CG 35.69 
Glu' 26 N 121.97 
His' 27 H 8.33 
His 127 HA 4.50 
His 127 HB2 3.04 
His 127 HB3 3.04 
His 127 CA 55.47 
His 127 CB 28.98 
His 127 N 118.54 
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